Antimicrobial Activity and Effect of Selected Essential Oil Components on Cell Membrane Lipids by Ling, Valerie W
University of Tennessee, Knoxville
Trace: Tennessee Research and Creative
Exchange
Doctoral Dissertations Graduate School
12-2004
Antimicrobial Activity and Effect of Selected
Essential Oil Components on Cell Membrane
Lipids
Valerie W. Ling
University of Tennessee - Knoxville
This Dissertation is brought to you for free and open access by the Graduate School at Trace: Tennessee Research and Creative Exchange. It has been
accepted for inclusion in Doctoral Dissertations by an authorized administrator of Trace: Tennessee Research and Creative Exchange. For more
information, please contact trace@utk.edu.
Recommended Citation
Ling, Valerie W., "Antimicrobial Activity and Effect of Selected Essential Oil Components on Cell Membrane Lipids. " PhD diss.,
University of Tennessee, 2004.
https://trace.tennessee.edu/utk_graddiss/2347
To the Graduate Council:
I am submitting herewith a dissertation written by Valerie W. Ling entitled "Antimicrobial Activity and
Effect of Selected Essential Oil Components on Cell Membrane Lipids." I have examined the final
electronic copy of this dissertation for form and content and recommend that it be accepted in partial
fulfillment of the requirements for the degree of Doctor of Philosophy, with a major in Food Science and
Technology.
F. Ann Draughon, Major Professor
We have read this dissertation and recommend its acceptance:
P. Michael Davidson, Jochen Weiss, David C. White
Accepted for the Council:
Carolyn R. Hodges
Vice Provost and Dean of the Graduate School
(Original signatures are on file with official student records.)
 To the Graduate Council: 
 
I am submitting herewith a dissertation written by Valerie W. Ling entitled 
“Antimicrobial Activity and Effect of Selected Essential Oil Components on Cell 
Membrane Lipids.”  I have examined the final electronic copy of this dissertation 
for form and content and recommend that it be accepted in partial fulfillment of 
the requirements for the degree of Doctor of Philosophy, with a major in Food 
Science and Technology. 
 
                                      
   F. Ann Draughon 
Major Professor 
  
We have read this dissertation 
and recommend its acceptance: 
 
   P. Michael Davidson 
 
   Jochen Weiss 
 
   David C. White 
 
Accepted for the Council: 
                                                                             
  Anne Mayhew          
Vice Chancellor and 
Dean of Graduate Studies 
 
 
 
(Original signatures are on file with official student records.) 
 
  
 
ANTIMICROBIAL ACTIVITY AND EFFECT OF SELECTED ESSENTIAL OIL 
COMPONENTS ON CELL MEMBRANE LIPIDS 
 
 
 
 
 
 
 
 
 
 
 
 
A Dissertation 
Presented for the 
Doctor of Philosophy 
Degree 
The University of Tennessee, Knoxville 
 
 
 
 
 
 
Valerie W. Ling 
 
December 2004 
 
 
 ii
 
 
 
 
 
 
 
 
 
Copyright © 2004 by Valerie W. Ling 
All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
DEDICATION 
 
 
This dissertation is dedicated to my parents, Frederick and Linda Ling, and  
 
my sister, Wendy Ling Chin for their support, 
 
and my Heavenly Father for the dedication of His life to me. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv 
ACKNOWLEDGEMENTS 
 
 
 I wish to thank Dr. F. Ann Draughon for her professional and personal 
support and guidance.  She was the first person to inspire my interest in food 
safety and taught me invaluable information about food microbiology.  She is the 
best mentor and professor that any graduate student can have.  I appreciated all 
her encouragement and patience with me.   
 I extend thanks to my committee members, Dr. P. Michael Davidson, Dr. 
David C. White, and Dr. Jochen Weiss, for their time, technical expertise, and 
editing skills.  I am especially grateful for use of Dr. White’s Center for Biomarker 
Analysis lab and assistance from his staff.  Training from James Cantu, Amanda 
Smithgall, and Aaron Peacock from Dr. White’s lab were crucial to the lipids 
portion of my dissertation work.   
 I thank Carolina Naar, who helped me enormously with media preparation 
and Dr. Philipus Panglioli.  Their assistance during long days of experiments was 
invaluable.  I appreciated help from Willie Taylor with equipment and teaching me 
in lab techniques.  I valued the support of everyone in Dr. Draughon’s group: Kim 
Lamar, Min Huang, Andres Rodriguez, Omaima Ahmed, David Rasmussen, Jake 
Stevens, Andy Doane, Felix Jackson, and Dr. Harry Richards.  I thank Jason Noh 
and Katie Davenport, who helped me in the lab.   
 I’m grateful for my friends in Knoxville: Dr. Amy White, Shelley Woods, 
Jennifer Viar, Connelly Hull, and Dee Lewis.  The kindness, cheer, and prayers 
 v 
that they invested in me have brought refreshment and hope in a long and 
difficult journey.  They had strength and courage when I lacked them.   
 I thank my long-time friends Amy Hwang and Jennifer Tseung for their 
comfort and understanding.  I appreciate Mei Ran, for her lightheartedness and 
delicious meals, and friends that I met through Navigators, like Paul and Jane 
Slay.  I thank my new friends Mark Pate, Karen Ellison, and Dolly Fox who gave 
me an eternal perspective on trust, joy, and freedom.  From my friends I learned 
how to receive when people give gladly and how to give goodness to others. 
 I thank and honor my mom and dad, Frederick and Linda Ling, who have 
worked and sacrificed to ensure that I was well-fed and would receive an 
education at Cornell University and the University of Tennessee.  I respect and 
appreciate them for their care and love.  I appreciate my sister, Wendy Ling Chin, 
Doctor of Pharmacy candidate, for her thoughtfulness and support. 
 Most of all, I thank the Father, Son, and Holy Spirit.  His goodness 
became tangible to me through these aforementioned people.  I thank Him for 
renewing my strength and determination, despite setbacks (ex. power outages, 
A/C malfunctioning, and my lack of wisdom sometimes).  The Father has blessed 
me with intelligence and other talents and gifts.  I hope to continue to develop 
them and use them responsibly so that I may display His excellence and 
kindness as I care for others and my world, which is my goal and joy.  There is 
delight in learning and discovering the complexity He created in food and 
microbiology. 
 vi 
 “Trust in the Lord and do good; dwell in the land and enjoy safe pasture.  
Delight yourself in the Lord and he will give you the desires of your heart.  
Commit your way to the Lord; trust in Him and he will do this: He will make your 
righteousness shine like the dawn, the justice of your cause like the noonday 
sun.  Be still before the Lord and wait patiently for him.”  (Ps. 37:3-7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vii 
ABSTRACT 
 
The objectives of this study were to evaluate the antimicrobial activity of 
essential oil components (EOC) against Salmonella Typhimurium and Listeria 
monocytogenes and evaluate changes in bacterial membrane composition by 
observing changes in the fatty acids of Salmonella associated with exposure and 
adaptation to (or growth in the presence of) cinnamaldehyde (CIN) and carvacrol 
(CRV) EOC.   Ten EOC were tested for efficacy using the broth microdilution and 
macrodilution methods.  Beta -caryophyllene, limonene, alpha-pinene, and thymol 
were not lethal to Salmonella and Listeria at 2800mg/L.  Dose-response models 
showed that the most effective EOC against Salmonella were CIN and CRV 
(50% probability of lethality with avg. of 280mg/L and 1080mg/L, respectively) 
regardless of method.  CIN (790mg/L) and RHO (1810mg/L) were the most lethal 
against Listeria.  CIN- or CRV-adapted or non-adapted Salmonella were 
inoculated into broth containing 250mg/L CIN, 871mg/L CRV, or no EOC.  At 2 
and 24h, the saturated fatty acid (SFA) to unsaturated fatty acid (UFA) ratio in 
the membrane of CIN- or CRV-adapted cells treated with CIN or CRV was 
numerically higher than in the non-adapted cells treated with CIN or CRV.  
Significant (p<0.05) changes were observed with CIN or CRV exposure.  After 2h 
of exposure to CIN, the non-adapted CIN-treated cells had lower total 
phospholipid fatty acid (PLFA), lower C16:1w7c, and higher C18:0 and SFA than 
the non-adapted control.  After 24h of exposure to CIN, the non-adapted CIN-
treated Salmonella had lower Cy17:0 and Cy19:0 than the non-adapted control 
 viii 
and higher C16:0 and SFA.  Compared to the non-adapted control at 2h, the 
non-adapted CRV-treated Salmonella had lower PLFA, and lower C16:1w7c, 
Cy17:0, C18:1w9c, C18:1w7c, and UFA and higher C14:0, C18:0, SFA, and 
SFA/UFA ratio.  At 24h, the non-adapted CRV-treated cells had lower PLFA, 
Cy17:0, C18:1w7c, and UFA and higher C16:1w7c and SFA than the non-
adapted control.  Antimicrobial treatment appeared to decrease the fluidity of the 
Salmonella membrane by increasing SFA.  This decreased fluidity may prevent 
additional CIN and CRV from permeating.  Growth in the presence of the 
antimicrobial had a much smaller effect on the fatty acid composition.  Additional 
measurement of the membrane transition temperature from gel-to-liquid-
crystalline phase would indicate fluidity.   
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Introduction 
 
In 2003 there were only 15,600 cases of foodborne infections that were 
diagnosed in laboratories (CDC 2004).  The number of cases caused by 9 
identified pathogens was: 6,017, Salmonella; 5,215, Campylobacter; 3,021, 
Shigella; 480, Cryptosporidium; 443, E. coli O157; 161, Yersinia; 138, Listeria; 
110, Vibrio; and 15, Cyclospora.  Of the 5,455 (91%) Salmonella isolates 
serotyped, S. Typhimurium (759 cases) was the serotype most often isolated and 
identified in human salmonellosis cases (14% o f foodborne salmonellosis 
infections).  Although 15,600 foodborne bacterial infections were diagnosed in 
2003 (CDC 2004), it is estimated that there are over 2 million cases of 
salmonellosis and 1600 cases of listeriosis that occur in the U.S. each year 
(FDA-CFSAN 2003a, b).   
The prevalence of L. monocytogenes in meats was found to be highly 
variable with about 16% of products testing positive from 1971-1994.  L. 
monocytogenes serotype 4b has most often been associated with human 
listeriosis outbreaks (Jay 1996).  A more recent study found that 577 of 31,700 
samples of ready-to-eat foods tested positive for L. monocytogenes (prevalence 
of 1.82%) (Gombas and others 2003).  The latest multistate outbreak of listeriosis 
was in the northeastern U.S. in 2002 with 46 confirmed cases and seven deaths 
(CDC 2002).  Listeriosis is a concern because of the high mortality rate, which 
can be as high as 70% when listeric meningitis occurs or more than 80% with 
perinatal/neonatal infections (FDA-CFSAN 2003b). 
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Characteristics of Gram-positive and negative membranes  
 L. monocytogenes is a Gram-positive bacterium.  The Gram-positive cell 
has an open, hydrophilic structure.  It contains a thick and hydrated 
peptidoglycan (PG) layer, which forms 90% of the cell wall.  The PG layer is 
covalently bonded to teichoic acids.  Teichoic acids are acidic anionic 
polysaccharides that give the cell wall a net negative charge.  Teichoic acids bind 
cations such as Ca2+ and Mg2+.  Lipoteichoic acid is a type of teichoic acid, which 
has a glycerophosphate chain that is exposed on the cell surface at one end.  At 
the other end, lipoteichoic acid is covalently linked to a glycolipid situated on the 
outer side of the cytoplasmic membrane.  This glycerophosphate chain extends 
through the cell wall.  Important proteins that have a role in interacting with the 
environment are covalently and noncovalently linked to the PG layer.  
Teichuronic acids, which replace teichoic acids when phosphate concentrations 
are low, have carboxylate groups that carry a negative charge (Atlas 1995a; 
Lambert 2002).   
The PG layer allows the penetration of molecules with a molecular weight 
of 30,000 to 57,000 Da.  Phenols, alcohols, aldehydes, and quaternary 
ammonium compounds, which are small, can permeate readily.  The permeability 
of the cell wall may depend on the chemical structure of the PG layer, such as 
the extent of cross-linking and glycan chain length (Lambert 2002).   
S. Typhimurium is a Gram-negative bacterium.  The Gram-negative cell 
wall is complex and has multiple layers.  The outer membrane, a thin PG layer, 
and the periplasmic space form the outer layer of the cell wall.  The periplasmic 
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space is between the PG layer and the cytoplasmic membrane.  The outer 
membrane contains lipopolysaccharide (LPS), phospholipids, and proteins, such 
as porins (Atlas 1995a).   
The exterior layer of the outer membrane contains LPS that carries a net 
negative charge.  The innermost part of the LPS is lipid A that attaches the LPS 
to the hydrophobic section of the outer membrane.  Lipid A is a N-
acetylglucosamine disaccharide linked to unusual fatty acids, such as caproic 
and lauric acids.  External to the lipid A is the central core polysaccharide, which 
is a complex polysaccharide, and an outermost polysaccharide layer called the 
O-antigen that extends into the environment.  The negatively charged core of 
LPS is stabilized by Ca2+ and Mg2+ cations that crosslink the LPS (Atlas 1995a).   
On the interior of the outer membrane is a layer of phospholipids, which 
consist of a phosphate polar head covalently bonded to a glycerol backbone, 
which is ester-linked to two fatty acids.  Interior to the inner layer of phospholipid 
is the periplasmic space (Atlas 1995a).  This space contains nutrient binding 
proteins and lipoproteins, which have a fatty acid portion that associates with 
phospholipids of the outer membrane and a protein region that is bonded to the 
PG layer.  This space contains proteins that create an active metabolic center 
within the cell.  Interior to the PG is the cytoplasmic membrane consisting of a 
phospholipid bilayer with embedded proteins, such as enzymes and efflux 
proteins (Denyer and Maillard 2002).  The cytoplasmic membrane has an 
important role in maintaining energy status, solute transport, and regulation of the 
intracellular environment.  Homeostasis is mostly affected by the fluidity of the 
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cell membrane.  Changes in the lipid composition of the cytoplasmic membrane 
occur in response to external stimuli to maintain a relatively constant fluidity 
(Sikkema and others 1995).  Membrane fluidity is the “combined expression of 
the effects of [fatty acid] chain conformation, lateral and rotational diffusion [of the 
lipids within the membrane] and the resistance of the membrane to sheer forces” 
(Denich and others 2003). 
 Porins are hydrophilic channels within the outer membrane that allow the 
diffusion of small hydrophilic molecules with a molecular weight of up to 800 Da 
for E. coli (Atlas 1995a; Denyer and Maillard 2002).  Tightly packed LPS in 
membrane of the Gram-negative cell is the cause of the very low permeability of 
the outer membrane to hydrophobic compounds.  In contrast, the cytoplasmic 
membrane has a low permeability for polar and charged molecules, except for 
water.  Apolar molecules, such as cyclic hydrocarbons, can pass easily.  
Permeability of the cytoplasmic membrane depends on the hydrophobicity of the 
molecules.  These hydrophobic molecules partition into the cytoplasmic 
membrane and accumulate or are metabolized (Sikkema and others 1995).   
The oil:water partition coefficient is the ratio of the concentration of a 
substance in oil and in water at equilibrium and at a specified temperature.  The 
optimal oil:water partition coefficient (log P) for Gram-negative and Gram-positive 
bacteria is 4.0 and 6.0 for the oil phase, respectively.  Aromatic solvents with a 
log P of 2.0 - 4.0 changed the cytoplasmic membrane organization in Gram-
negative bacteria (Denyer and Maillard 2002).  Carvacrol (CRV), a component 
found in oregano and thyme essential oils, has a log P of 3.6, and prefers to 
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partition to a nonpolar solvent rather than water (Ultee and others 2002).  
Therefore, CRV may be more effective against Gram-negative bacteria since the 
optimal log P of Gram-negative bacteria is closer to that of CRV. 
Because Gram-positive bacteria have a more permeable cell wall they are 
more susceptible to antibiotics than Gram-negative bacteria, which has the thick 
outer LPS layer as a permeability barrier.  Gram-positive organisms seem to be 
more sensitive to lipophilic compounds than Gram-negative organisms because 
of their lack of an outer membrane.  Since LPS of the outer membrane is highly 
hydrophilic, small hydrophilic solutes may pass through the porins, but the outer 
membrane acts as a barrier to most hydrophobic compounds (Sikkema and 
others 1995; Lambert 2002).   
Essential oils and components 
Natural antimicrobials, such as herbs and spices, have been used for 
centuries to preserve and flavor food.  Today, consumers desire high-quality, 
minimally processed foods that have fewer preservatives and an extended shelf-
life (Brul and Coote 1999).  Essential oils, which are obtained from plants by 
extraction or distillation, contain flavor, aroma, and antimicrobial components.  
They are used mainly for flavoring agents.  Herbs, spices, and their components 
are Generally Recognized As Safe food ingredients under conditions of 
customary use (Ultee and others 1998).  Studies have reported cinnamon, clove 
and mustard to be highly active against various microorganisms.  Other inhibitory 
herbs and spices include allspice, bay leaf, caraway, coriander, cumin, oregano, 
rosemary, sage and thyme (Zaika 1988).  Carvacrol, the bioactive component 
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found in oregano and thyme essential oils, is used to flavor baked goods, 
nonalcoholic beverages, and chewing gum (Ultee and others 1999).  Eugenol 
and cinnamic aldehyde are used as flavorings in candies and baked goods (Kim 
and others 1995).   
Antimicrobial activity of essential oils 
 In the past two decades, many studies have reported the inhibitory and 
lethal effects of essential oils tested against a wide variety of microorganisms in 
various media and food products.  In studies that compared various essential 
oils, the most effective oils against bacteria were thyme, oregano, cloves, 
cinnamon, lemongrass and bay (Deans and Ritchie 1987; Hammer and others 
1999).  For example, 0.03% (v/v) thyme and 0.12% oregano essential oils 
inhibited the growth of Escherichia coli.  However, comparison of the efficacy of 
various oils is complex because their composition varies among the different 
plant genera as well as within the same genus.  Variation in composition of active 
components may result from geographic origin, climate, processing, and variety 
differences (Zaika 1988).  Carvacrol and thymol, which are bioactive constituents 
in oregano essential oil, are present in different percentages in various species of 
Origanum. 
Antimicrobial activity of essential oil components 
 The study of essential oil components (EOC) produces more useful data 
about their mechanism than essential oils, which vary in their composition of 
components.  Table 1.1 describes selected essential oils and their major 
antimicrobial components.  Evaluation of these components may present 
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Table 1.1.  Plants and their bioactive components (Bauer and others 1997). 
 
 
problems because of the low water solubility of components, such as thymol, 
carvacrol (CRV), eugenol, and trans-cinnamaldehyde (CIN) (Griffin and others 
1999).  The minimum inhibitory concentration (MIC) of CRV, CIN, and thymol 
against S. Typhimurium were 150, 396, and 150 mg/L, respectively, using the 
broth macrodilution method (Helander and others 1998).  Eugenol was found to 
inhibit the growth of E. coli O157:H7 and L. monocytogenes at 1000 mg/L 
(Blaszyk and Holley 1998).  The concentration of CIN needed to achieve a 50% 
decrease in 1,500-2000 CFU/well of E. coli O157:H7, S. enterica Hadar, and L. 
monocytogenes was 600, 400, and 100 mg/L, respectively (Friedman and others 
2002).  Although there have been several studies to investigate the efficacy of 
some common constituents of essential oils, there are limited studies that 
examine the mechanism of inhibition of essential oil constituents.   
Main food-related plant source  Bioactive component Base structure  
Origanum and thyme oils Carvacrol Phenol 
Clove oil Beta-caryophyllene Cyclic sesquiterpene hydrocarbon 
Cassia and cinnamon bark oils Cinnamic aldehyde Aromatic unsaturated aldehyde 
Clove and cinnamon leaf oils Eugenol Phenol 
Citrus peel and caraway oils Limonene Cyclic terpene hydrocarbon 
Sweet basil and sage oils Linalool Acyclic terpene alcohol 
Rose and geranium oils Rhodinol Acyclic terpene alcohol 
Rosemary oil Alpha-pinene Bicyclic terpene hydrocarbon 
Origanum and thyme oils Thymol Phenol 
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Antimicrobial activity assay 
A broth dilution assay is a type of invitro method that is conducted when 
quantitative results are needed (Parish and Davidson 1993).  A range of 
concentrations of antimicrobials is prepared in non-selective broth.  Consecutive 
two-fold dilutions are typically prepared in clinical microbiology, but arithmetic 
intervals may be used as well.  A single concentration is dispensed into a tube 
(broth macrodilution) or a lane in a microtiter plane (broth microdilution).   
The test vessel is incubated with the test organism usually for 16-24 hours 
at the optimum temperature of the organism (Parish and Davidson 1993).  The 
test vessel is observed for the lowest concentration at which there is no turbidity 
or no growth.  This is called the minimum inhibitory concentration (MIC).  To 
determine the minimum lethal or bactericidal concentration (MLC or MBC), 10-
100 ul are plated from the last tubes or wells with growth and all those with no 
growth.  The MLC or MBC is the lowest concentration that results in >99.9% 
killing of the final inoculum (NCCLS 1993).   
Four factors that affect results of antimicrobial tests are the test method, 
medium, microorganism, and antimicrobial (Zaika 1988; Parish and Davidson 
1993).  Common test mediums include water, microbiological media such as 
broth and agar, foods, beverages, or food systems with defined composition.  
The pH is of particular importance since the activity of organic acids, such as 
benzoic acid depends on the acid being in its undissociated form, which allows 
the antimicrobial to penetrate the cell membrane more easily (Parish and 
Davidson 1993).  Most EOC are slightly soluble in aqueous systems like broth, at 
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best (Zaika 1988).   Therefore, evaluation of EOC may present problems, such 
as visibility of growth end-points.   
The application of the spice or component may include various 
concentrations and botanical compositions.  The form of the spice may be 
ground, extract, infusion, or essential oil.  EOC, such as CRV, are available 
commercially in liquid or in crystalline form.  The antimicrobial activity may be 
detected by applying the component to agar with a paper disk or in a cup or 
mixed with the test medium (Zaika 1988).  The solubility of the essential oil or 
component and method of preparing stock solutions of the oil or component may 
influence antimicrobial activity.  Assay methods have different sensitivity as well 
(Friedman and others 2002).  An antimicrobial could be effective in media but 
exhibit lower antimicrobial activity in food, such as in high fat foods in which the 
antimicrobial may partition into the food lipids (Zaika 1988).    
Characteristics of the organism are important factor influencing results.  
Strains may vary in genotype and phenotype (Parish and Davidson 1993).  
Microorganisms that are antibiotic resistant are a concern since antibiotic 
treatment for serious infections may be useless if the microbe is resistant.  
Microorganisms may be tested in the form of vegetative cells or spores (Zaika 
1988).  The inoculum can be directly applied to the agar surface or mixed with 
the medium.  Actively growing cells in the log phase are more sensitive than 
stationary-phase cells or spores (Parish and Davidson 1993).  A higher inoculum 
size (log 7 or 8) of log-phase cells are more rapidly killed than a stationary-phase 
inoculum diluted to low inocula (log 4) (NCCLS 1993).  Although population size 
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and growth phase independently influence the rate of lethality, the inoculum size 
will have the greatest effect on results (NCCLS 1993).  The National Committee 
for Clinical Laboratory Standards (NCCLS) suggests an inoculum of log 5.7 for 
testing aerobic bacteria using broth dilution assays.  Studies of essential oils and 
components are difficult to compare since a variety of assays have been used to 
evaluate antimicrobials, but there is no standardized test method or format for 
reporting assay results of antimicrobial activity of essential oils (Friedman and 
others 2002).   
Mechanisms of inhibition by changes in membrane function  
Concentrations of essential oils that are lethal to bacteria tend to be much 
higher than tolerable taste thresholds.  However, essential oils can be used at 
lower inhibitory concentrations (Brul and Coote 1999).  Knowledge about the 
mechanism of action of antimicrobials is needed to effectively combine 
antimicrobial additives and food processing technology to prevent food from 
spoilage and growth of pathogenic microorganisms without sacrificing 
organoleptic qualities. 
The mechanism of action of some antimicrobials, such as CRV, is the 
disruption of the cytoplasmic membrane, which leads to a decrease in the proton 
motive force of the bacterial cell (Ultee and others 2002).  The energy for cell 
processes is generated from a proton motive force (or hydrogen ion gradient), 
which is established by the separation of protons across the cytoplasmic 
membrane.  During metabolism, the cell translocates protons out of the 
cytoplasmic membrane that creates an excess of hydrogen ions and positive 
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charges outside of the membrane.  The concentration and electrical differences 
between the inside and outside of the cell across the cytoplasmic membrane 
produce the proton motive force, which consists of the proton potential (or pH 
gradient) and electrical (or membrane) potential.  Protons cannot diffuse across 
the cytoplasmic membrane.  They can only pass into the cell again through a 
specific proton channel, ATPase.  As protons pass through the channel, ATPase 
catalyzes the conversion of ADP to ATP to provide energy for the cell to do other 
work (Atlas 1995b). 
The interaction of lipophilic compounds with the bacterial membrane 
affects the structure of the cytoplasmic membrane, which may increase the 
passive proton (ion) flux across the membrane.  The leakage of protons 
decreases the proton gradient and therefore dissipates the proton motive force.  
Lipophilic compounds, such as CRV and ethanol, have been associated with 
ATP depletion (Sikkema and others 1995; Ultee and others 1999).  
CRV partitions into the cytoplasmic membrane.  Ultee and others (1999) 
investigated the mechanisms of action of CRV when it was added to a Bacillus 
cereus cell pellet suspended in buffer.  Viable cell numbers decreased 
exponentially when vegetative B. cereus cells were incubated for 30 min with 150 
- 451 mg/L CRV.  This reduction was related to a change in the membrane 
potential.  CRV (2 mg/L) significantly decreased the membrane potential and 
dissipated the potential at concentrations greater than 23 mg/L.  CRV (38 mg/L) 
reduced the pH gradient and dissipated the gradient at 150 mg/L and higher.  
The intracellular potassium pool decreased and extracellular potassium pools 
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increased with 150 mg/L CRV.  Within 7 min, 300 mg/L CRV depleted the 
intracellular ATP pool without a proportional increase in extracellular ATP.  It was 
concluded that CRV acted at the cytoplasmic membrane to increase permeability 
to protons and potassium ions.   
CRV and thymol totally disrupted the outer membrane of E. coli O157:H7 
and S. Typhimurium as indicated by increased uptake of 1-N-
phenylnaphthylamine (NPN), which is a probe that fluoresces in a hydrophobic 
environment, and the release of LPS.  Uptake occurred since the membrane was 
no longer acting as a strong permeability barrier.  CRV (300 mg/L) disrupted the 
cytoplasmic membrane since it decreased the intracellular ATP pool and induced 
a small, but not proportional increase, in the extracellular ATP pool of E. coli 
O157:H7.  Changes that occurred with thymol were similar, but less prominent.  
This indicates that they had a measurable effect on the cytoplasmic membrane.  
CIN did not affect NPN uptake and did not significantly affect intracellular or 
extracellular ATP (Helander and others 1998).   
Therefore, it appears that the mechanism of action of CIN is not 
associated with an increase in permeability of the cell membrane.  CIN is an 
aromatic aldehyde.  It has been suggested that the carbonyl group of aldehydes 
can bind to metal ions, sulfhydryl groups, amino acids, and proteins (Bowles and 
Miller 1993).  CIN was found to be an effective inhibitor of histidine 
decarboxylase activity of Enterobacter aerogenes.  Therefore it was suggested 
that binding of the CIN carbonyl group to the decarboxylase protein resulted in 
loss of decarboxylase activity (Wendakoon and Sakaguchi 1995).   
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Ramos-Nino and others (1996) developed multiple regression equations 
that described the effects of physicochemical and structural properties of 
benzaldehyde and benzoic and cinnamic acids on antibacterial activity.  Steric 
parameters contributed more to benzaldehyde activity, while lipophilicity and 
ionization (pKa) parameters did not.  Therefore, benzaldehyde was suggested to 
act on the outside of the cytoplasmic membrane.  In contrast, lipophilicity and pKa 
of benzoic and cinnamic acid contributed most to their activity.  They also found 
that the greater the molecular size of the aldehyde, the lower the antibacterial 
activity (Ramos-Nino and others 1996).  This is the opposite of organic acids, 
which show increased antimicrobial activity with increased chain length (Jay 
2000).  
One study found that CIN at 0.3 ml/L was lethal to B. cereus cells but no 
significant amount of protein was lost.  It was reported that treatment with CIN 
caused exponential phase cells to become long and filamentous and inhibited 
them from separating from each other (Kwon and others 2003).   
Mechanisms of inhibition by changes in lipids 
 Lipophilic compounds, such as EOC, partition in the lipid bilayer 
membrane of microorganisms.  The polarity of the compound determines where 
it accumulates in the membrane.  Different compounds have preferential 
accumulation sites and cause different perturbations of the membrane.  
Accumulation of the compound correlates with its lipophilicity (Sikkema and 
others 1995). 
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 Lipophilic molecules disrupt the interaction between lipids molecules and 
the membrane proteins (enzymes) that they border.  These compounds may 
interact with hydrophobic regions of the enzymes.  The interaction of these 
compounds affect fluidity and fatty acid composition of the bacterial membrane, 
which regulates the activity of membrane-embedded enzymes.  This interaction 
can also change protein conformation.  It has been proposed that the 
accumulation of lipophilic molecules in the membrane disrupts lipid-protein and 
lipid-lipid interaction, leading to toxicity (Sikkema and others 1995).   
 Bilayer membranes can exist in three phases: gel (ordered lipid chains), 
liquid-crystalline (disordered lipid chains) and hexagonal II (Ultee and others 
2000b).  Bacterial responses to the accumulation of hydrophobic compounds are 
an attempt to: 1) maintain a sufficient ratio of liquid-crystalline lipid in the 
membrane to restore membrane fluidity, 2) keep a balance between 
phospholipids that facilitate or do not promote a bilayer, and 3) extrude the 
hydrophobic compound through drug efflux systems.  The fluidity of the 
membrane affects the growth of the cell and the proper functioning and structural 
integrity of the membrane (Denich and others 2003).  For example, the 
percentage of unsaturated fatty acids in E. coli phospholipids is usually about 
50%.  This percentage can decrease to 30% without ceasing bacterial growth.  If 
the percentage of saturated fatty acids decreases to less than 15% the 
membrane permeability increases (Seltmann and Holst 2002). 
 Cells adapt to hydrophobic compounds by changing the fatty acid 
composition (type of branching, chain length, and degree of unsaturation) and by 
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changing the phospholipid head-group composition (Ultee and others 2000a).  
The changes in bacterial lipids in the membrane are a defense mechanism used 
to maintain optimal fluidity in the liquid-crystalline phase, which is required for 
important cell processes.  Lipids directly affect passive permeability and indirectly 
affect cell processes because of their interactions with membrane proteins 
(Russell and others 1995).   
 A modified fatty acid composition affects the lipid membrane melting point, 
which influences membrane fluidity (Li and others 2002).  For example, the 
melting point of unsaturated fatty acids and branched-chain fatty acids is lower 
than that of saturated fatty acids.  Therefore an increase in these fatty acids 
causes a decrease in the phase transition temperature and an increase in 
membrane fluidity (Casadei and others 2002).  Fatty acids with high melting 
points, such as saturated, long, and straight-chain fatty acids, decreases 
membrane fluidity (Juneja and Davidson 1993).     
Changes in the fatty acid composition are influenced by various 
environmental factors such as growth temperature and pressure (Casadei and 
others 2002; Li and others 2002).  At decreasing temperatures the lipids in the 
membrane become ordered and the regions consisting only of lipids partly 
separate from the regions rich with proteins (Seltmann and Holst 2002).   
Changes in fatty acid composition of bacterial membranes have also been 
studied in the presence of various antimicrobials, such as nisin (Mazzotta and 
Montville 1997; Li and others 2002), sodium chloride, tertiary 
butylhydroxyquinone, methyl paraben, and propyl paraben (Juneja and Davidson 
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1993), acidulants (Juneja and others 1998), and phenolic compounds (acid 
phenols and tannins) (Rozes and Peres 1998).  Phenolic compounds were 
shown to increase membrane fluidity, which influences membrane permeability 
(Diefenbach and Keweloh 1994).   
Post and Davidson (1986) reported a relationship (R=0.89) between the 
ratio of saturated to unsaturated fatty acids (SFA /UFA) in the total lipid fraction 
of the membrane of Gram-positive bacteria (S. aureus, B. cereus, and C. 
perfringens) and susceptibility to butylated hydroxyanisole (BHA).  SFA/UFA ratio 
in Gram-negative bacteria (P. fluorescens, P. fragi, E. coli, and S. “anatum”) was 
not related to their susceptibility.  The highest SFA/UFA ratio was found in the 
two most resistant strains, which were S. aureus 12600 and LP (LD90 =293 and 
304 mg/L BHA, respectively).  C. perfringens was the most susceptible (LD90 
=110 mg/L BHA) and had the lowest SFA/UFA ratio.  It was suggested that the 
higher SFA/UFA ratio increased the ordering of fatty acid alkyl chains, which 
enhanced resistance.  There was no relationship found between susceptibility 
and individual fatty acids or SFA/UFA ratios of the polar lipid fraction. 
S. aureus LP was more resistant to methyl:propyl (2:1) paraben (MIC = 
900 mg/L), which is a phenolic compound, and had a higher percentage of total 
lipid than sensitive S. aureus strains (Bargiota and others 1987).  This resistant 
strain also had lower cyclopropyl 17:0 and cyclopropyl 19:0 than sensitive 
strains.  It was suggested that parabens partition into the membrane lipids.  This 
absorption into the lipids may protect the cells from additional penetration.  A 
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decrease in cyclopropyl fatty acids may lower the permeability or interaction of 
parabens by affecting membrane fluidity. 
Keweloh and others (1991) also found that phenolic compounds increase 
the permeability of the cell membrane.  This study concluded that sublethal 
concentrations of phenol in the g rowth medium for 3 hours impaired cell growth 
and caused an increase in the saturated to unsaturated fatty acid ratio (increase 
in 16:0 and decrease in 16:1 and 18:1) in the exponential growth phase, which 
decreased the fluidity of the E. coli K-12 membrane.  The authors suggested that 
this decrease in fluidity was a defense mechanism to decrease the damage by 
phenol.  Additional phenol molecules would not reach the lipid bilayer to disrupt it 
as easily because of tightly packed acyl chains in the more saturated membrane.  
The increase in saturation would also reduce leakage of cellular metabolites.   
When Pseudomonas putida adapted to phenol, the fatty acids converted 
from cis- to trans- form.  Since this conversion increased membrane ordering, the 
membrane fluidity decreased (Heipieper et al., 1992; Sikkema et al., 1995).  Cis-
trans conversion also occurred in bacteria deprived of nutrients.  The trans/cis 
ratio may be applied as an indication of starvation or stress (Guckert et al., 1986; 
Sikkema et al., 1995).   
EOC, such as CRV, disrupt the membrane (Brul and Coote 1999).  In 
liposomes prepared from E. coli phospholipids, cyclic hydrocarbons, such as 
alpha-pinene (9300 mg/L), accumulated in the bilayer interior, which caused 
swelling of the bilayer and therefore increased bilayer surface area (Sikkema and 
others 1994).  The accumulation disrupted interactions between the acyl chains, 
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leading to increased membrane fluidity.  It also caused decreased activity of 
cytochrome c oxidase and increased permeability to protons, which decreased 
the proton motive force.  Cytochrome c oxidase is a membrane enzyme.  The 
partitioning of the hydrocarbon into the cytoplasmic membrane may have caused 
the enzyme activity to decrease.  This partitioning may have changed the 
interactions between proteins and lipids, thickness of the membrane, membrane 
fluidity, and/or phospholipid headgroup hydration (Sikkema and others 1994).   
 It has been suggested that CRV occupies more area than the typical 
space between the fatty acid chains of two adjoining phospholipid molecules.  
This interferes with the van der Waal interactions between the chains and 
therefore increases fluidity (Ultee and others 2000b; Ultee and others 2002).  If 
the membranes become too fluid, additional CRV can continue to permeate the 
membrane, accumulate, and cause more damage (Ultee and others 1998).   
Ultee and others (2002) reported that CRV expanded model liposomal 
membranes using fluorescent probes.  They suggested that this swelling leads to 
a destabilized membrane and therefore a leakage of ions.  The phenolic hydroxyl 
group of CRV is required for its antimicrobial activity since structurally similar 
compounds were not as inhibitory.  Since Griffin and others (1999) categorized 
CRV in a group of oxygenated terpenoids of high antimicrobial activity associated 
with higher hydrogen binding capacity, this hypothesis is reasonable.  Also, 
during exposure to CRV an influx of H+ and efflux of K+ ions in B. cereus was 
reported.  The leakage of ions led to a drop in the pH gradient, destruction of the 
membrane potential and depletion of intracellular ATP (Ultee and others 1999).   
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Adaptation 
If a factor or condition negatively influences bacterial growth or survival, it 
is considered a stress (Yousef and Courtney 2003).  Mild or sublethal stresses 
are those that slow or stop bacterial growth without affecting viability.  Stresses 
that cease growth and result in some loss of viability are defined as moderate.  
Extreme or severe stresses cause lethality to a majority of the bacterial 
population.  Stresses affecting bacterial growth or survival may be physical, 
chemical, or biological.  
When bacterial cells detect stresses that affect membrane fluidity, cell 
protein structure, ribosomes, or nucleic acids, they respond both genetically and 
phenotypically.  This response involves transcription that results in regulatory 
proteins being synthesized.  Production of regulatory proteins may lead to 
synthesis of other proteins that deal with the stress.  Stress adaptation includes 
“1) production of proteins that repair damage, maintain the cell, or eliminate the 
stress agent, 2) transient increase in resistance or tolerance to deleterious 
factors, 3) cell transformation to a dormant state, 4) evasion of host organism 
defenses, and 5) adaptive mutations” (Yousef and Courtney 2003). 
According to Yousef and Courtney (2003), stress adaptation is an 
“increase of an organism’s resistance to deleterious factors following exposure to 
mild stress.”  In the food processing environment and in foods, pathogens are 
frequently exposed to sublethal stresses.  When a microorganism is exposed to 
these stresses it may respond to protect itself, or adapt, to increase its tolerance 
to the same or different type of stress.  Other terms for adaptation include 
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adaptive response, induced tolerance, habituation, acclimization, and stress 
hardening.   
The ability of an organism to survive a stress is defined as tolerance, 
which is similar to resistance.  When a microorganism is adapted to a stress, it 
may also resist a similar or different stress that was previously lethal or injurious 
to the cell (Yousef and Courtney 2003).  For example, heating raw milk at 
temperatures below pasteurization may cause bacteria to adapt to mild heat.  
When the milk is used to make cheese, the bacteria are highly resistant to further 
heat processing.  Therefore, adaptations to sublethal stresses are important to 
public health. 
Mechanism of stress response 
Stress responses depend on the stress and bacterial species.  
Microorganisms respond to stress immediately due to a sudden experience of 
stress or adapt to the stress over the long-term.  To respond, a microorganism 
must sense a stress through a sensor such as a lipid, protein, or nucleic acid.  A 
microorganism detects a stress when the stress affects the folding of mRNA, a 
change in a protein’s half-life or structure, alterations in cellular metabolites, and 
changes in the membrane structure or fluidity.  The sensor causes a change in 
transcription or translation of stress-related proteins, which alter cell physiology 
to increase tolerance (Yousef and Courtney 2003).   
The response can be general, which protects against various stresses, or 
specific.  Numerous changes in cell physiology, such as changes in cell envelope 
composition and morphology, are caused by the general stress response.  This 
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results in decreased growth rate and entry into the stationary phase.  General 
stress response is controlled by sigma factors in E. coli and other Gram-negative 
bacteria (Yousef and Courtney 2003). 
Microorganisms have been shown to respond to heat, cold, acid, osmotic 
stress, and oxidative stress (Yousef and Courtney 2003).  One of the changes in 
response to cold is a major alteration of the fatty acid composition of lipids in the 
bacterial membrane to increase membrane fluidity.  To increase fluidity in 
response to cold temperatures, bacteria increase unsaturation or decrease the 
chain length.  Only minor changes occur in the head-group composition (Russell 
and others 1995).   
 Monitoring stress response in research can be useful.  The effect of mild 
stresses may reveal if the organism becomes resistant or sensitized to further 
stress.  Adaptation is best observed at sublethal levels and during the 
exponential phase of growth, although adaptation has been induced in the 
stationary phase (Yousef and Courtney 2003).  Research on the mechanisms 
and effects on the membrane lipids by food antimicrobials will add to the 
knowledge needed to keep foods safer yet minimize the use of additives and 
processing (Russell and others 1995).  
 CRV is lipophilic and was shown to accumulate and expand membranes 
treated with CRV.  This swelling may cause a destabilized membrane in B. 
cereus.  Swelling increased fluidity as indicated by a decrease in the temperature 
at which the membrane transitions from gel to liquid-crystalline phase (Tm).  This 
led to increased passive permeability and therefore a leakage of ions.  In 
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contrast, growth of B. cereus cells in the presence of 60 mg/L CRV reduced the 
membrane fluidity since the Tm was higher than non-adapted control cells (Ultee 
and others 2000a).    
 In the same study, iso-C13:0 and iso-C15:0 fatty acids increased in the 
membrane lipid composition of B. cereus cells incubated with 60 mg/L CRV while 
cis-C16:1 fatty acid decreased.  These changes correlated with a decrease in 
membrane fluidity of cells adapted to CRV.  However, the decrease in long chain 
fatty acids (C18:0) did not correlate with the decrease in fluidity.  Therefore, more 
information is needed to understand these changes.  Cells adapted to CRV had 
additional phospholipids compared to non-adapted cells.  There were no 
noticeable differences in proportions of phosphatidylethanolamine (PE), 
diphosphatidylglycerol (DPG), and phosphatidylglycerol (PG) (Ultee and others 
2000b). 
 Further information is needed about the targets of essential oil 
components.  For example, since CRV accumulates in the membrane specific 
information about where it inserts itself in the membrane may elucidate how CRV 
may affect lipid-lipid and protein-lipid interactions.  Responses to antimicrobials, 
such as a change in fatty acid composition, should be determined as to whether 
they enhance cell survival (adaptive response) or present evidence of toxicity. 
 Herbal or botanical antimicrobials offer an exciting new array of chemicals, 
which may help to make foods safer by inhibiting growth of pathogenic bacteria.  
Some herbs and essential oils have been used for thousands of years for both 
flavoring and medicinal purposes.  It is only now that we are beginning to 
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understand the physiological activity of essential oils at the cellular level.  
Information is needed on the mechanism and mode of action of herbal 
antimicrobials to safely and economically use these powerful chemicals to not 
only flavor foods but also to ensure safety and preservation. 
 Research objectives 
 The objectives of this research were to: 
1) Evaluate the antimicrobial activity of ten essential oil components 
against L. monocytogenes and S. Typhimurium 
2) Compare results between the macro- to microdilution methods within an 
essential oil component by organism 
3) Compare the antimicrobial concentrations needed to be effective 
against the two organisms 
4) Determine the effect of exposure to cinnamaldehyde and carvacrol on 
the fatty acid composition of the bacterial membrane of Salmonella 
5) Determine whether changes in the fatty acid composition of the 
bacterial membrane of Salmonella occur due to growth in the presence of 
cinnamaldehyde and carvacrol as a possible adaptive response 
6) Determine whether reversal of these changes in fatty acid composition 
occurs when the stressors, cinnamaldehyde and carvacrol, are removed. 
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Abstract 
 
The antimicrobial activity of essential oils is due to the presence of various 
chemical components in the oil.  The objective of this study was to evaluate the 
antimicrobial activity of active chemical components of essential oils against 
Salmonella Typhimurium and Listeria monocytogenes using broth microdilution 
and macrodilution assays.  Carvacrol (CRV), beta-caryophyllene, trans-
cinnamaldehyde (CIN), eugenol (EUG), limonene, linalool (LNO), alpha-pinene, 
rhodinol (RHO), and thymol were tested for antimicrobial efficacy using a 21-h or 
24-h inoculum diluted to log 5.7 CFU/ml in phosphate -buffered brain-heart 
infusion broth (pH 7.2) with 1% Tween 20 in microtiter plates (microdilution) and 
glass tubes (macrodilution).  Tween was used to solubilize the antimicrobial in 
the aqueous phase.  SAS/PROBIT dose-response models were used to analyze 
the data.  Beta-caryophyllene, limonene, alpha-pinene, and thymol were not 
lethal to S. Typhimurium and L. monocytogenes at 2800 mg/L and 3200 mg/L, 
respectively.  LNO was more highly antimicrobial using the macrodilution 
method.  The most effective essential oil components against S. Typhimurium 
were CIN and CRV (50% probability of lethality using an avg. of 280 mg/L and 
1080 mg/L, respectively) with both methods.  CIN (avg. 790 mg/L) and RHO 
(avg. 1810 mg/L) were the most lethal essential oil components against L. 
monocytogenes.  L. monocytogenes required higher doses of antimicrobial 
components to achieve lethality regardless of method.   
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Introduction 
 
Consumers desire high-quality, minimally processed foods that have fewer 
preservatives and an extended shelf-life (Brul and Coote 1999).  Essential oils, 
which are obtained from plants by distillation, contain flavor, aroma, and 
antimicrobial components.  They are used mainly for flavors and fragrances.  
Carvacrol (CRV), the bioactive component found in oregano and thyme essential 
oils, is a flavoring agent in baked goods, nonalcoholic beverages, and chewing 
gum (Ultee and others 1999).  Eugenol and cinnamaldehyde (CIN) are used in 
candies and baked goods (Kim and others 1995b).  Essential oils of clove, 
cinnamon, and allspice contain eugenol.  CIN is a constituent of cinnamon and 
cassia oils (Davidson and Naidu 2000).   
 In the past two decades, many studies have reported the inhibitory and 
lethal effects of essential oils tested against a wide variety of microorganisms in 
various culture media and food products.  Studies have reported oregano, thyme, 
clove, and cinnamon essential oils to be highly active against various 
microorganisms (Lis-Balchin and Deans 1997; Hammer and others 1999 ; 
Friedman and others 2002; Valero and Salmerón 2003).  However, comparing 
the efficacy of various oils is complex because the composition of bioactive 
components within a genus, or even species, can vary due to a number of factors 
such as climate and geographic origin (Zaika 1988).  
Evaluation of these EOC presents challenges because of the low water 
solubility of components, such as thymol, carvacrol, eugenol, and 
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cinnamaldehyde (Griffin and others 1999).  Kim and others (1995a)  determined 
that the minimum bactericidal concentration (MBC) of carvacrol against Listeria 
monocytogenes and Salmonella Typhimurium was 500 mg/L and 250 mg/L, 
respectively, using macrodilution broth method.   The minimum inhibitory 
concentration (MIC) of carvacrol, trans -cinnamaldehyde, and thymol against S. 
Typhimurium were 150, 396, and 150 mg/L, respectively, using the broth 
macrodilution method (Helander and others 1998).  Eugenol was found to inhibit 
the growth of E. coli O157:H7 and L. monocytogenes at 1000 mg/L (Blaszyk and 
Holley 1998).  The concentrations of CIN need to achieve a 50% decrease in 
CFU in E. coli O157:H7, S. enterica Hadar, and L. monocytogenes were 600, 
400, and 100 mg/L, respectively (Friedman and others 2002).  Although several 
studies have investigated the efficacy of some common constituents, little 
information exists on the evaluation of less well-known components and their 
mechanisms of action. 
Although several studies have investigated the efficacy of EOC, only a few 
have examined their mechanisms of inhibition.  CRV was shown to cause 
potassium ions to leak, reduce intracellular pH, destroy the membrane potential, 
and deplete the intracellular ATP of Bacillus cereus cells, which would result in 
lethality (Ultee and others 1999).  Ultee and others (1999) investigated the effect 
of carvacrol and cymene of the membrane of B. cereus.  Cymene is structurally 
the same as CRV except that it lacks the hydroxyl group.  Both expanded the 
membrane and decreased the membrane potential. While 150 mg/L CRV 
completely destroyed the pH gradient, 268 mg/L of cymene did not.  In addition, 
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carvacrol decreased the membrane potential more than cymene.  Therefore, it 
was concluded that the hydroxyl group in CRV was important for its antimicrobial 
activity.  One study found that CIN caused exponential phase cells to become 
long and filamentous and inhibited them from separating from each other (Kwon 
and others 2003).  CRV disrupted the outer membrane of E. coli O157:H7 and S. 
Typhimurium since it decreased intracellular ATP and increased extracellular 
ATP in E. coli O157:H7.  CIN did not disrupt the outer membrane or influence 
intra- or extracellular ATP pools (Helander and others 1998).   
Common methods used to test antibacterial activity are filter paper disk 
diffusion, double plate, gradient plate, agar cup, and broth macro- and 
microdilution (Zaika 1988).  Since some components are hydrophobic, disk and 
agar methods are less suitable and broth dilution assays are preferred (Davidson 
and Naidu 2000).  Difficulties encountered when working with essential oils and 
their components include poor solubility, turbidity, and volatility.  The 
measurement accuracy of EOC has not been previously compared between the 
two dilution methods.  The objectives of this study were to evaluate the 
effectiveness of the antimicrobial activity of selected EOC against L. 
monocytogenes and S. Typhimurium using dose-response curves and to 
compare the minimum lethal concentrations obtained from broth macro- and 
microdilution assays. 
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Materials and methods 
 
Essential oil components  
Materials and methods for microdilution or macrodilution assays were 
based on the National Committee for Clinical Laboratory Standards Broth Dilution 
Procedures with modifications as described below (NCCLS 1993).   The efficacy 
of carvacrol, beta-caryophyllene, trans-cinnamaldehyde, eugenol, (S)-(-)-
limonene, linalool, (1R)-(+)-alpha-pinene, (1S)-(-)-alpha-pinene, rhodinol (mixture 
of citronellol and geraniol), and thymol were tested.  Chemicals were purchased 
from Aldrich (Milwaukee, WI), except trans-cinnamaldehyde (Fisher Scientific - 
Acros, Fairlawn, NJ) and eugenol (Fluka, Buchs, Switzerland).  Table of essential 
oil component abbreviations and solubilities are in Table 2.1. 
Stock solutions of EOC were prepared in ethanol, absolute (Aldrich, St. 
Louis, MO).  Sterile water dissolved into ethanol served as the control stock 
solution.  Aliquots (<160 µl) of freshly prepared EOC or control stock solutions 
were added into 8 ml Brain Heart Infusion Broth, Modified (BHI, BBL, Sparks MD) 
with 2% Tween 20 (Fisher Scientific, Fairlawn, NJ) with glass beads such that the 
final concentration of ethanol did not exceed 1%.  Tween and glass beads were 
used to aid with dispersion of EOC in BHI.  All BHI was prepared with phosphate 
buffer (0.1M, pH 7.2 + 0.1) instead of water to prevent pH changes.  The pH of 
BHI was adjusted to 7.35 (+ 0.1) prior to autoclaving with 2N NaOH, after which 
the final pH was pH 7.2 (+ 0.1).  Glass tubes containing the EOC and BHI were 
shaken vigorously forty times to disperse the oil-based components.  Dispersions  
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Essential oil component Abbreviation Purity (%) Solubility 
Carvacrol CRV 98 Practically insoluble in H2O, freely soluble in alcohol  
Beta-caryophyllene CYP >98 Not available 
Trans-cinnamaldehyde CIN 99 Dissolves in 700 parts H2O, 7 volumes of 60% alcohol 
Eugenol EUG >99 1 ml dissolves in 2 ml 70% alcohol 
Limonene LIM 96 Practically insoluble in H2O, miscible with alcohol 
Linalool LNO 97 Soluble in 4 volumes 60% a alcoho l 
(1R)-(+)-alpha-pinene RAP 98 Practically insoluble in H2O 
(1S)-(-)-alpha-pinene SAP >99 Practically insoluble in H2O 
Rhodinol  RHO >83 Very slightly soluble in H2O, miscible with alcohol 
Thymol THY 98 1 g dissolves in 1L H2O or 1 ml alcohol 
Essential oil components EOC 
 
--- 
Table 2.1.  Abbreviations, purities, and solubilities of essential oil components (Merck & Co, Inc. 2001). 
 36 
containing some components, such as CRV or RHO, became cloudy-white or 
cloudy-yellow, respectively.   
Preparation of EOC concentrations for assays 
For the microdilution broth assay, 50 µl  of a specific EOC in BHI were 
dispensed into a microtiter plate (MIC 2000 Thermo Labsystems VWR Scientific 
Products, West Chester, PA) with each lane containing a different concentration, 
covered with tape and a lid, and frozen at -14.3°C in freezer bags to decrease 
volatility of the 10 antimicrobials during preparation and storage.  Plates were 
stored for less than one week.  To prepare for the macrodilution assay, 1 ml of 
each antimicrobial concentration in BHI was dispensed into 4 glass tubes and 
stored at 4°C.  Stocks and dispersions for the  macrodilution assay were prepared 
two days before an experiment.  Both microtiter plates and tubes were warmed to 
room temperature half an hour before inoculation.  The inoculum volume diluted 
the antimicrobial concentrations by one-half.  
 A wide range o f concentrations was initially tested using all selected 
EOC.  Less effective EOC were eliminated from the study.  Then the more 
effective EOC were tested in a narrower range in smaller increments.  The lowest 
concentration tested allowed growth.  No growth was detected at the highest 
concentration. The final Tween concentration was 1% and ethanol concentration 
was less than 1%.  The concentrations tested for each EOC are shown in Tables 
2.2 and 2.3.  Some of the EOC were tested in smaller increments because they 
were found to be more lethal in preliminary experiments.  The effective EOC  
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Table 2.2.  Concentrations of essential oil components tested against L. 
monocytogenes using microdilution and macrodilution broth methods. 
 
 Concentration range in mg/L (increments tested) 
Component Microtiter plates Glass tubes 
CRV 2200-3200 (200mg/L) 2400-3200 (200mg/L) 
CYP 400-2000 (400mg/L) 2400-3200 (400mg/L) 
CIN 400-1200 (200mg/L) 200-1200 (200mg/L) 
EUG 1800-2800 (200mg/L) 2400-3000 (200mg/L) 
LIM 400-2000 (400mg/L) 2400-3200 (400mg/L) 
LNO 400-2800 (400mg/L) 2400-3200 (200mg/L) 
RAP 400-2000 (400mg/L) 2400-3200 (400mg/L) 
SAP 400-2000 (400mg/L) 2400-3200 (400mg/L) 
RHO 1400-2200 (200mg/L) 1400-2200 (200mg/L) 
THY 400-2000 (400mg/L) 2400-3200 (400mg/L) 
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Table 2.3.  Concentrations of essential oil components tested against S. 
Typhimurium using microdilution and macrodilution broth methods 
 
 Concentration in mg/L (increments tested) 
Component Microtiter plates Glass tubes 
CRV 800-2000 (200mg/L) 800-1600 (200mg/L) 
CYP 400-2000 (400mg/L) 2000, 2800 
CIN 200-800 (200mg/L) 200, 250, 300, 400, 600 
EUG 1000-1600 (200mg/L) 1200-1800 (200mg/L) 
LIM 400-2000 (400mg/L) 2000, 2800 
LNO 1200-2000 (200mg/L) 1000-1800 (200mg/L) 
RAP 400-2000 (400mg/L) 2000, 2800 
SAP 400-2000 (400mg/L) 2000, 2800 
RHO 800-1800 (200mg/L) 1200-3000 (200mg/L) 
THY 400-2000 (400mg/L) 2000, 2800 
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were more of interest.  Therefore, smaller increments were tested to determine a 
concentration at which there may be a threshold to its antimicrobial activity. 
Bacterial culture preparation 
Listeria monocytogenes serotype 4b ATCC 19115 and Salmonella 
Typhimurium DT104 ATCC BAA-186 were obtained from the American Type 
Culture Collection (ATCC, Rockville, MD).  Experimental cultures were 
maintained on Tryptic Soy Agar slants.  A loopful of culture was to inoculate 9 ml 
of BHI with L. monocytogenes or S. Typhimurium.  The BHI tube was incubated 
for 24h at 35°C.  Then a loopful was transferred into 9 ml BHI.  The BHI tube 
inoculated with L. monocytogenes or S. Typhimurium was incubated at 35°C for 
21h or 24h, respectively,  to prepare the inoculum for experiments.  The 21h or 
24h culture was serially diluted to 10-3 in 9 ml and 99 ml BHI to prepare the 
inoculum.  A one ml aliquot from the 10-3 diluted culture was serially diluted in 
0.1% peptone water and spread plated onto Standard Methods Agar (SMA) to 
determine the inoculum size.  The inoculum size in the10-3 diluted culture was 
approximately log 6 CFU/ml.   
Microdilution method.  The 10-3 diluted inoculum (50 µl) was added to 
the 50 µl of EOC in the microtiter plate to achieve a final concentration of bacteria 
of approximately log 5.7 CFU/ml or log 4.7 CFU/well.  Final volume in the well 
was 100 µl.  Microtiter plates were incubated at 35°C for 24 h on a microtiter 
plate shaker.   
Macrodilution method.  One ml of the 10-3 diluted inoculum was added to 
the tube containing 1 ml of EOC to achieve a final inoculum of approximately log 
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5.7 CFU/ml.  Final volume in the tube was 2 ml.  Tubes were vortexed and 
incubated in a shaking water bath at 35°C for 24h.   
The MIC was determined as the lowest concentration of antimicrobial 
agent that completely inhibited growth of the organism in the wells as detected by 
the unaided eye.  The MIC was difficult to determine in macrodilution and 
especially microdilution methods because some EOC would appear turbid due to 
the low solubility of EOC rather than due to bacterial growth.  CRV and RHO 
were two such antimicrobials.  Therefore, it was necessary to subculture from the 
wells to clearly determine if there was growth and to test antimicrobials using 
macrodilution broth instead.   
Although macrodilution method improved visibility of results, tubes 
containing RHO and CRV appeared turbid with pellet, but when subcultured, 
contained no detectable colonies.  Within the tubes small droplets of carvacrol 
were visible, especially at higher concentrations.  The pellets may have been due 
to the phosphate precipitation.  Therefore, it was easier to evaluate effectiveness 
by detecting growth on agar plates and finding the minimum lethal concentration 
(MLC).  MLC was determined as the lowest concentration that permitted no 
growth after subculture. 
To determine the MLC 10 µl was obtained from the microtiter wells or 
glass tubes and plated onto SMA.  Plates were incubated 35°C for 24h and 
counted.  MLC was determined according to the NCCLS Guidelines for the 
Rejection Value for Each Initial Inoculum Concentration on the Basis of a Single 
0.01-ml Sample.  These guidelines suggest that when the number of colonies 
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from a test vessel is equal to or less than the rejection value (which is >11 CFU 
for a log 5.7 CFU/ml inoculum) the concentration of the antimicrobial in the test 
vessel is considered lethal (99.9% or greater reduction in the final inoculum 
(NCCLS 1993).   
Statistical analysis 
Three replications were performed for each antimicrobial and method.  
The data were analyzed using SAS procedure PROBIT analysis (Statistical 
Analysis System Institute, Cary, NC) to develop dose-response models.  Since 
the response of interest is lethality or nonlethality, the dependent variable is a 
binary discrete variable.  PROBIT is a type of logistic regression that fits 
regression equations to categorical responses.  Bacterial response, such as 
probability of lethality, was plotted as a function of the dose (López-Malo and 
others 2002).  
The concentration of antimicrobial was transformed to log10 to obtain a 
more linear regression line.  First, PROBIT analysis was conducted to evaluate if 
there was a difference among EOC stock solutions of a certain antimicrobial that 
were prepared at different times within a certain method and organism.  The data 
were summarized across the EOC stock solutions, for each antimicrobial, within 
a method and by organism.  PROBIT analysis used the summarized data to 
determine if there were dose effects and to generate dose-response curves to 
compare the effectiveness across antimicrobials.  Next, the data were analyzed 
to compare methods within each organism.  Lastly, the doses of each chemical 
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were compared to determine if an organism required higher doses than the other 
organism for the macrodilution method.   
 
Results 
 
PROBIT dose-response curves 
The dose-response curves for L. monocytogenes and S. Typhimurium 
exposed to EOC have a sigmoid shape since there is no response from the 
population until the dose reaches a threshold response.  When the higher 
saturation dose has been applied no increase in response occurs.  In this study 
the initial region at lower doses is one of insignificant lethality.  Then there is a 
linear region of exponential inactivation (after a logarithmic transformation), and 
then a final region where higher concentrations do not cause additional lethality 
(López-Malo and others 2002).   
The PROBIT procedure estimates the probability of successful response 
(lethality) for a dose (concentration of antimicrobial), which is the independent 
variable.  Zero to 100% probability is the range of response.  This probability is 
based on regression parameters of the number of successful responses and the 
total number of events and the threshold response rate.  Dose-response curves 
are useful when deciding what probability of lethality is desired in cost-benefit 
analysis and risk assessment.  Dose-response curves for L. monocytogenes 
exposed to EOC are presented in Figures 2.1 and 2.2.  The solid line represents 
the regression line, which is used to obtain the prediction for the mean probability  
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Figure 2.1. Probability of lethality of Listeria monocytogenes treated by essential oil 
components using microdilution method (microtiter plates). 
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Figure 2.2. Probability of lethality of Listeria monocytogenes treated by essential oil components 
using macrodilution method (glass tubes). 
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      CIN                 x  CRV                     EUG                    LNO                    RHO           
mg/L 
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of lethality at a given dose.  The dotted lines on each side of the mean predicted 
probability represent the 95% confidence interval.  The confidence interval is a 
range of values that is expected to contain the mean predicted probability of 
lethality in 95% of experiments.  
L. monocytogenes 
Microdilution method 
The essential oil components (EOC) CYP, LIM, RAP, SAP, and THY were 
not lethal to L. monocytogenes at 2000 mg/L and LNO was not lethal at 2800 
mg/L against L. monocytogenes using the microtiter plate assay (Table 2.4).  
CIN, CRV, EUG, and RHO exhibited lethality to L. monocytogenes at 
concentrations greater than 760 mg/L.  CIN was the most effective EOC, 
followed by RHO (Table 2.4 and Figure 2.1).  The difference between the doses 
of CIN and RHO at 50% probability of lethality was approximately 1200 mg/L 
(Table 2.4).  At 99% probability of lethality, this difference was greater than 1700 
mg/L.  The MIC values of EUG and CRV were similar but less than that of CIN 
and RHO.   
Macrodilution method 
CYP, LIM, RAP, SAP, and THY were not lethal at 3200 mg/L (Table 2.4).  
Colonies grew abundantly on SMA plates after these samples were subplated.  
Implementation of the macrodilution method determined that CIN was the most 
effective EOC against L. monocytogenes followed by RHO (Table 2.4 and Figure 
2.2).  The difference between their doses at 50% probability was >800 mg/L 
(Table 2.4).  At 99% probability of lethality, this difference decreased to  
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Dose (mg/L) corresponding to  
50% probability of lethality 
Dose (mg/L) corresponding to  
99% probability of lethality 
Component* Microtiter p late Tubes Microtiter plate Tubes 
CIN 818 760 875 1236 
CRV 2704 2600 3698 3214 
EUG 2500 2698 2877 3199 
LNO --- 2582 --- 2838 
RHO 1986 1626 2600 1995 
* Microtiter plate: CYP, LIM, RAP, SAP, and THY at 2000 mg/L and LNO at 2800 mg/L were not lethal. 
   Tubes: CYP, LIM, RAP, SAP, and THY at 3200 mg/L were not lethal. 
Table 2.4.  Antimicrobial doses corresponding to 50% and 99% probability of lethality against L. monocytogenes. 
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>700mg/L.  CRV, EUG, and LNO and were similar in antimicrobial activity, but 
not as effective as CIN and RHO.      
Comparison of micro- and macrodilution methods for an 
antimicrobial 
In both the micro- and macrodilution methods, CIN was the most effective 
against L. monocytogenes followed by RHO.  CIN and CRV were as active in the 
microtiter plates as in the tubes (Table 2.4).  Statistically, it appeared that EUG 
was more effective in the  microtiter plates (p<0.01) than in the tubes and that 
RHO was more effective in the glass tubes (p<0.01) than in the microtiter plates.  
However, these differences were probably due to pipetting error.  Since ethanol 
has no surface tension, the volume transferred from the EOC stock solutions in 
ethanol to the BHI broth was likely inconsistent.  The differences between the 
micro- and macrodilution methods for RHO and EUG were less than two-fold.  A 
two-fold difference in MIC values is considered to be within experimental error 
(Inouye and others 2001).   
S. Typhimurium 
Microdilution method 
CYP, LIM, RAP, SAP, and THY were not lethal at 2000 mg/L against S. 
Typhimurium in the microtiter plates (Table 2.5).  CIN was the most effective 
EOC, followed by CRV, EUG, RHO, and LNO at 50% probability pf lethality 
(Figure 2.3 and Table 2.5).  The difference between CIN and CRV doses was 
>700 mg/L at 50% probability of lethality and increased to >1000 mg/L at 99% 
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Dose (mg/L) corresponding to  
50% probability of lethality 
Dose (mg/L) corresponding to  
99% probability of lethality 
Component* Microtiter plate Tubes Microtiter plate Tubes 
CIN 284 280 312 419 
CRV 1033 1130 1380 1556 
EUG 1227 1294 1282 2094 
LNO 2056 1567 2576 1845 
RHO 1535 --- 2495 --- 
* Microtiter plate: CYP, LIM, RAP, SAP, and THY at 2000 mg/L were not lethal. 
   Tubes: CYP, LIM, RAP, SAP, and THY at 2800 mg/L and RHO at 3000 mg/L were not lethal. 
Table 2.5.   Antimicrobial doses corresponding to 50% and 99% probability of lethality against S. Typhimurium. 
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Figure 2.3. Probability of lethality of Salmonella Typhimurium treated by essential oil 
components using microdilution method (microtiter plates). 
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probability (Table 2.5).  CIN lacked a 95% confidence interval because there 
were fewer distinct doses tested in the sublethal range.  The 95% confidence 
interval for LNO was wider since the concentration that may achieve a 100% 
lethal dose was not prepared for the assay. 
Macrodilution method 
CYP, LIM, RAP, SAP, and THY were not lethal at 2800 mg/L in the glass 
tube assay (Table 2.5).  RHO was not lethal at 3000 mg/L.  CIN was the most 
effective EOC against S. Typhimurium followed by CRV, LNO, and EUG at 50% 
probability of lethality (Figure 2.4 and Table 2.5).  The difference between CIN 
and CRV doses was >800 mg/L at 50% probability of lethality and increased to 
>1100 mg/L at 99% probability (Table 2.5).   
Comparison of micro- and macrodilution methods for an 
antimicrobial 
The inhibitory activity of CIN, CRV, and EUG was not different between 
the macro- and microdilution methods when tested against S. Typhimurium.  
LNO was statistically more effective against S. Typhimurium using the 
macrodilution method (p<0.0001) and required 490 mg/L less to achieve a 50% 
probability of lethality (Table 2.5).  Since this difference was less than two-fold 
the difference may have been due to pipetting error.  Although the comparison 
was not statistically analyzed, RHO seemed to be more effective in the microtiter 
plates, since there was abundant growth of S. Typhimurium when samples were 
subplated from glass tubes containing 3000 mg/L RHO.  There was a strong 
stock solution effect among different stocks of RHO when tested against L. 
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Figure 2.4. Probability of lethality of Salmonella Typhimurium treated by essential oil 
components using macrodilution method (glass tubes). 
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monocytogenes in microtiter plates.  The variation may be due to inconsistency 
when pipetting stock solutions because of the low surface tension of ethanol.  In 
addition, it was difficult to determine if the variation in RHO antimicrobial activity 
was due to loss of RHO during storage or incubation of plates because of the 
volatility of RHO.    
Comparison of effectiveness against L. monocytogenes and S. 
Typhimurium 
All figures show that CIN was much more bactericidal than the other 
antimicrobials.  RHO and CRV were the next most effective antimicrobials 
against L. monocytogenes and S. Typhimurium, respectively.  L. monocytogenes 
required higher doses of CIN, CRV, EUG, LNO and RHO regardless of which 
method was used.  At 50% probability of lethality, >500 mg/L more of CIN was 
needed to be effective against L. monocytogenes than S. Typhimurium.  At 99%, 
the concentration increased to >600 mg/L.  For CRV to be lethal with 50% 
probability, >1600 mg/L CRV was needed against L. monocytogenes.  At 99%, 
the concentration increased to >1900 mg/L. 
 
Discussion 
 
Statistical differences compared to scientific differences 
A two-fold difference in MIC values is considered to be within experimental 
error (Inouye and others 2001).  Although the results of our study showed 
statistical differences between the micro- and macrodilution methods for EUG, 
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LNO, and RHO, they may not be scientifically significant since the differences 
were much lower than a two-fold difference and may be due to experimental 
error instead.  The doses of CIN, CRV, and EUG needed to be lethal against L. 
monocytogenes were more than two-fold higher than those against S. 
Typhimurium and therefore scientifically significant. 
Comparisons with other studies 
When these results were compared with those of other studies, similarities 
and differences were found.  Studies of essential oils and components were 
difficult to compare since there are various assays used to evaluate 
antimicrobials, but there is no standardized test method or format for reporting 
assay results of bactericidal activity (Friedman and others 2002).  Sensitivities of 
bacterial strains, method of growth, and phase of growth when the antimicrobial 
was applied, and enumeration of survivors may affect results.  Solubility of the oil 
or component and method of preparing stocks may influence activity (Friedman 
and others 2002).  Variations in experimental procedures, composition of 
medium, and preparation of slightly soluble phenolics lead to wide differences in 
results (Wen and others 2003). 
In a microtiter plate assay of 96 essential oils and 23 oil components, CIN, 
EUG, THY, CRV, citral, geraniol, perillaldehyde, carvone S, estragole, and 
salicylaldehyde were the most effective components tested against L. 
monocytogenes F2379 (Friedman and others 2002).  Similarly, our study found 
that CIN, EUG, and CRV were most lethal to L. monocytogenes.  However, 
doses of CIN, EUG, and CRV at 50% probability of lethality were about three to 
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four times higher than the BA50 values of Friedman and others (2002) (Table 
2.6).  The BA50 values were determined from the linear regression model as the 
dose that resulted in a 50% decrease in the number of CFU compared to that of 
the negative control rather than through a dose-response PROBIT analysis.  
BA50 value of THY was 770 mg/L, but our study did not find THY to be as 
effective as the other antimicrobials.  LIM and LNO were not evaluated above 
2080 mg/L and 2890 mg/L respectively.   The lower activity of LIM and LNO 
agrees with these authors’ findings that LIM and LNO were not effective at 6700 
mg/L.  Friedman and others (2002) did not evaluate RHO. 
They tested these components against S. enterica serovar Hadar (isolated 
from ground turkey).   They found that THY, CIN, CRV, EUG, salicylaldehyde, 
geraniol, isoeugenol, terpineol, perillaldehyde, and estragole were the most 
active.  Doses of CIN, EUG, and CRV at 50% probability of lethality of our study 
were about two times higher than their BA50 values (Table 2.6).  However, the 
LNO dose at 50% lethality was about two-fold lower than the BA50 value.  THY 
was found to be effective at a BA50 value 340 mg/L but our study did not find it to 
be effective.  Friedman and others (2002) reported that LIM was not effective up 
to 6700 mg/L and our study did not test it above 3300 mg/L.  Similarly, they found 
that CRV and LNO doses needed to inactivate S. enterica were lower than that of 
L. monocytogenes, which agrees with our findings of the relative susceptibility of 
Salmonella compared to Listeria. 
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    Concentration (mg/L) 
 BA50 values (mg/L) from Friedman and others (2002)  to reach 50% probability of lethality  
 L. monocytogenes S. enterica L. monocytogenes S. Typhimurium 
  F2379 RM2388 serovar Hadar MH136 serotype 4b  DT104 
CIN 190 + 10 80 + 10 330 + 140 818 284 
CRV 830 + 100 860 + 100 540 + 0.01 2704 1033 
EUG 610, 500 810 + 10 870 + 350 2500 1227 
LNO 6700, 8500 6700, 6800 3700 + 400 - 2056 
THY 770 + 100 770 + 200 340 + 20 - - 
Table 2.6.  Comparison of BA50 values adapted from Friedman and others (2002) and concentrations to 
reach 50% probability of lethality from this present study using microdilution assay. 
 56 
These differences in the lethality values between the two studies may be 
due to their preparation in phosphate-buffered saline (PBS; pH=7.0) (Friedman 
and others 2002).  For example, to prepare the THY treatment, they vortexed the 
THY solids in a microcentrifuge tube with PBS, warmed it for 4s, and vortexed it.  
The preparation led to a more mixed suspension and therefore a higher 
antibacterial activity than in this study.  This may explain why our study found 
that THY was less active than other antimicrobials, although it appeared to 
dissolve in ethanol.    
The variation in efficacy may be due to differences in inoculum size, 
incubation time, and the- formation of mixed micelles from Tween and <1% 
ethanol from the stock solution.  The most influential factor in these assays is the 
inoculum size (NCCLS 1993).  Larger bacterial populations may be more likely 
than smaller populations to have some more resistant cells, which can survive 
and grow.  Therefore, smaller populations will be more quickly and fully inhibited 
(Amsterdam 1996).  The susceptibility of antimicrobials increases with a smaller 
inoculum size (Collins and others 1995).  For example, the antimicrobial activity 
of essential oils of oregano, thyme, and clove were found to increase with 
decreasing inoculum level of Staphylococcus aureus and Salmonella Hadar 
(Remmal and others 1993).  The mean suggested inoculum is log 6 CFU/ml for 
microdilution (NCCLS 1993).  Friedman and others (2002) added 50-µl of 1,500 
to 2,000 CFU/well in PBS to 100-µl of antimicrobial in microtiter plates.  Since the 
inoculum size in our study (log 5.7CFU/ml or 50,000 CFU/well) was considerably 
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larger as recommended by NCCLS, this may explain the higher concentrations 
required for lethality. 
Another important difference between the studies was the incubation time.  
Friedman and others (2002) incubated the microtiter plates for one hour, a 
significantly shorter time compared to 24 h.  They had found in previous 
experiments with E. coli and S. enterica that the % kill by cinnamon oil, oregano 
oil, and eugenol approached a maximum at 60 min and reached a plateau.  The 
strong influence of incubation time was demonstrated when ampicillin was tested 
against S. aureus and E. coli strains.  The MIC values for 24-h incubation were at 
least two-fold more than those of 12-h incubation (Amsterdam 1996).  The 
method of determining survivors was different as well as the statistical model 
used for the dose-response curve.  It can be argued that lethality at 60 min 
should also be demonstrated at 24h if the dose is actually lethal, rather than 
inhibitory. 
Furthermore, Friedman and others (2002) did not use Tween 20 to 
increase solubility of the hydrophobic antimicrobials, but used vigorous shaking 
in PBS.  In our study the concentration of Tween was 1%.  Tween 20 has been 
reported to decrease the antimicrobial activity of oregano, thyme, and clove 
essential oils and EUG.  Dispersions of oregano, thyme, and clove essential oils 
in 0.2% agar solution produced lower MIC values than those with 2% ethanol and  
2.5% Tween.  MIC values were lower with Tween 20 than with Tween 80 
(Remmal and others 1993).  In another study, Tween 20 was used at >0.25% to 
increase eugenol solubility, but it decreased inhibitory activity (Blaszyk and 
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Holley 1998).  Blaszyk and Holley (1998) hypothesized that while Tween 
increases the solubility of thymol in water, it decreases its solubility in the 
cytoplasmic membrane since the membrane is hydrophobic.  This may help 
explain the much higher values of our study.   
Friedman and others (2002) also tested various strains of S. enterica 
serovars Meleagridis, Hadar, and Newport and L. monocytogenes F2379 
(isolated from cheese associated with outbreak) and RM2388 (isolated from a 
retail mint herb, serotype 1).  They calculated the BA50 values for cinnamon bark 
oil, oregano origanum oil, and eugenol.  The differences in BA50 values were 
less than two-fold among strains within a species.  These authors noted that the 
L. monocytogenes F2379, which was isolated from cheese associated with an 
outbreak, seemed more resistant than the L. monocytogenes RM2388.  They 
believed that the F2379 strain had virulence factors that RM2388 lacked.  It was 
hypothesized that F2379 developed resistance while in the cheese, but RM2388 
did not develop resistance in the mint.  The authors emphasized the need to 
ascertain if resistance is associated with the source of the isolate or a response 
of the strain to adapt to the food processing environment.  Since the strains in 
our study are known to be associated with outbreaks, these strains may be more 
resistant than the previous study because of their source or virulence factors. 
In a study by Kim and others (1995a), the MBC value for CRV was three to five 
times lower than the concentrations to achieve 50% probability of lethality against 
S. Typhimurium and L. monocytogenes in our study (Table 2.7).  The MBC 
values for EUG and LNO were about three times lower against S. Typhimurium
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   Concentration (mg/L) to reach: 
 MBC (mg/L) from Kim et al (1995) 50% probability of lethality  99% probability of lethality 
 L. monocytogenes S. Typhimurium L. monocytogenes S. Typhimurium L. monocytogenes S. Typhimurium 
  Scott A ATCC 6539 serotype 4b  DT104  serotype 4b DT104 
CRV 500 250 2600 1130 3214 1556 
EUG >1000 500 2698 1294 3199 2094 
LNO >1000 1000 2582 1567 2838 1845 
Table 2.7.  Comparison of minimum bactericidal concentrations (MBC) adapted from Kim and others (1995) and 
concentrations to reach 50% and 99% probability of lethality from this present study using macrodilution assay. 
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 (Kim and others 1995a).  Similarly, they found that higher concentrations of 
antimicrobials were required to inactivate L. monocytogenes.  It was unclear from 
the article at which sampling time the MBC was determined.  Although the 
concentration of 1% Tween and inoculum size of log 6 were similar to our study, 
the assay was conducted with a much larger volume of 20 ml of tryptic soy broth 
(TSB) in flasks.   
Structure and molecular characteristics associated with activity 
In our study, the aldehyde component (CIN) was the most effective, 
followed by the phenolics (CRV and EUG) and acyclic terpene alcohols (LNO 
and RHO) (Figure 2.5).  This agreed with the findings of Friedman and others 
(2002), who found that the aldehydes and phenolics were very active.  Phenolics 
are believed to be the main antimicrobial components in many essential oils 
(López-Malo and others 2002).  CRV and THY are both phenolic and differ only 
in the position of the hydroxyl group.  The hydroxyl group is the necessary 
characteristic required for the action of CRV against B. cereus to decrease the 
membrane potential and pH gradient (Ultee and others 2002).   
The carbonyl group of aldehydes has the capacity to undergo oxidation 
and reduction reactions and nucleophilic additions which allows it to bind metal 
ions, sulfhydryl and amino groups of membrane proteins (Bowles and Miller 
1993).  Cinnamaldehyde was found to be an effective inhibitor of histidine 
decarboxylase activity of Enterobacter aerogenes and its carbonyl group was 
suggested as the functional group (Wendakoon and Sakaguchi 1995).
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Cinnamaldehyde 
Linalool Rhodinol 
ß-caryophyllene (S)-(?)-Limonene (1R)-(+)-a-pinene (1S)-(-)-a-pinene 
Carvacrol Thymol Eugenol 
Aromatic unsaturated aldehyde 
Phenolics 
Acyclic terpene alcohols 
Terpene hydrocarbons 
Figure 2.5.  Structures of selected essential oil components. 
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In a study of the effect of structure and molecular characteristics on 
antimicrobial activity, hierarchical cluster analysis arranged 60 terpenoids into 
five groups based on their activity patterns against Pseudomonas aeruginosa, E. 
coli O157:H7, Staphylococcus aureus, and Candida albicans (Griffin and others 
1999).  THY and CRV were in group I, EUG and LNO in group II, and LIM, RAP, 
and SAP in group IV.  Group I, which inhibited all four microorganisms, was more 
soluble in water (although low in solubility in general) and had a higher capacity 
to form hydrogen bonds than group IV, which was not inhibitory.  Overall group I 
and II were similar in structure and molecular characteristics, but group I was 
more active.  Compared to group II, group I was more capable of forming a 
hydrogen bond, had a smaller surface area, and a lower hydrophilic/lipophilic 
balance.  Group IV included hydrocarbons like CYP, RAP, SAP, and LIM which 
are inactive because of their lower water solubility and lower H-bonding capacity 
(Griffin and others 1999).   
Hydrophobic molecules cannot easily diffuse through the LPS of Gram-
negative bacteria.  In contrast, small hydrophilic compounds can pass through 
porins.  Group I is more likely to permeate because of its smaller size and 
capacity to form H-bonds to interact with the water layer on the exterior of 
bacteria (Griffin and others 1999).  Griffin and others (1999) conclude that 
“specificity and activity was not always defined by the functional group present 
but were associated with H-bonding parameters.”  However, they cautioned that 
solubility and H-bonding did not explain all the patterns in antimicrobial activity 
and there were other molecular properties to be measured.   
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Sensitivity of Gram-negative and Gram-positive organisms 
Most studies have found that Gram-positive organisms are more 
susceptible than Gram-negative to essential oils and their components (as 
reviewed by Burt 2004).  This might be expected since the dense LPS of Gram-
negative organisms is hydrophilic and acts as an impermeable barrier to 
hydrophobic molecules, which can diffuse slowly (Vaara 1992).  However, other 
studies that that S. Typhimurium was more sensitive than L. monocytogenes 
(Kim and others 1995a).  Our study also found S. Typhimurium was more 
susceptible than L. monocytogenes.  Perhaps, it is more difficult for hydrophobic 
EOC to penetrate the thick peptidoglycan layer of L. monocytogenes in order to 
act on the cytoplasmic membrane.  It is hypothesized that after they diffuse past 
the LPS in Gram-negative bacteria, they can act on the proteins in the 
periplasmic space and then pass through only a thin peptidoglycan layer to act 
on the cytoplasmic membrane.  More research is needed on the main target on 
which these essential oils act. 
The partitioning of EOC in the membrane may also help explain the 
different susceptibility of Gram-negative and positive bacteria to EOC.  The 
optimal oil:water partition coefficient (log P) for Gram-negative and Gram-positive 
bacteria is 4.0 and 6.0 for the oil phase, respectively.  Aromatic solvents of 2.0 - 
4.0 log P changed the cytoplasmic membrane organization in Gram-negative 
bacteria (Denyer and Maillard 2002).  CRV has a log P of 3.6, preferring to 
partition in the nonpolar solvent more than water (Ultee and others 2002).  
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Therefore, CRV may be more effective against Gram-negative bacteria since the 
optimal log P of Gram-negative bacteria is closer to the log P of CRV. 
Mechanisms of action 
It has been suggested that carvacrol occupies more area than the typical 
space between the fatty acid chains of two adjoining phospholipid molecules.  
This interferes with the van der Waals interactions between the chains and 
therefore affects fluidity (Ultee and others 2000; Ultee and others 2002).  Liquid-
crystalline is the optimal state of the membrane lipids in which fatty acyl chains 
are loosely packed and interactions between the chains are not at a maximum 
because the chains or its -CH2- groups is rotated (Seltmann and Holst 2002).  If 
the membranes become too fluid, additional carvacrol can continue to permeate 
the membrane, accumulate, and cause more damage (Ultee and others 1998).   
It was found that carvacrol expanded the single-membrane liposomes 
prepared from phosphatidylethanoloamine shown by an increase in fluorescence 
of a probe (Ultee and others 2002).  It is believed that this swelling leads to a 
destabilized membrane and therefore a leakage of ions.  During exposure to 
carvacrol, an influx of protons from outside the cytoplasmic membrane and efflux 
of potassium ions in Bacillus cereus was reported (Ultee and others 1999).  This 
leakage was also evident in the decrease of the pH gradient across the 
membrane (Ultee and others 2002).  The leakage of ions leads to a drop in the 
membrane potential and depletion of the intracellular ATP pool (Ultee and others 
2002).  It was found that 300 mg/L CRV reduced viable counts of Bacillus cereus 
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cells in 30 min and depleted intracellular ATP within 7 min without a proportional 
increase in extracellular ATP (Ultee and others 1999). 
 Similarly, Helander and others (1998) reported that CRV at 300 mg/L (MIC 
= 451 mg/L) increased the uptake of hydrophobic fluorescent probe NPN in E. 
coli O157:H7 and S. Typhimurium.  Uptake of NPN occurred because the outer 
membrane was no longer acting as a strong permeability barrier.  CRV also 
decreased intracellular ATP in E. coli O157:H7, but with a smaller increase in 
extracellular ATP.  These effects indicated that CRV disrupted the outer 
membrane.  In contrast, it was suggested that CIN did not disrupt the outer 
membrane because at 264 mg/L (MIC = 396 mg/L) it did not increase the uptake 
of NPN or influence intra- or extracellular ATP pools (Helander and others 1998) 
.  CRV was reported to impair the cell membrane and increase permeability 
because of the increased fluorescence of nuclear stain EB after Staphyloccus 
aureus and Pseudomonas aeruginosa were exposed to 0.1% CRV (Lambert and 
others 2001).   
Technical limitations of broth dilution assays 
Compared to the macrodilution assay, the microtiter plate assay was less 
laborious to prepare the concentrations and inoculate (which NCCLS suggests to 
do within 15 min).  Results were more difficult to reproduce with the microtiter 
plates, especially due to the low solubility of CRV and RHO, which contributed to 
turbidity.  Oil droplets settled within CRV dispersions in tubes and wells, which 
may not have contacted the cells uniformly during incubation.  If the plates were 
not uniformly manufactured, interaction between the antimicrobials and lipophilic 
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components in the wells may have been inconsistent.  It is more difficult to 
assess the MLC with the microdilution method, but less broth is required (NCCLS 
1993).  The macrodilution method is more appropriate when there are fewer 
assays to conduct, since preparing many sets of tubes can be tedious and more 
operators are needed to inoculate during a short time (Collins and others 1995).   
Limitations of minimum lethal or bactericidal concentration 
There are microbiologic and technical problems with the MLC 
determination (Amsterdam 1996).  The definition of MLC is the concentration 
resulting in a 99.9% decrease in the number of initial bacteria in the inoculum 
(NCCLS 1993).  Amsterdam (1996) asserted that it has not been demonstrated 
that 99% is more clinically relevant than 98%.  NCCLS (1993) noted that this 
distinction might not have biological relevance.  Bacteria also tend adhere and 
proliferate above the meniscus of the medium to possibly avoid contact with the 
antimicrobial (Amsterdam 1996).  This happens more often with plastic test tubes 
than with acid-treated borosilicate glassware or with plastic microtiter plates 
(NCCLS 1993).  In addition, the adhesion of bacteria to the interior of the test 
vessel depends on the type of material (NCCLS 1993).  NCCLS cautioned, “the 
determination of the MLC is subject to methodological variables such that the 
clinical relevance of MLC values is nearly impossible to assess.  
A microbiologic complication is the “persistence” phenomenon, which 
describes a small number (<0.1% of the inoculum) of cells, or “persisters,” that 
survive the bactericidal activity of the antimicrobial because they are 
metabolically inactive or replicating slowly (NCCLS 1993).  If the persisters are 
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retested, they are as susceptible as the original strain and no greater percentage 
of cells that persist.  The persistence phenomenon is a type of tolerance.  
Tolerance is defined as the ability of the microorganism to escape lethal effect of 
the antimicrobial, but the MIC remains the same since it can grow (NCCLS 1993; 
Amsterdam 1996).  Other types of tolerance are genotypic and phenotypic, which 
can occur more often and are more relevant (Amsterdam 1996).   
Applications of components to food  
One of the limitations of this study is that the broth dilution assay is an 
artificial way of bringing the antimicrobial and the pathogen in contact, but 
outside of food.  Once an antimicrobial is found to be effective with in vitro 
methods, its action in a food system can be tested.  Because of the interactions 
of the antimicrobial with food components, the inhibitory effect is lower in foods 
than in microbiological media.  Foods high in fat would require higher 
concentrations to inhibit growth (Zaika 1988).   
Since essential oils are components are pungent, they may cause 
undesirable flavors or aromas (López-Malo and others 2002).  Although 300-400 
mg/L was lethal to S. Typhimurium in-vitro in our study, higher levels would be 
needed if the control microorganisms was intended.  The concentrations needed 
for lethal action by essential oils exceed tolerable taste thresholds.  Therefore, to 
achieve desired effects against microorganisms essential oils and their 
components may be added to foods at inhibitory levels and be combined with 
other antimicrobials or processing conditions (Brul and Coote 1999).  Since these 
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inhibitory levels are greater than those used for flavoring, manufacturers would 
be required to submit a GRAS notice to FDA (Draughon 2004).   
Although NCCLS suggested an inoculum of log 5.7 for clinical assays, this 
may or may not be applicable in food.  The selection of the inoculum size 
depends on the food intended for application of the antimicrobial.  Various foods 
differ in their initial microflora as well as possible contaminating microorganisms.  
The selection of the microorganism depends on the target food and whether the 
natural microflora and/or contaminating microorganisms are of interest.  The 
intended use of the antimicrobial should be defined, such as to increase shelf life.  
At normal usage levels most food antimicrobials do not inactivate pathogens 
(Parish and Davidson 1993).  Therefore, it would be beneficial to combine other 
intervention strategies if antimicrobials are used.  Food processing conditions 
such as with those with heat will affect the activity of EOC due to their volatility.  
At 60°C pure CIN was converted to benzaldehyde, but CIN in cinnamon oil was 
stable (Friedman and others 2000).  There is a shortage of knowledge about 
these effects (Friedman and others 2002).   More research is needed on 
essential oils and components in foods as well as in combinations with other 
intervention strategies for synergistic action while maintaining acceptable quality 
and safety. 
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Significant findings 
 
Beta-caryophyllene, limonene, alpha-pinene, and thymol were not lethal to 
S. Typhimurium  and  L. monocytogenes at 2800 mg/L and 3200 mg/L, 
respectively.  The most effective essential oil components against S. 
Typhimurium were CIN and CRV (50% probability of lethality using an avg. of 
280 mg/L and 1080 mg/L, respectively) with both methods.  CIN (avg. 790 mg/L) 
and RHO (avg. 1810 mg/L) were the most lethal against L. monocytogenes.  L. 
monocytogenes required higher doses of antimicrobial components to achieve 
lethality regardless of which method was used to determine MLC.  Since selected 
components of essential oils were inhibitory to S. Typhimurium and L. 
monocytogenes, combinations of these components may be useful as 
antimicrobials and should be evaluated. 
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Abstract 
 
 Trans-cinnamaldehyde (CIN) is a major component found in the essential 
oil fraction of cinnamon cassia oils.  It has been reported to be inhibitory to 
various pathogens.  The mechanism of this inhibition is not fully understood, but 
is assumed to occur at the membrane level.  To increase understanding of the 
inhibitory effect of CIN, the objective of this study was to evaluate changes in 
bacterial membrane composition by observing changes in total phospholipid fatty 
acid (PLFA) and fatty acid composition associated with exposure and adaptation 
to CIN.  Salmonella Typhimurium DT104 cells were grown for 24h at 35°C with or 
without 250mg/L CIN in 9-ml brain heart infusion broth.  Log 5.7 CFU/ml of 
S.Typhimurium was inoculated into 200ml broth containing 250mg/L CIN.  At 2h 
and 24h, samples were centrifuged, washed, lyophilized, and extracted for lipids.  
Fatty acid methyl esters prepared from phospholipids were quantified by GC-MS.  
After 2h of exposure to CIN, the non-adapted treatment group had lower (p<0.05) 
total phospholipid fatty acid (PLFA), lower C16:1w7c and unsaturated fatty acid 
(UFA) and higher (p<0.05) C18:0, saturated fatty acid (SFA), and Cy17:0 to 
C16:1w7c ratio than the non-adapted control.  After 24h of exposure to CIN, the 
non-adapted treatment group had lower (p<0.05) Cy17:0, Cy19:0, and UFA than 
the non-adapted control and higher (p<0.05) C16:0 and SFA.  At 2h, SFA/UFA 
ratio in the membranes of adapted cells exposed to CIN was numerically higher 
than in the non-adapted cells treated with CIN.  At 24h the SFA /UFA ratios of the 
adapted and non-adapted Salmonella were similar.  Since the fatty acid 
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composition and total PLFA of the non-adapted control and adapted controls 
were similar at 2 and 24h, the adaptive response had been reversed since the 
stressor, CIN, was not used to treat the adapted controls.  It appears that CIN 
treatment at sub-lethal concentrations decreased the fluidity of the Salmonella 
membrane by increasing SFA.  This decreased fluidity may prevent additional 
CIN from permeating.  The effect of bacterial growth in the presence of CIN on 
the fatty acid composition was much smaller.  Measurement of the membrane 
transition temperature from gel-to-liquid-crystalline phase would indicate fluidity.  
Investigation about the target site that CIN acts upon and the interactions of CIN 
with membrane lipids and proteins would contribute to the understanding of its 
mechanism of action and the bacterial response. 
 
Introduction 
 
Consumers desire high-quality, minimally processed foods that have fewer 
preservatives and an extended shelf-life (Brul and Coote 1999).  Studies have 
frequently reported cinnamon essential oil to be highly active against various 
microorganisms (Lis-Balchin and Deans 1997; Friedman and others 2002; Valero 
and Salmerón 2003).  Trans-cinnamaldehyde (CIN), which is a component found 
in cinnamon oil, is used in candies and baked goods (Kim and others 1995).   
Cinnamon has been used in human foods for thousands of years and has 
been used as a deodorizer and sanitizer.  The minimum inhibitory concentration 
(MIC) of CIN against S. Typhimurium and E. coli O157:H7 was 396 mg/L 
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(Helander and others 1998).   The concentrations of CIN needed to achieve a 
50% decrease in CFU in E. coli O157:H7, S. enterica Hadar, and L. 
monocytogenes were 600, 400, and 100 mg/L, respectively (Friedman and 
others 2002).   
Concentrations that are lethal to bacteria are much higher than tolerable 
taste thresholds.  Therefore, it is preferable to use them at inhibitory 
concentrations rather than at lethal concentrations (Brul and Coote 1999).  
Knowledge about the mechanisms of action of antimicrobials is needed to 
develop effective and economical combinations of antimicrobial additives and 
formulations to prevent food from spoilage and pathogenic microorganisms 
without sacrificing organoleptic qualities.   
Compounds from essential oils are believed to disrupt the membrane (Brul 
and Coote 1999), however, there are diverse chemical families representing 
essential oil components.  Lipophilic compounds, such as essential oil 
components, have been shown to accumulate and act on the cell membrane 
(Sikkema and others 1994, 1995; Ultee and others 1999).  As they interact with 
the phospholipid bilayer of the cell membrane, they may increase membrane 
permeability and cause cellular constituents to leak (Sikkema and others 1994; 
Ultee and others 1998).   
Although a few studies have investigated the efficacy of CIN, only a 
couple have examined its mechanism of inhibition.  One study found that CIN at 
0.3 ml/L was lethal to Bacillus cereus cells but no significant amount of protein 
was lost.  It was reported that treatment with CIN caused exponential phase cells 
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to become long and filamentous and inhibited them from separating from each 
other (Kwon and others 2003).  It was suggested that CIN did not disrupt the 
outer membrane of E. coli O157:H7 and S. Typhimurium because at 264 mg/L it 
did not increase the uptake of a hydrophobic fluorescent probe or influence intra- 
or extracellular ATP pools (Helander and others 1998).   
When a microorganism is exposed to sublethal doses of a chemical that 
negatively influences bacterial growth or survival, it may respond to protect itself, 
or adapt, to increase its tolerance to the same or different type of stress.  A lipid 
can act as a sensor of stress and cause a change in transcription or translation of 
stress-related proteins, which alter cell physiology to increase tolerance to stress.  
A change in fluidity or membrane structure can be detected and the cell may 
respond with alterations in bacterial membrane composition (Yousef and 
Courtney 2003). 
Changes in bacterial lipids in the membrane are a defense mechanism 
used to maintain optimal fluidity in the liquid-crystalline phase for important cell 
processes.  Membrane fluidity is the “combined expression of the effects of [fatty 
acid] chain conformation, lateral and rotational diffusion [of the lipids within the 
membrane] and the resistance of the membrane to sheer forces” (Denich and 
others 2003).  The fluidity of the membrane affects the growth of the cell and the 
proper functioning and structural integrity of the membrane (Denich and others 
2003).  For example, the percentage of unsaturated fatty acids in E. coli 
phospholipids is usually about 50%.  This percentage can decrease to 30% 
without ceasing bacterial growth.   If the percentage of saturated fatty acids 
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decreases to less than 15% the membrane permeability increases (Seltmann 
and Holst 2002).  Lipids directly affect passive permeability and indirectly 
influence cell processes because of their interactions with membrane proteins 
(Russell and others 1995).   
To maintain optimal fluidity the cell may change the fatty acid and 
phospholipid head-group composition which affect the lipid membrane melting 
point (Keweloh and Heipieper 1996).  As melting point decreases, fluidity 
increases (Casadei and others 2002).  For example, fatty acids with high melting 
points, such as saturated, long, and straight-chain fatty acids, decrease 
membrane fluidity (Juneja and Davidson 1993).  A change in the fatty acid 
composition to decrease the fluidity has been shown to be an adaptive response 
to the compensate for the fluidizing effect of an essential oil component (Ultee 
and others 2000).  No studies about the adaptive response to CIN have been 
published.  The objectives of this study were to determine: 
1) the effect of exposure to CIN on the fatty acid composition of the 
bacterial membrane of Salmonella, 
2) whether changes in the fatty acid composition of the bacterial 
membrane of Salmonella occur due to growth in the presence of CIN as a 
possible adaptive response to CIN, and 
3) whether reversal of these changes in fatty acid composition occur when 
the stressor, CIN, was removed. 
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Materials and methods 
 
Bacterial culture preparation 
Salmonella Typhimurium DT104 ATCC BAA-186 was obtained from the 
American Type Culture Collection (ATCC, Rockville, MD).  Experimental cultures 
were maintained on Tryptic Soy Agar slants.  A loopful of culture was used to 
inoculate 9 ml o f BHI with S. Typhimurium.  The BHI tube was incubated for 24 h 
at 35°C.  Then a loopful was transferred into 9 ml BHI and incubated for 21 h at 
35°C.   
Essential oil component  
Stocks solutions of CIN (Fisher Scientific, Fairlawn, NJ) were prepared in 
ethanol, absolute (Aldrich, St. Louis, MO).  Sterile water dissolved into ethanol 
served as the control stock solution.  Aliquots of CIN stock solution were added 
into 8 ml brain heart infusion broth, modified (BHI, BBL, Sparks MD) with 2% 
Tween 20 (Fisher Scientific, Fairlawn, NJ) with glass beads.  The final 
concentration of Tween was 1% and ethanol was 0.5% during adaptation and 
treatment.  Tween and glass beads were used to aid with dispersion of CIN in 
BHI.  All BHI was prepared with phosphate buffer (0.1M, pH 7.2 + 0.1) instead of 
water to prevent pH changes, which could affect the fatty acid composition of 
bacterial membranes.  The pH of BHI was adjusted to 7.35 (+ 0.1) prior to 
autoclaving, after which the final pH was pH 7.2 (+ 0.1).  Glass tubes containing 
the stock and BHI were shaken vigorously forty times to disperse the oil-based 
components. 
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Adaptation 
 In our study adaptation was defined as growth in sublethal concentrations 
of CIN for 24h.  One ml of the 21-h culture was serially diluted 10-3 with three 
tubes of 9 ml BHI.  This dilution was repeated with another set of BHI tubes.  The 
diluted cultures from the two tubes of the 10-3 dilution were combined in a large 
tube.  Five ml of the diluted culture were used to inoculate a 5-ml BHI tube 
containing CIN and a 5-ml BHI tube containing 0.5% ethanol control.  Both tubes 
had 1% Tween. 
 The stock and 5-ml CIN dispersions in BHI were prepared the day before, 
refrigerated, and allowed to warm to room temperature for 30 min before the 5-ml 
diluted culture was added.  This inoculation halved the concentrations and the 
final inoculum was approximately log 5.7 CFU/ml.  The final concentration of 
Tween was 1% and ethanol was 0.5%.  The two inoculated BHI tubes containing 
CIN or ethanol control were vortexed and the cells were allowed to adapt to CIN 
or ethanol (non-adapted) by incubating in a shaking waterbath at 125 rpm for 24 
h at 35°C. 
 Extrapolating from dose-response curves, the concentration that would 
achieve a 25% probability of lethality was used to adapt cells.  This low 
probability of lethality was chosen to induce changes in the membrane lipid 
composition yet also allow enough growth for harvesting cells for lipid analysis.  
This 25% probability of lethality corresponded to 251 mg/L CIN.  After a 24-hour 
growth in or adaptation to 251 mg/L CIN, adapted cells were inoculated into 200 
ml BHI in bottles to treat adapted cells with 251 mg/L CIN for 2 and 24 hours.  
 81 
After inoculation, the desired inoculum in these experiments was about log 5.7 
CFU/ml to adhere to the same inoculum size as in the adaptation procedure.   
 The population of cells resulting after 24-h adaptation was tested since 
these cells would be used to inoculate the bottles.  The population of cells 
adapted to CIN was log 8.5 CFU/ml (average of three repetitions).  The control 
population exposed to 0.5% ethanol was log 8.8 CFU/ml (average).   
 Treatment of adapted cells 
 A total of twelve screw-capped glass bottles containing 190 ml BHI were 
prepared for two and twenty-four hour exposures to CIN.  Ten ml CIN dispersion 
were added to six bottles for a final concentration of 251 mg/L.  Salmonella 
adapted to CIN would be added to two bottles.  Salmonella “adapted” only to 
ethanol would be added to two bottles.  Two bottles would not be inocula ted and 
were designated as sterile CIN controls since the BHI broth media contained fatty 
acids.  Ten ml of ethanol solution were added to six bottles (with no CIN).  
Salmonella adapted to CIN would be added to two bottles.  Salmonella exposed 
only to ethanol (non-adapted) would be added to two bottles.  Two bottles were 
not to be inoculated and were designated as sterile ethanol controls since the 
BHI broth media contained fatty acids from the manufacturer formulation.  The 
final concentrations would contain about 1% Tween and 0.5% ethanol, similar to 
those used to adapt cells.  These twelve bottles containing CIN or ethanol were 
shaken and stored at 4°C until two hours before use, at which time they were 
allowed to warm to 25°C.  Before adding adapted Salmonella, bottles were 
shaken.  The treatments for 2 and 24h incubation were: Sterile controls: sterile + 
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CIN, sterile + ethanol, treatments: non-adapted Salmonella + CIN, adapted 
Salmonella + CIN, inoculated controls: non-adapted + ethanol, adapted + 
ethanol. 
 Tubes containing adapted cells were vortexed prior to inoculating 
Salmonella into the designated bottles.  Based on the preliminary data of 
adapted cell counts, 212 µl of cells adapted to CIN and 166 µl of cells “adapted” 
to ethanol were added to designated bottles for a final inoculum size of about log 
5.7 CFU/ml.  The bottles were shaken and incubated in a shaking waterbath at 
125 rpm for either two or twenty-four hours.  After incubation the samples were 
centrifuged on a large volume centrifuge (Beckman J2-HS, Schaumberg, IL) at 
12,000 rpm for 30 minutes at 4°C.  The pellet was transferred from the centrifuge 
bottles to centrifuge tubes and washed three times with 0.1 M phosphate buffer 
(pH 7.2) at 10,000 rpm for 10 minutes at 4°C using a table-top centrifuge (Baxter 
Biofuge 17 R, VWR Scientific Products, West Chester, PA).  The pellet was 
suspended in less than 1.5 ml phosphate buffer in small ampoules, wrapped in 
parafilm and foil and frozen at -30°C.  The pellet was lyophilized and ampoules 
were wrapped until extraction. 
 Lipid extraction 
 Lipid extraction and analysis procedures were developed by Dr. David C. 
White’s lab, the University of TN Center for Biomarker Analysis.  Lipids from 8-18 
mg lyophilized cells were extracted using a modified Bligh/Dyer method (Guckert 
and others 1985; Guckert and others 1986).  The extraction solvent contained 4 
ml phosphate buffer, 10 ml methanol, and 5 ml chloroform.  After three hours the 
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phases were split with 5 ml water and 5 ml chloroform and allowed to sit 
overnight for layer separation.  The lower chloroform layer was removed and 
dried under nitrogen.  The total lipid extract was suspended in chloroform and 
separated into the lipid classes (neutral lipids, glycolipids, and polar lipids) with 
silicic acid (500 mg) columns using three solvents of increasing polarity (5 ml 
chloroform, 5 ml acetone, and 10 ml methanol) to elute the lipid classes from the 
silicic acid stationary phase (Guckert and others 1985; Guckert and others 1986).   
 Analysis of fatty acid methyl esters 
 To prepare fatty acid methyl esters (FAME) in a mild alkaline methanolic 
transesterification reaction, 0.5 ml chloroform, 0.5 ml methanol, and 1 ml of 
methanolic KOH were added to the dried polar lipids and heated at 60°C for 30 
minutes.  To extract the FAME, 2 ml hexanes, 200 µl glacial acetic acid, and 2 ml 
nanopure water was added.  After centrifuging, the hexane layer was removed.  
This was repeated twice.  The FAME were dried under nitrogen and transferred 
three times with 100 µl hexanes to autosampling vials.   
 The samples were diluted with hexanes containing a 21:0 internal 
standard (50pmol/µl).  The samples and a vial of GC-MIX (mixture of 20 FAME 
standards) were analyzed on a HP6890 gas chromatograph (GC) coupled to a 
HP5973 mass spectrophotometer (MS).  The GC was equipped with a RJX1 
fused silica capillary column (60m, 250µm internal diameter x 25 µm film 
thickness, Restek, Bellefonte, PA).  The column was programmed from an initial 
temperature of 60°C for 2 min then raised at a rate of 10°C/min to 150°C.  The 
temperature was increased at 30°C/min to a final temperature of 312°C.  The 
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injector port temperature was 230°C in split-less mode.  Helium was used as the 
carrier gas at a flow rate of 1.41 ml/min.  Fatty acids were identified by 
comparison of retention times to the FAME standards and a mass spectral data 
library.  Fatty acids were quantified based on comparison to the 21:0 internal 
standard and area under each sample peak and standard peak.   
 Statistical analysis 
Box and whisker plots were generated with Statistica (StatsSoft, Inc., 
Tulsa, OK) to compare total phospholipid fatty acid (PLFA) and fatty acid 
composition.  The 2 and 24h data were divided and a randomized block design 
with blocking on each of three replications was used to test the effect of 
treatments or controls on total PLFA and fatty acids for 2h or 24h.  Data were 
analyzed using SAS (Statistical Analysis System, Cary, NC) to compare 
differences in total PLFA and fatty acids between treatment and control groups 
within 2h or 24h with alpha value at 0.05.  The generalized linear model (GLM) 
was used to test for differences in total PLFA and fatty acids between 2 and 24h 
within each treatment or control group with a Bonferonni correction factor.  This 
correction minimized Type I error, which increases with the number of statistical 
tests.  The Bonferonni p value was calculated as the alpha value at 0.10 divided 
by 6 (the number of follow-up tests conducted to test the interaction between the 
6 treatments at 2h or 24h), which equals 0.017. 
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Results 
 
Total phospholipid fatty acid (PLFA) 
Total phospholipid fatty acid (PLFA ) is the sum of all fatty acids that were 
hydrolyzed from phospholipids in the membrane.  The mean total PLFA is shown 
in Table 3.1.  Depicted in Figures 3.1 and 3.2 are box and whisker plots 
representing the mean, standard error, and standard deviation of the total PLFA 
of the sterile groups of Salmonella under each of the experimental treatments.  
The boundaries of the box around the mean consist of the mean + standard 
error.  The standard error is the standard deviation of the sample mean and is 
computed as the standard deviation divided by the square root of the sample 
size.  The horizontal bars represent the mean + standard deviation.  The 
standard deviation is the positive square root of the variance.  The variance is the 
sum of the squared deviations from the mean divided by the sample size minus 
one.   
An analysis was performed to determine if there was a correlation 
between total PLFA and occurrence of specific fatty acids.  It was found that 
higher total PLFA was positively correlated to the presence of C15:0 (R2=0.81), 
Cy17:0 (R2=0.91), C17:0 (R2=0.78), Cy19:0 (R2=0.85), ratio of Cy17:0 to 
C16:1w7c (R2=0.82), and the ratio of Cy19:0 to C18:1w7c (R2=0.83).  The 
correlation of total PLFA to cyclopropyl fatty acids was expected because as cells 
age and enter stationary phase, the cyclopropyl fatty acids increase (Guckert and 
White 1988; Casadei and others 2002).
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Treatment/control 
and incubation hr  
Total 
PLFA 
(pmol/mg) 
  C12:0 (%) 
  C14:0 (%) 
  C15:0 (%) 
  C16:1w7c (%) 
  C16:0 (%) 
  Cy17:0 (%) 
  C17:0 (%) 
  C18:1w9c (%) 
  
2h                                      
Sterile + CIN 42.9 B 39.8 A 29.3 A 0.0  0.0 C 18.0 B 0.0 B 0.0 0.9  
Sterile + EtOH 191.9 B 35.4 A 29.0 A 0.0  0.0 C 21.6 AB 0.0 B 0.0 1.2  
Non-adapt + CIN 1817.5 B 19.4 AB 16.6 BC 0.0  5.2 B 27.3 AB 2.5 A 0.0 1.9  
Adapt + CIN 635.2 B 22.1 AB 19.8 AB 0.0  2.5 BC 25.2 AB 1.1 ABZ 0.0Z 2.3  
Non-adapt + EtOH 7625.3 AZ 0.8 B 7.8 C 0.0 Z 25.7 AZ 29.5 AZ 2.3 ABZ 0.0Z 0.5  
Adapt + EtOH 3729.1 BZ 0.9 B 7.8 BC 0.0  25.8 AZ 29.7 ABZ 2.0 ABZ 0.0 0.4  
24h                                      
Sterile + CIN 741.6 B 46.5 A 27.2 A 0.0 B 0.0 C 16.7 D 0.0 C 0.0C 1.3 B 
Sterile + EtOH 2396.1 B 23.7 B 31.7 A 0.0 B 0.0 C 21.7 C 0.0 C 0.0C 3.9 A 
Non-adapt + CIN 41495.6 A 4.8 C 8.8 B  0.1 AB 14.6 AB 40.8 A 8.6 B 0.0BC 0.3 B 
Adapt + CIN 53991.8 A 0.2 C 5.9 B  0.1 AB 16.1 A 41.9 A 11.7 AB 0.1AB 0.1 B 
Non-adapt + EtOH 69791.6 A 0.3 C 7.7 B 0.2 A  13.7 B 36.7 B 16.0 A 0.1AB 0.3 B 
Adapt + EtOH 64520.6 A 0.2 C 7.4 B 0.1 AB 14.0 B 38.4 AB 15.3 A 0.0BC 0.2 B 
ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).      
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).    
Table 3.1.  Comparison of total PLFA and fatty acid (FA) composition of CIN-adapted or non-adapted cells with or 
without trans-cinnamaldehyde (CIN) to inoculated controls (+ EtOH) and sterile controls after 2h and 24h incubation. 
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Treatment/control 
and incubation hr  
C18:1w7c 
(%) 
  C18:1w7t (%) 
  C18:0 (%) 
  Cy19:0 (%) 
  Sat. FA (%) 
  Unsat. FA (%) 
  
Cy17 to 
C16:1 
ratio 
  
Cy19 to 
C18:1 
ratio 
  
SFA to 
UFA 
ratio 
  
2-h                                     
Sterile + CIN 0.6 C 0.2  11.2 A 0.0  98.3 A 1.7 C 0.0  0.0  18.1 AB 
Sterile + EtOH 0.9 C 0.2  11.7 A 0.0  97.7 A 2.3 C 0.0  0.0  30.0 A 
Non-adapt + CIN 17.4 ABC 0.4  9.3 A 0.0  72.5 B 27.4 B 0.5 A 0.0  4.9 BC 
Adapt + CIN 13.7 BC 0.3  12.9 AZ 0.0  80.1 AB 19.9 BC 0.2 AB 0.0  8.7 BC 
Non-adapt + EtOH 32.6 AZ 0.0  0.9 B 0.0 Z 38.9 CZ 61.1 AZ 0.1 BZ 0.0 Z 0.6 CZ 
Adapt + EtOH 32.4 ABZ 0.0  1.0 B 0.0  39.4 CZ 60.6 AZ 0.1 BZ 0.0  0.7 CZ 
24-h                                      
Sterile + CIN 1.0 B 0.5 AB 6.9 B 0.0 C 97.2 A 2.8 C 0.0 B 0.0 B 17.1 A 
Sterile + EtOH 1.5 B 0.7 A  16.7 A 0.0 C 93.8 A 6.2 C 0.0 B 0.0 B 15.4 A 
Non-adapt + CIN 19.8 A 0.0 B 1.7 B 0.4 BC 56.2 B 43.8 B 0.6 AB 0.0 AB 1.4 B  
Adapt + CIN 22.6 A 0.0 AB 0.4 B 0.9 AB 48.6 BC 51.4 AB 0.7 AB 0.0 AB 0.9 B 
Non-adapt + EtOH 23.2 A 0.0 B 0.5 B 1.2 A  45.6 C 54.4 A 1.2 A  0.1 A  0.8 B 
Adapt + EtOH 23.0 A 0.0 B 0.4 B 0.8 AB 46.6 BC 53.4 AB 1.1 A 0.0 AB 0.9 B 
ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).      
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017) .    
Table 3.1.  Continued. 
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Figure 3.1.  Comparison of total PLFA or biomass of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 3.2.  Comparison of total PLFA or biomass of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Comparison of total PLFA and each fatty acid across sterile, treatment, 
and control groups (refer to Table 3.1 for means). 
Total PLFA.  Mean total PLFA of treatment groups at 2h is shown in Table 
3.1.  Two outlying data points were eliminated.  One 2h replicate of the adapted 
control (+ ethanol or EtOH) had a total PLFA of 124.1 pmol/mg.  One 24h 
replicate of the adapted treatment (+ CIN) had a total PLFA of 228.1 pmol/mg.  
These were eliminated because of their low total PLFA, which indicated very low 
or no growth and their fatty acid compositions correlated highly with the sterile 
groups.  This replicate of the adapted treatment was likely to have been 
completely inhibited by CIN since the concentrations used for adaptation and 
treatment were the dosage at which 25% probability of lethality was predicted.    
In the 2-hr samples, the non-adapted Salmonella inoculated EtOH control 
(no CIN) had the highest total PLFA (Figure 3.1 and Table 3.1).  The total PLFA 
of the non-adapted Salmonella inoculated EtOH control was highest because the 
cells were not exposed to CIN and were able to grow more quickly than the other 
groups even at 2 hours.  The total PLFA of all other groups was lower and not 
different from each other (p>0.05).   
Although not significantly (p>0.05) higher, the adapted control appeared to 
have more total PLFA than the non-adapted and adapted cells treated with CIN.  
The bacteria in the adapted and non-adapted EtOH controls seemed to grow 
faster because they were not inhibited by CIN.  The sterile controls contained 
very low total PLFA because they were not inoculated (Figures 3.1 and 3.2).  The
 90 
total PLFA found in uninoculated controls was due to the fatty acids present in 
the culture medium from the manufacturer’s formulation of BHI.   
At 24h of incubation the total PLFA of all inoculated groups was 
significantly (p<0.05) higher than the sterile groups (Figure 3.2).  Only the 
adapted and non-adapted EtOH controls had a significantly (p<0.001 and 
p<0.05, respectively) higher total PLFA at 24h compared to 2h (Table 3.1).  The 
adapted and non-adapted treatment groups had a trend of increasing total PLFA 
over time, but this was not significantly different (p>0.05 and p>0.02, 
respectively).  The wide variability within the groups probably obscured the 
significance of this increase.   
C12:0 fatty acid.  At 2h of incubation, the C12:0 fatty acid detected in the 
sterile groups was from the culture medium (Figure 3.3).  The sterile groups had 
more C12:0 fatty acid than the non-adapted and adapted controls.  This 
difference indicates that even at 2h the bacteria in the controls were growing and 
using C12:0, and therefore decreasing the relative percentage of C12:0.  The 
abundance of C12:0 in the non-adapted and adapted treatment groups did not 
differ from each other and the sterile controls.  The growth of bacterial cells in the 
treatment groups was inhibited by CIN so lipid biosynthesis by the anaerobic 
pathway was decelerated.  They incorporated C12:0 from the medium but could 
not oxidize and convert it to other fatty acids in the presence of CIN. 
At 24h all four inoculated groups contained significantly (p<0.05) less 
C12:0 than sterile groups (Figure 3.4).  This reflects the difference in total PLFA 
at 24h and utilization of C12:0.  The bacteria in the inoculated groups had more 
 91 
盨td. Dev.
盨td. Err.
Mean
Treatment
C
12
:0
 F
at
ty
 a
ci
d 
(r
el
at
iv
e 
%
)
-5
5
15
25
35
45
55
65
Sterile
+CIN
Sterile
+EtOH
Nonadapt
+CIN
Adapt
+CIN 
Nonadapt
+EtOH
Adapt
+EtOH
Figure 3.3.  Comparison of C12:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.4.  Comparison of C12:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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time to grow and utilize 12:0.  There were no significant (p>0.05) differences 
among the inoculated groups because the bacteria in the treatment groups were 
able to grow and convert 12:0 to another fatty acid.   
However, the wider standard error of the non-adapted cells treated with 
CIN implies that some Salmonella cells in a culture were less able to decrease 
the proportion 12:0 than others because they were more inhibited due to CIN 
exposure.  This wider range of response indicates that a population of non-
adapted cells can display a range of sensitivity to CIN and therefore a range in 
the ability to grow and decrease the percentage of C12:0.   
In contrast, the adapted cells group seem to be less inhibited than its non-
adapted counterpart because they were able to decrease C12:0 percentage 
more readily with a narrower range of error.  The population of adapted cells 
seems to demonstrate more similar sensitivity to CIN than non-adapted cells.  
The groups did not have more C12:0 fatty acid at 24h compared to 2h. 
C14:0 fatty acid.  At 2 and 24h, the sterile groups had similar percentages 
of C14:0 (Figures 3.5 and 3.6).  Even at 2h the inoculated controls (+EtOH) were 
able to grow and convert 14:0, which resulted in significantly (p<0.05) lower 
C14:0 than the sterile groups.  The level of C14:0 in the adapted and non-
adapted cells treated with CIN was in between that of the sterile and inoculated 
controls.  The growth of bacterial cells in the treatment groups was inhibited by 
CIN so lipid biosynthesis was decelerated.  They incorporated C14:0 from the 
medium but could not oxidize and convert it to other fatty acids as well as the 
inoculated controls. 
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Figure 3.5.  Comparison of C14:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.6.  Comparison of C14:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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At 24h the bacteria in all four inoculated groups grew and the proportion of 
C14:0 was significantly (p<0.05) lower than the sterile groups (Figure 3.6).  The 
abundance of C14:0 did not differ significantly (p>0.05) among inoculated groups 
because the bacteria in the treatment groups grew and were able to convert 14:0 
to another fatty acid.   As with C12:0 at 24h, the wider standard error indicates 
that some non-adapted cells treated with CIN were not as able to lower the 
percentage of C14:0 as quickly as the adapted cells treated with CIN and 
inoculated controls since the cells were more inhibited by exposure to CIN.  The 
percentage of C14:0 did not differ from 2h to 24h for all groups. 
C15:0 fatty acid.  C15:0 was detected at very low percentages at 2h 
(Figure 3.7).  There were no significant (p<0.05) differences among the groups.  
Only the non-adapted control had a significantly (p<0.) higher abundance C15:0 
at 24h than at 2h (Table 3.1).  At 24 hours the bacteria in the non-adapted control 
produced significantly (p<0.05) more C15:0 than the very low level present in the 
culture medium of the sterile controls (Figure 3.8).  Among the inoculated groups 
there were no significant (p>0.05) differences at 24h.   
C16:1w7c fatty acid.  At 2h the inoculated controls (+EtOH) were able to 
produce more C16:1w7c than all the other groups since the bacteria were not 
inhibited by CIN (Figure 3.9).  The non-adapted and adapted treatment groups 
were still inhibited by C IN at 2h and not able to produce as much C16:1w7c.  At 
24h, the levels of C16:1w7c produced by bacteria in the four inoculated groups 
was greater (p<0.05) than the low amount present in the culture medium of the 
sterile controls (Figure 3.10).  C16:1w7c in the adapted cells treated with CIN 
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Figure 3.8.  Comparison of C15:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 3.7.  Comparison of C15:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.10.  Comparison of C16:1w7c fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 3.9.  Comparison of C16:1w7c fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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were higher than in the inoculated controls.  Only the adapted and non-adapted 
controls significantly (p<0.0001 and p<0.0005) decreased C16:1w7c from 2h to 
24h (Table 3.1).  In contrast, there was a trend of increased C16:1w7c at 24h 
produced by the two treatment groups exposed to CIN, but this was not 
significant (p>0.04 and p>0.02, respectively).  
C16:0 fatty acid.  At 2h there was a broad range of converting C16:0 in the 
non-adapted and adapted cells treated with CIN (Figure 3.11).  The broad range 
reflected the different CIN sensitivities of cells in the population.  In contrast, the 
inoculated controls had a narrower range.  Overall, the sterile groups did not 
differ from inoculated groups in percentage of C16:0.   
At 24h, the percentage of C16:0 in the inoculated groups was significantly 
(p<0.05) higher than the sterile groups (Figure 3.12).  The non-adapted and 
adapted cells treated with CIN produced more C16:0 than the non-adapted 
control.  Only the non-adapted and adapted controls produced more C16:0 at 
24h than at 2h (p<0.001 and p<0.01, respectively) (Table 3.1).  The non-adapted 
treatment group seemed to synthesize more C16:0 at 24h, but this was not 
significant (p>0.04), and perhaps obscured by variation within the group. 
Cy17:0 fatty acid.  The percentage of Cy17:0 did not differ among the four 
inoculated groups at 2h (Figure 3.13).  The non-adapted cells treated with CIN 
had a significantly (p<0.05) higher percentage of Cy17:0 than the steriles.  Again, 
there is a wide range of response from the non-adapted cells treated with CIN.   
At 24h Cy17:0 was more abundant in the control than in the sterile groups 
and non-adapted treatment group, which was inhibited by CIN (Figure 3.14).  
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Figure 3.12.  Comparison of C16:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 3.11.  Comparison of C16:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.14.  Comparison of Cy17:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 3.13.  Comparison of Cy17:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
 100 
This indicated that the controls reached stationary phase sooner since they were 
not inhibited.  The adapted cells treated with CIN did not differ from the non-
adapted treated cells and the controls.  The adapted treatment and control 
groups formed significantly (p<0.05 and p<0.005, respectively) more Cy17:0 at 
24h than at 2h (Table 3.1). 
C17:0 fatty acid.  At 2h, there were no differences (p>0.05) in C17:0 
among all the groups (Figure 3.15).  The pattern of wider standard errors in the 
non-adapted treatment group and adapted control group resembled that of C15:0 
at 2h.  At 24h the non-adapted control produced more C17:0 than the sterile 
groups, adapted control, and non-adapted cells treated with CIN (Figure 3.16).   
Compared to 2h, C17:0 was significantly more abundant in the adapted 
treatment and non-adapted control groups at 24h (p<0.0005 and p<0.005, 
respectively) (Table 3.1).  
C18:1w9c fatty acid.  The percentages of C18:1w9c among all six groups 
were not significantly (p>0.05) different at 2h (Figure 3.17).  The four inoculated 
groups did not differ from the sterile + CIN group in this fatty acid at 24h (Figure 
3.18).  The sterile + EtOH group had more C18:1w9c than all other groups.  The 
abundance of this fatty acid did not differ from 2h to 24h within each group, 
except for a slight, but insignificant (p>0.02) decrease in the adapted cells treated 
with CIN.    
C18:1w7c fatty acid.  The non-adapted control had higher (p<0.05) levels 
of C18:1w7c than the sterile groups at 2 and 24h (Figures 3.19 and 3.20).  This 
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Figure 3.16.  Comparison of C17:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 3.15.  Comparison of C17:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.17.  Comparison of C18:1w9c fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 3.18.  Comparison of C18:1w9c fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 3.19.  Comparison of C18:1w7c fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 3.20.  Comparison of C18:1w7c fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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fatty acid was not detected in the medium.  As seen with other fatty acids, there 
was a wide standard error of C18:1w7c produced in the non-adapted and 
adapted cells treated with CIN, which reflected the range of sensitivity of cells to 
CIN.  At 24h, these cells were able to grow and synthesize at proportions similar 
to the control groups because the percentage of C18:1w7c was not different 
(Figure 3.20).  All four inoculated groups produced more of this fatty acid than the 
sterile groups.  Compared across time, only the controls significantly (p<0.02) 
decreased C18:1w7c from 2h to 24h (Table 3.1). 
C18:1w7t fatty acid.  The abundance of C18:1w7t at 2h did not differ 
among the groups (Figure 3.21).  It was only present in the sterile groups at 2 
and 24h and in the treatment groups at 2h, but depleted at 24h.  It was only 
present in the treatment groups because the bacteria were inhibited by CIN and 
had not yet metabolized it.  There were no significant changes in C18:1w7t from 
2h to 24h and no differences among groups at 24h (Figure 3.22).   
C18:0 fatty acid.  At 2h, the non-adapted and adapted controls lowered 
the proportion of C18:0 because they were able to grow (Figure 3.23).  The non-
adapted and adapted cells treated with CIN had percentages of C18:0 similar to 
those of the sterile groups.  They had incorporated C18:0 from the medium.  The 
growth of bacterial cells in the treatment groups was inhibited by CIN so lipid 
biosynthesis was decelerated.  They incorporated C18:0 from the medium but 
could not oxidize and convert it to other fatty acids as well as the inoculated 
controls, but this changed at 24h (Figure 3.24).
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Figure 3.21.  Comparison of C18:1w7t fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 3.22.  Comparison of C18:1w7t fatty acid of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 3.23.  Comparison of C18:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.24.  Comparison of C18:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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At 24h, as the cells grew in the non-adapted and adapted treatment 
groups, they were able to convert C18:0 to another fatty acid and therefore 
decrease the percentage of C18:0 (Figure 3.24).  The percentage of C18:0 
significantly (p<0.005) decreased from 2h to 24h in adapted cells treated with 
CIN (Table 3.1).  Therefore, the abundance of C18:0 did not differ among the 
inoculated groups.  There was a pattern of decreased fatty acid over time in the 
non-adapted control, but this was not significant. 
Cy19:0 fatty acid.  Cy19:0 was not detected in any group at 2h (Figure 
3.25).  However, at 24h the non-adapted control had formed more Cy19:0 than 
the non-adapted treatment because it reached stationary phase sooner (Figure 
3.26).  Since the treatment group had a longer lag phase it did not produce as 
much Cy19:0.  There were no differences among the treatment groups and the 
adapted control at 24h.  The non-adapted control formed significantly (p<0.01) 
more Cy19:0 at 24h than at 2h (Table 3.1).  The same trend occurred with the 
adapted treatment group, but this was not significant. 
Saturated fatty acids.  At 2h, the control groups had less SFA than the 
other groups (Figure 3.27).  At 24h, the treatment groups were able to decrease 
the percentage of SFA to similar levels as the controls (Figure 3.28).  These fatty 
acids were highest in the sterile groups.  There was wide variation in the non-
adapted treatment group and more SFA than in the non-adapted control.  From 
2h to 24h, the controls significantly (p<0.02) produced more SFA (Table 3.1).   
Monounsaturated fatty acids.  The controls synthesized more UFA than 
the other groups at 2h (Figure 3.29).  At 24h (Figure 3.30) the treatment groups 
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Figure 3.25.  Comparison of Cy19:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 3.26.  Comparison of Cy19:0 fatty acid of CIN-adapted or non-
adapted cells with or without CIN to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 3.27.  Comparison of saturated fatty acids of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
盨td. Dev.
盨td. Err.
Mean
Treatment
S
at
ur
at
ed
 fa
tty
 a
ci
ds
 (r
el
at
iv
e 
%
)
40
50
60
70
80
90
100
110
Sterile
+CIN
Sterile
+EtOH
Nonadapt
+CIN
Adapt
+CIN 
Nonadapt
+EtOH
Adapt
+EtOH
Figure 3.28.  Comparison of saturated fatty acids of CIN-adapted or 
non-adapted cells with or without CIN to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 3.29.  Comparison of monounsaturated fatty acids of CIN-
adapted or non-adapted cells with or without CIN to inoculated controls 
(+EtOH) and sterile controls after 2-hr incubation  
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Figure 3.30.  Comparison of monounsaturated fatty acids of CIN-
adapted or non-adapted cells with or without CIN to inoculated controls 
(+EtOH) and sterile controls after 24-hr incubation  
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produced more UFA to levels similar to the controls.  These fatty acids were 
higher in the non-adapted control than in the non-adapted treatment.  The 
controls significantly (p<0.02) decreased UFA from 2h to 24h (Table 3.1). 
Ratio of Cy17:0 to C16:1w7c.  C16:1w7c is the precursor to Cy17:0.  
There were no values for this ratio in the sterile groups because no Cy17:0 was 
present in the culture medium nor bacterial cells to form it (Figures 3.31 and 
3.32).  The ratio did not differ between the treatments groups or between the 
control groups at 2h.  The non-adapted treatment group had a higher ratio than 
the control groups.  At 24h, there were no differences among the inoculated 
groups, although the ratio appears to be higher in the control groups, suggesting 
earlier entry into the stationary phase (Figure 3.32).  From 2h to 24h, the ratio 
increased significantly (p<0.01) for the control groups (Table 3.1).  The ratio 
increases in the treatment groups were not significant, but probably obscured by 
the wide variation at 2h. 
Ratio of Cy19:0 to C18:1w7c.  C18:1w7c is the precursor to Cy19:0.  The 
ratios of Cy19:0 to C18:1w7c were zero at 2h since no Cy19:0 was detected 
(Figure 3.33).  At 24h, the ratios were not different among the inoculated groups 
(Figure 3.34).  The ratio increased from 2 to 24h for the non-adapted control 
group only (p<0.02) (Table 3.1).  There were slight increases in the adapted 
treatment and adapted control groups, but these were not significant.  
Ratio of saturated to unsaturated fatty acids.  At 2 and 24h, the sterile 
groups had a higher ratio because of the medium (Figures 3.35 and 3.36).  It 
seemed that that these ratios were varied more in treatment groups.  This 
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Figure 3.31.  Comparison of ratio of Cy17:0 to 16:1w7c fatty acid of 
CIN-adapted or non-adapted cells with or without CIN to inoculated 
controls (+EtOH) and sterile controls after 2 -hr incubation  
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Figure 3.32.  Comparison of ratio of Cy17:0 to 16:1w7c fatty acid of 
CIN-adapted or non-adapted cells  with or without CIN to inoculated 
controls (+EtOH) and sterile controls after 24-hr incubation  
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Figure 3.33.  Comparison of ratio of Cy19:0 to 18:1w7c fatty acid of 
CIN-adapted or non-adapted cells with or without CIN to inoculated 
controls (+EtOH) and sterile controls after 2 -hr incubation  
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Figure 3.34.  Comparison of ratio of Cy19:0 to 18:1w7c fatty acid of 
CIN-adapted or non-adapted cells with or without CIN to inoculated 
controls (+EtOH) and sterile controls after 24-hr incubation  
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Figure 3.35.  Comparison of ratio of saturated to unsaturated fatty 
acids of CIN-adapted or non-adapted cells with or without CIN to 
inoculated controls (+EtOH) and sterile controls after 2-hr incubation  
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Figure 3.36.  Comparison of ratio of saturated to unsaturated fatty 
acids of CIN-adapted or non-adapted cells with or without CIN to 
inoculated controls (+EtOH) and sterile controls after 24-hr incubation  
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indicated that the groups were more inhibited by CIN and the cells differed in 
their sensitivity to CIN.  Their ratios were numerically greater than in the controls.  
They were less able to decrease the ratio of SFA to UFA than the controls 
because they were inhibited.  However, the ratios of the four inoculated groups 
did not differ significantly (p>0.05) from each other.   
At 24h, all four inoculated groups had lower ratios than the sterile groups 
(Figure 3.36).  From 2h to 24h, the ratio increased significantly (p<0.02) only in 
the controls (Table 3.1).  Numerically, it seemed that the ratio decreased for the 
treatment groups.  However, this was not significant (p>0.1) and the difference 
may have been obscured by the variability at 2h.   
 
Discussion 
 
Anaerobes, facultative anaerobes, and also some aerobic bacteria 
synthesize lipids via the anaerobic pathway, which has been studied in E. coli.  
The starting reactants are acetyl-CoA and 3 malonyl-ACP.  A trans double bond 
is produced during elongation.  From that point, it can be reduced to form a 
saturated fatty acid or isomerized into a cis-monoenoic fatty acid.  This cis fatty 
acid cannot be reduced and remain unchanged with further elongation.  These 
saturated and cis-unsaturated chains are incorporated into phospholipids of the 
membrane.  Since the degree of saturation cannot change after synthesis, the 
ratio of SFA to UFA cannot be changed in cells that cease growth.  Phospholipid 
biosynthesis quickly decelerates if growth stops.  However, post-synthesis 
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modification of cis-monoenoic fatty acids to their cyclopropyl derivatives and 
trans-isomers can still occur (Diefenbach and others 1992; Keweloh and 
Heipieper 1996).   
The uptake of fatty acids from the culture medium can occur by acyl-chain 
unspecific or active or passive transport.  They are oxidized or incorporated in 
membrane lipids, which is regulated.  Biosynthesis is regulated as well 
(Diefenbach and others 1992; Keweloh and Heipieper 1996). 
Membrane fluidity has been correlated with changes in fatty acid 
composition (Mazzotta and Montville 1997).  Certain types of lipid may have a 
greater influence on the fluidity than other.  For example, converting a cis-
monoenoic acid to its trans-isomer greatly reduces fluidity, but not as significant 
as a change in cis to saturated fatty acids (Keweloh and Heipieper 1996).   
The melting points of unsaturated fatty acid (UFA) and branched chain 
fatty acids are lower than that of saturated fatty acids (SFA).  There are 
hydrophobic interactions among acyl chains of SFA.  In membranes rich with 
SFA the membrane is packed and rigid.  The chain can extend at its maximum if 
the saturated chain rotates into a trans -conformation (Keweloh and Heipieper 
1996).   
In contrast, the double bond in cis-UFA creates a 30° angle in the acyl 
chain.  This kink disrupts the ordered packing of the acyl chains in the membrane 
(Keweloh and Heipieper 1996).  Therefore, an increase in UFA causes a 
decrease in the temperature for the transition from the gel to the liquid-crystal 
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membrane phase and an increase in fluidity (Keweloh and Heipieper 1996; 
Casadei and others 2002).   
A shortening in the acyl chain length will also lower the melting 
temperature and increase fluidity.  A change in the degree of saturation is 
thought to be more effective than a change in the chain length (Keweloh and 
others 1991).  Cyclopropyl fatty acids (CFA) are more physically similar to cis-
monoenoic fatty acids, which are precursors of CFA.  Trans-fatty acids are more 
stable and resemble SFA (Guckert and others 1986).  Trans-UFA acyl chains are 
long and extended, packing more rigidly and occupying lower molar volume in 
the membrane to significantly increase the phase transition temperature 
(Diefenbach and others 1992; Keweloh and Heipieper 1996).   
The ratio of UFA to SFA indicates membrane fluidity.  Casadei and 
colleagues (2002) developed a fluidity index that was calculated as the ratio of 
UFA plus cyclopropane fatty acids (CFA) in stationary phase to SFA.  They 
extracted phospholipids from E. coli grown at different temperatures and 
measured the phase transition temperatures by DSC.   
Casadei and colleagues (2002) confirmed the validity of the fluidity index 
as an indicator of membrane fluidity.  They found that there was a direct linear 
relationship between the phase transition temperature and growth temperature 
and then an inverse linear relationship between the phase transition temperature 
and the fluidity index of phospholipids.  The proportion of SFA increased while 
the proportion of UFA decreased with increasing growth temperature in 
stationary and exponential phase cells.  The fluidity index was slightly greater in 
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exponential than stationary phase cells.  They reported that the abundance of 
CFA increased and C18:1 and C16:1 decreased in stationary phase cells.  Since 
most of the treatment groups in this present data contained mostly SFA, a ratio 
was calculated of SFA to UFA plus CFA.   
The measurement of the ester-linked phospholipid fatty acids (PLFA) is 
useful.  The PLFA content quantitatively indicates the viable biomass since they 
have a high turnover rate and are present in consistent abundance in cell 
membranes.  When cells die or lyse, hydrolysis of phospholipids quickly occur 
and the polar head group and diglyceride remain (White and Ringelberg 1997).   
In addition to providing an estimate of the viable biomass, PLFAs can 
indicate nutritional and physiological status using the ratio of trans-monoenoic 
fatty acids to their cis homologues and the ratio of cyclopropyl derivatives to their 
monoenoic fatty acid precursors (White and Ringelberg 1997).  During starvation 
of cultures of Vibrio cholerae, the trans/cis ratio increased.  The cis-monoenoic 
fatty acids (such as 16:1w7c and 18:1w7c) decreased and the SFA, CFA, and 
trans-monoenoic fatty acids increased.  During starvation, membrane fluidity 
decreased overall (Guckert and others 1986).   
When loss of phospholipid occurred during starvation, cis-monoenoic 
acids were preferentially utilized to possibly enhance survival.  Cis fatty acids 
have faster turnover than saturated fatty acids and are more easily metabolized.  
During starvation, bacteria may synthesize trans-monoenoic acids, which 
bacteria do not readily metabolize, or transmethylate unstable cis- monoenoic 
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fatty acids to form their cyclopropyl derivatives to survive (Guckert and others 
1986).   
It has been suggested that CFA are more stable to turnover and 
degradation (Guckert and others 1986).  CFAs were formed (with a decline in 
their cis-fatty acid precursors) in Vibrio cholerae and Pseudomonas putida as 
cells aged and entered the stationary phase (Guckert and others 1986; 
Diefenbach and others 1992; Loffeld and Keweloh 1996).  It has been 
hypothesized that CFA are formed under stress when growth stops (Guckert and 
others 1986). 
The objectives in our study were to: 
1) Determine the effect of exposure to CIN on the fatty acid composition of 
the bacterial membrane of Salmonella. 
At 2h the non-adapted treatment group had significantly (p<0.05) lower 
total PLFA and lower (p<0.05) C16:1w7c than the non-adapted control (+ EtOH), 
which contributed to lower (p<0.05) UFA and a higher (p<0.05) Cy17:0 to 
C16:1w7c ratio.  C18:0 was also higher (p<0.05), which increased the 
abundance of the saturated fatty acids.  CIN decreased the fluidity of the 
membrane within 2h of exposure and inhibited growth.  At 2h, the non-adapted + 
CIN group had a numerically higher SFA to UFA ratio than the non-adapted + 
EtOH group, which also suggested that CIN decreased fluidity.  However, this 
difference lessened at 24h.  
At 24h the non-adapted treatment group had significantly (p<0.05) higher 
C16:0, but lower Cy17:0 and Cy19:0 than the non-adapted control.  Similar to 
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results at 2h, CIN decreased the fluidity.  SFA was significantly (p<0.05) higher 
and UFA was significantly (p<0.05) lower in the non-adapted treatment group 
than in the non-adapted control.  The total PLFA of the non-adapted treatment 
group was lower than the control group, which indicated lower lipid biosynthesis 
and growth.  The non-adapted treatment group had a numerically higher SFA to 
UFA ratio than the non-adapted control group, which indicated that long-term CIN 
exposure reduced fluidity. 
2) Determine whether changes in the fatty acid composition of the 
bacterial membrane of Salmonella occur due to growth in the presence of CIN as 
a possible adaptive response to CIN. 
At 2h and 24h there were no significant (p>0.02) differences in the total 
PLFA or fatty acids between the treatment groups as a function of the incubation 
time (Table 3.1).  However, at 2h the SFA to UFA ratio of the adapted treatment 
group was numerically higher than that of non-adapted group.  This suggested 
that adaptation decreased membrane  fluidity.   
At 24h, the SFA to UFA ratio was smaller in the adapted than non-adapted 
group, perhaps because the numeric increase in C16:1w7c in the adapted 
treatment was more drastic than in the non-adapted group.  At 24h the difference 
in the SFA to UFA ratio between the groups is considerably smaller, perhaps 
because the 24h growth allowed adaptation of the non-adapted treatment group, 
which allowed it to synthesize lipid similarly to the adapted treatment group.   
3) Determine whether reversal of these changes in fatty acid composition 
occurs when the stressor, CIN, is removed. 
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At 2h and 24h there were no significant (p>0.05) differences in the fatty 
acids between the groups.  Even the SFA to UFA ratios were similar.  This 
indicated that any changes during adaptation (in the absence of subsequent 
exposure) were not maintained.  At 24h, the total PLFA of the non-adapted 
control was numerically higher than that of the adapted control, which may 
indicate that the initial adaptation caused some growth inhibition. 
4) Determine whether any adaptive changes in the fatty acid composition 
are maintained after subsequent exposure to the CIN. 
At 2h the adapted treatment group had less C16:1w7c than the adapted 
control, which decreased the overall UFA, and more C18:0 which increased the 
abundance of SFA.  The SFA to UFA ratio in the adapted treatment was also 
numerically greater.  CIN adaptation and subsequent exposure decreased the 
fluidity within 2h, and also inhibited growth as shown in the numerically lower 
total PLFA. 
At 24h the only significant (p<0.05) difference was that the adapted 
treatment group produced more C16:1w7c.  The adapted treatment group had a 
numerically higher SFA to UFA ratio than the adapted control at 24h, but not as 
higher as it was at 2h.  Therefore, at 24h the membrane was less fluid in the 
adapted control. 
Adaptation, in terms of decreased fluidity, seems to have been maintained with 
subsequent exposure for 2 and 24h.  
5) Determine the effect of growth in the presence of CIN (adaptation) and 
subsequent CIN treatment on affect fatty acid composition. 
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Overall, most of the changes were in the longer chain fatty acids than in 
the shorter chain fatty acids such as C12:0, 14:0, and 15:0.  At 2h compared to 
the non-adapted control, the adapted treatment group had lower total PLFA, 
C16:1w7c, C18:1w7c, and monounsaturated fatty acids and higher C14:0, C18:0, 
and SFA.  Therefore, with adaptation and subsequent exposure, CIN caused a 
decrease in fluidity.  At 24h, the group had higher C16:1w7c and C16:0 than the 
non-adapted control.  The SFA to UFA ratio of the adapted treatment was much 
greater than the control at 2h, but that magnitude of difference declined at 24h.   
It appears that in both treatment groups the membrane became more fluid 
and in the control groups less fluid with time.  At 24h differences between the 
treatments and controls had decreased compared to 2h in terms of the SFA to 
UFA ratio.  With only 2h of exposure to CIN, both treatment groups synthesized a 
numerically higher proportion of SFA (compared to the non-adapted control) in 
response to CIN.  Perhaps this response to 2h incubation was more similar to an 
adaptation.  The length of time needed for an adaptation to develop to CIN is not 
known.   
Significant (p<0.02) changes from 2h to 24h occurred mostly with the 
control groups and occasionally with the adapted treatment group.  However, 
significant differences may not have been detected due to variability within these 
treatment groups.  At 2h, the proportions of C12:0, C14:0 and C18:0 of the 
treatment groups were more similar to that sterile controls or in between that of 
the sterile controls and inoculated controls.  It is hypothesized that the bacteria of 
the treatment groups had incorporated these fatty acids from the medium but 
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were not able to convert them to other fatty acids because growth was inhibited 
by CIN treatment.  With time, the non-adapted treatment overcame the inhibition 
and was able to grow and synthesize phospholipids (as evidenced by the 
numerical increase in total PLFA and decrease in these fatty acids) for a more 
favorable proportion of SFA to UFA ratio that is closer to homeostasis such as in 
the non-adapted + EtOH group.   
The concentration of membrane fatty acids in the controls was expected to 
increase in the SFA to UFA ratio because C16:1w7c and C18:1w7c typically 
decline and CFA increase in stationary phase (Casadei and others 2002).  These 
significant (p<0.02) changes occurred in the controls from 2 to 24h.  Over time, 
SFA increased in the controls, which was a sign of starvation, along with the 
decrease in C16:1w7c and C18:1w7c and increase in CFA (Guckert and others 
1986).  The treatments did not seem to have entered stationary phase over time 
because there were numerical increases in C16:1w7c and C18:1w7c.  However, 
there was also a significant increase of Cy17:0 in the adapted treatment and a 
numerical increase in the non-adapted treatment as well as numeric increases in 
Cy19:0. 
 Since lipophilic compounds accumulate and act on the membrane, it was 
expected that membranes would respond to CIN, which is a lipophilic, aromatic 
aldehyde.  Carvacrol, which is a lipophilic and phenolic essential oil component, 
was found to expand the liposomal membrane using fluorescent probes.  This 
suggested an increased fluidity (Ultee and others 2002).  If the membranes 
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become too fluid, additional carvacrol can continue to permeate the membrane, 
accumulate, and cause more damage (Ultee and others 1998).   
It is believed that this swelling leads to a destabilized membrane and 
therefore a leakage of ions (Ultee and others 2002).  During exposure to 
carvacrol (CRV), an influx of protons and efflux of potassium ions in Bacillus 
cereus was reported (Ultee and others 1999).  This leakage was also evident in 
the decrease of the pH gradient across the membrane (Ultee and others 2002).  
The leakage of ions leads to a drop in the membrane potential and depletion of 
the intracellular ATP pool (Ultee and others 2002).  It was found that 300 mg/L of 
CRV reduced viable count of Bacillus cereus cells in 30 min and depleted 
intracellular ATP within 7 min without a proportional increase in extracellular ATP 
(Ultee and others 1999). 
 There was no literature that has determined the precise mechanism of 
action of CIN.  Helander and others (1998), who reported that carvacrol at 300 
mg/L (MIC = 451 mg/L) increased the uptake of hydrophobic fluorescent probe 
NPN in E. coli O157:H7 and S. Typhimurium and decreased intracellular ATP in 
E. coli O157:H7, but with a smaller increase in extracellular ATP.  Uptake of NPN 
occurred because the outer membrane was no longer acting as a strong 
permeability barrier.  These effects indicated that CRV disrupted the outer 
membrane.  In contrast, it was suggested that CIN did not disrupt the outer 
membrane of E. coli O157:H7 and S. Typhimurium because at 264 mg/L it did 
not increase the uptake of NPN or influence intra- or extracellular ATP pools of 
(Helander and others 1998).   
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 No literature has been published that has investigated the adaptation to 
CIN.  There was a study that examined the adaptive response of Bacillus cereus 
to CRV (Ultee and others 2000).  They reported that after CRV was added to 
exponentially growing, non-adapted cells there was a decrease in the melting 
temperature (Tm) of the membrane (20.5°C to 12.6°C).  This disagreed with the 
finding in this present study that exposure to CIN decreased membrane fluidity 
as reflected by the higher SFA to UFA ratio.  Ultee and others (2000) reported 
that compared to non-adapted cells, cells adapted to 60 mg/L exhibited a less 
fluid membrane because the Tm increased from 20.5°C to 28.3°C.  Iso-C13:0, 
C14:0 and iso-C15:0 fatty acids (which are higher melting) increased in the 
membrane lipid composition of B. cereus cells incubated with 60 mg/L carvacrol.  
Similarly, this study found a higher SFA to UFA ratio with adaptation, which 
indicated decreased fluidity. 
 Greater saturation found with adaptation to phenol was suggested to 
result in a more rigid membrane that compensated for an increase in fluidity and 
permeability caused by phenol.  Saturated fatty acids have acyl chains that are 
packed more closely, which could limit the entry of phenol and therefore, its toxic 
effect (Keweloh and others 1991).  In the same way, the increase of saturation 
upon exposure and adaptation to CIN could reduce its accessibility into or its 
impact on the cell. 
   CIN did not disrupt the outer membrane because it did not increase the 
uptake of a hydrophobic probe or affect ATP pools according to Helander and 
others (1998).  Therefore, it is reasonable that an increase in fluidity upon 
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exposure or adaptation was not observed in this present study.  It appears that 
the mechanism of action of CIN is not an increase in permeability.  Its 
mechanism is unlikely to be related to an interaction with acyl chains as with 
CRV.  The carbonyl group of aldehydes can bind to metal ions, sulfhydryl groups, 
amino acids, and proteins (Bowles and Miller 1993).  CIN was found to be an 
effective inhibitor of histidine decarboxylase activity of Enterobacter aerogenes 
and its carbonyl group was suggested as the functional group (Wendakoon and 
Sakaguchi 1995). 
 
Significant findings 
 
 After 2h of exposure to CIN, the non-adapted treatment group had 
significantly (p<0.05) lower total phospholipid fatty acid (PLFA), lower C16:1w7c 
and unsaturated fatty acid (UFA) and higher (p<0.05) C18:0, saturated fatty acid 
(SFA), and Cy17:0/C16:1w7c ratio than the non-adapted control.  After 24h of 
exposure to CIN, the non-adapted treatment group had significantly (p<0.05) 
lower Cy17:0, Cy19:0, and UFA than the non-adapted control and higher 
(p<0.05) C16:0 and SFA.  At 2h, the SFA/UFA ratio in the membranes of adapted 
cells exposed to CIN was numerically higher than in the non-adapted cells 
treated with CIN.  Although there were no significant differences in fatty acids as 
a function of incubation time, at 24h the SFA /UFA ratios of the adapted and non-
adapted Salmonella were similar.  Since the fatty acid composition and total 
PLFA of the non-adapted control and adapted controls were similar at 2 and 24h, 
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the adaptive response had been reversed since the stressor, CIN, was not used 
to treat the adapted controls.   
Most of the changes from 2 to 24h occurred in the membrane of the non-
adapted and adapted control Salmonella.  Over time there was a decrease 
(p<0.01) in C16:1w7c, C18:1w7c, and UFA and an increase (p<0.01) in total 
PLFA, C16:0, Cy17:0, SFA, Cy17:0/ C16:1w7c ratio, and SFA/UFA ratio in the 
control groups.  In the adapted and non-adapted treated Salmonella there was a 
numerical decrease in SFA/UFA ratio from 2 to 24h 
Since fatty acid composition is one of the factors that affect membrane 
fluidity it appears that short- and long-term treatment with CIN at sub-lethal 
concentrations decreased the fluidity of the Salmonella membrane by 
significantly increasing the proportion of saturated fatty acids.  This decreased 
fluidity may prevent additional CIN from permeating.  The effect of bacterial 
growth in the presence of CIN on the fatty acid composition was much smaller.  
Determination of any changes in the phospholipid head groups would be useful 
because of their affect on fluidity.  Measurement of the membrane transition 
temperature from gel-to-liquid-crystalline phase by Fourier-transformed infrared 
spectrometry would indicate the interaction between their acyl chains and 
therefore fluidity.  A nuclear magnetic resonance spectrometer or a Langmuir-
Blodgett trough can also measure fluidity.  Investigation about the target site that 
CIN acts upon and the specific interactions of CIN with membrane lipids and 
proteins using differential scanning calorimetry would contribute to the 
understanding of its mechanism of action and the bacterial response. 
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Abstract 
 
Carvacrol (CRV) is a component found in the essential oil fraction of 
oregano oil and is inhibitory to various pathogens.  The objective of this study 
was to evaluate changes in bacterial membrane composition by observing 
changes in total phospholipid fatty acid (PLFA) and fatty acid composition 
associated with exposure and adaptation to CRV.  Salmonella Typhimurium 
DT104 cells were grown for 24h at 35°C with or without 871 mg/L CRV in 9-ml ml 
brain heart infusion broth.  Log 5.7 CFU/ml of S. Typhimurium was inoculated 
into 200ml broth containing 871 mg/L CRV.  At 2h and 24h, samples were 
centrifuged, washed, lyophilized, and extracted for lipids.  Fatty acid methyl 
esters prepared from phospholipids were quantified by GC-MS.  Compared to the 
non-adapted Salmonella at 2h, the non-adapted treatment had lower (p<0.05) 
C16:1w7c, Cy17:0, C18:1w7c, and unsaturated fatty acid (UFA) and higher 
(p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty acid (SFA), and SFA/UFA 
ratio.  At 24h, the non-adapted treatment had lower (p<0.05) total phospholipid 
fatty acid (PLFA), lower (p<0.05) Cy17:0, C17:0, C18:1w7c, and UFA than the 
non-adapted control and higher (p<0.05) C16:1w7c and SFA.  At 2h there were 
no significant differences between the fatty acid compositions of adapted 
Salmonella treated with CRV and non-adapted cells treated with CRV.  At 24h, 
the adapted cells treated with CRV had lower (p<0.05) C16:1w7c and UFA and 
higher (p<0.05) SFA than non-adapted cells treated with CRV.  The SFA/UFA 
ratio was numerically higher in the adapted Salmonella than the non-adapted 
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cells at 24h.  Since the fatty acid composition and total PLFA of the non-adapted 
control and adapted controls were similar, the adaptive response had been 
reversed since the stressor, CRV, was not used to treat the adapted controls.  It 
appears that CRV treatment at sub-lethal concentrations decreased the fluidity of 
the Salmonella membrane by increasing SFA.  This decreased fluidity may 
prevent additional CRV from permeating.  The effect of bacterial growth in the 
presence of CRV on the fatty acid composition was much smaller.  Measurement 
of the membrane transition temperature from gel-to-liquid-crystalline phase would 
indicate fluidity.  Investigation about the target site that CRV acts upon and the 
interactions of CRV with membrane lipids and proteins would contribute to the 
understanding of its mechanism of action and the bacterial response. 
 
Introduction 
 
Consumers desire high-quality, minimally processed foods that have fewer 
preservatives and an extended shelf-life (Brul and Coote 1999).  Studies have 
reported oregano essential oil to be highly active against various microorganisms 
(Lis-Balchin and Deans 1997; Hammer and others 1999 ; Friedman and others 
2002; Valero and Salmerón 2003).   Carvacrol (CRV), the bioactive component 
found in oregano and thyme essential oils, is used in baked goods, nonalcoholic 
beverages, and chewing gum (Ultee and others 1999).  In-vitro studies have 
reported the antimicrobial activity of CRV against E. coli O157:H7, S. enterica 
Hadar, S. Typhimurium, and L. monocytogenes were (Kim and others 1995a; 
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Helander and others 1998; Friedman and others 2002).   It has been tested in 
fish cubes (Kim and others 1995b) and rice (Ultee and others 2000a). 
Concentrations that are lethal to bacteria are much higher than tolerable 
taste thresholds.  Therefore, it is preferable to use them at inhibitory 
concentrations rather than at lethal concentrations (Brul and Coote 1999).  
Knowledge about the mechanisms of action of antimicrobials is needed to 
develop effective and economical combinations of antimicrobial additives and 
formulations to protect foods from spoilage and pathogenic microorganisms 
without sacrificing organoleptic qualities.   
Compounds from essential oils are believed to disrupt the membrane (Brul 
and Coote 1999), however, there are diverse chemical families representing 
essential oil components.  Lipophilic compounds, such as essential oil 
components, have been shown to accumulate and act on the cell membrane 
(Sikkema and others 1994, 1995).  As they interact with the phospholipid bilayer 
of the cell membrane, they may increase membrane permeability and cause 
cellular constituents to leak (Sikkema and others 1994; Ultee and others 1998).   
Although a several studies have investigated the efficacy of CRV, only a 
few have examined its mechanism of inhibition.  It was suggested that CRV 
disrupts the outer membrane because it decreases the intracellular ATP and 
increases extracellular ATP in E. coli O157:H7 (Helander and others 1998).  Due 
to its hydroxyl group, it caused potassium ions to leak, reduced intracellular pH, 
dissipated the membrane potential, and depleted the intracellular ATP of B. 
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cereus cells, which would result in lethality (Ultee and others 1999; Ultee and 
others 2002).   
When a microorganism is exposed to sublethal doses of a chemical that 
negatively influences bacterial growth or survival, it may respond to protect itself, 
or adapt, to increase its tolerance.  A lipid can act as a sensor of stress and 
cause a change the synthesis of stress-related proteins, which alter cell 
physiology to increase tolerance to stress.  A change in fluidity or membrane 
structure can be detected and the cell may respond with alterations in membrane 
composition (Yousef and Courtney 2003).   
Changes in bacterial lipids in the membrane are a defense mechanism 
used to maintain optimal fluidity in the liquid-crystalline phase for important cell 
processes.  Membrane fluidity is the “combined expression of the effects of [fatty 
acid] chain conformation, lateral and rotational diffusion [of the lipids within the 
membrane] and the resistance of the membrane to sheer forces” (Denich and 
others 2003).  The fluidity of the membrane affects the growth of the cell and the 
proper functioning and structural integrity of the membrane (Denich and others 
2003).  For example, the percentage of unsaturated fatty acids in E. coli 
phospholipids is usually about 50%.  This percentage can decrease to 30% 
without ceasing bacterial growth.   If the percentage of saturated fatty acids 
decreases to less than 15% the membrane permeability increases (Seltmann 
and Holst 2002).  Lipids directly affect passive permeability and indirectly 
influence cell processes because of their interactions with membrane proteins 
(Russell and others 1995).   
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Membrane fluidity is determined by the effect of changes in the fatty acid 
and phospholipid head-group composition, which modify the lipid membrane 
melting point (Keweloh and Heipieper 1996).  As melting point decreases, fluidity 
increases (Casadei and others 2002).  For example, fatty acids with high melting 
points, such as saturated, long, and straight-chain fatty acids, decrease 
membrane fluidity (Juneja and Davidson 1993).   
Since CRV is lipophilic it accumulated and expanded liposomal 
membranes.  This swelling was suggested to cause a destabilized membrane in 
B. cereus, which increased fluidity as shown by a decrease in the membrane 
transition temperature from gel to liquid-crystalline phase (Tm).  This led to 
increased passive permeability and therefore a leakage of ions.  Adaptation to 
CRV of B. cereus cells caused an increase in Tm and fatty acid acids with higher 
melting points, which resulted in decreased sensitivity.  This reduction in fluidity 
was an adaptive response to the compensate for the fluidizing and 
permeabilizing effect of CRV (Ultee and others 1999; Ultee and others 2000b).   
The objectives of this study were to determine: 
1) the effect of exposure to CIN on the fatty acid composition of the 
bacterial membrane of Salmonella, 
2) whether changes in the fatty acid composition of the bacterial 
membrane of Salmonella occur due to growth in the presence of CIN as a 
possible adaptive response to CIN, and 
3) whether reversal of these changes in fatty acid composition occur when 
the stressor, CIN, was removed. 
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Materials and methods 
 
Essential oil component 
Stock solutions of CRV (Aldrich, Milwaukee, WI) were prepared in ethanol, 
absolute (Aldrich, St. Louis, MO).  Sterile water dissolved into ethanol served as 
the control stock solution.  Aliquots of CRV stock solution were added into 8 ml 
brain heart infusion broth, modified (BHI, BBL, Sparks MD) with 2% Tween 20 
(Fisher Scientific, Fairlawn, NJ) with glass beads.  The final concentration of 
Tween was 1% and ethanol was 0.5% during adaptation and treatment.  Tween 
and glass beads were used to aid with dispersion of CRV in BHI.  All BHI was 
prepared with phosphate buffer (0.1M, pH 7.2 + 0.1) instead of water to prevent 
pH changes, which could affect the fatty acid composition of bacterial 
membranes.  The pH of BHI was adjusted to 7.35 (+ 0.1) prior to autoclaving, 
after which the final pH was pH 7.2 (+ 0.1).  Glass tubes containing the stock and 
BHI were shaken vigorously forty times to disperse the oil-based components.  
Dispersions became cloudy-white.   
Bacterial culture preparation 
Salmonella Typhimurium DT104 ATCC BAA-186 was obtained from the 
American Type Culture Collection (ATCC, Rockville, MD).  Experimental cultures 
were maintained on Tryptic Soy Agar slants.  A loopful of culture was used to 
inoculate 9 ml of BHI with S. Typhimurium.  The BHI tube was incubated for 24 h 
at 35°C.  Then a loopful was transferred into 9 ml BHI and incubated for 21 h at 
35°C.   
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 Adaptation 
 In our study adaptation was defined as growth in sublethal concentrations 
of CRV for 24h.  On the day of adapting cells to antimicrobials, one ml of the 21-h 
culture was serially diluted into two sets of three tubes of 9 ml BHI.  The diluted 
cultures from the two tubes of the 10-3 dilution were combined in a large tube.  
Five ml of the diluted culture were used to inoculate a 5-ml BHI tube containing 
CRV and a 5-ml BHI tube containing 0.5% ethanol control.  Both tubes had 1% 
Tween. 
 The stock and 5-ml CRV dispersions in BHI were prepared the day before, 
refrigerated, and allowed to warm to room temperature for 30 min before the 5-ml 
diluted culture was added.  This inoculation halved the concentrations and the 
final inoculum was approximately log 5.7 CFU/ml.  The final concentration of 
Tween was 1% and ethanol was 0.5%.  The two inoculated BHI tubes containing  
CRV or ethanol control were vortexed and the cells were allowed to adapt to 
CRV or ethanol (non-adapted) by incubating in a shaking waterbath at 125 rpm 
for 24 h at 35°C. 
 Extrapolating from dose-response curves, the concentrations that would 
achieve a 25% probability of lethality were initially used to adapt cells.  This low 
probability of lethality was chosen to induce changes in the membrane lipid 
composition yet also allow enough growth for harvesting cells for lipid analysis.  
This 25% probability of lethality corresponded to 1023 mg/L CRV.  After a 24-
hour growth in or adaptation to 1023 mg/L CRV, adapted cells would be 
inoculated into 200 ml BHI in bottles to treat adapted cells to sublethal 
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concentrations of CRV for 2 and 24 hours.  After inoculation, the desired 
inoculum in these experiments was about log 5.7 CFU/ml to adhere to the same 
inoculum size as in the adaptation procedure.   
 The population o f cells resulting after 24-h adaptation was tested since 
these cells would be used to inoculate the bottles.  The population of cells 
exposed to CRV was log 5 CFU/ml.  To inoculate several bottles to a final 
inoculum of log 5.7 CFU/ml with a log 5 CFU/ml culture would be impossible.  
Then cells were exposed to CRV concentrations corresponding to 15%, 10%, 
and 5%, after which the cell count was about log 6 CFU/ml.  To inoculate bottles 
with 200 ml BHI would have required a very large inoculum volume of “adapted” 
cells.  There was concern that these were new non-adapted cells that survived 
and were able to grow under stressed conditions with no physiological changes.  
Finally after three repetitions, the count of cells exposed 871 mg/L CRV, which 
corresponded to 2.5% probability of lethality, was log 8.1 CFU/ml.  The control 
population “adapted” to 0.5% ethanol was log 8.8 CFU/ml (average).   
 Treatment of adapted cells 
 A total of twelve screw-capped glass bottles containing 190 ml BHI were 
prepared for two and twenty-four hour exposures to CRV.  Ten ml CRV 
dispersion were added to six bottles for a final concentration of 871 mg/L.  
Salmonella adapted to CRV would be added to two bottles.  Salmonella 
“adapted” only to ethanol would be added to two bottles.  Two bottles would not 
be inoculated and were designated as sterile CRV controls since the BHI broth 
media contained fatty acids.  Ten ml of ethanol solution were added to six bottles 
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(with no CRV).  Salmonella adapted to CRV would be added to two bottles.  
Salmonella “adapted” only to ethanol would be added to two bottles.  Two bottles 
were not to be inoculated and were designated as sterile ethanol controls since 
the BHI broth media contained fatty acids from the manufacturer formulation.  
The final concentrations would contain about 1% Tween and 0.5% ethanol, 
similar to those used to adapt cells.  These twelve bottles containing CRV or 
ethanol were shaken and stored at 4°C until two hours before use, at which time 
they were allowed to warm to 25°C.  Before adding adapted Salmonella, bottles 
were shaken.  The treatments for 2 and 24h incubation were: Sterile controls: 
sterile + CRV, sterile + ethanol, treatments: non-adapted Salmonella + CRV, 
adapted Salmonella + CRV, inoculated controls: non-adapted + ethanol, adapted 
+ ethanol. 
 Tubes containing adapted cells were vortexed to inoculating Salmonella 
into the designated bottles.  Based on the preliminary data of adapted cell 
counts, 872 µl of cells adapted to CRV and 166 µl of cells exposed to ethanol 
(non-adapted) were added to designated bottles for a final inoculum size of about 
log 5.7 CFU/ml.  The bottles were shaken and incubated in a shaking waterbath 
at 125 rpm for either two or twenty-four hours.  After incubation the samples were 
centrifuged on a large volume centrifuge (Beckman J2-HS, Schaumberg, IL) at 
12,000 rpm for 30 minutes at 4°C.  The pellet was transferred from the centrifuge 
bottles to centrifuge tubes and washed three times with 0.1 M phosphate buffer 
(pH 7.2) at 10,000 rpm for 10 minutes at 4°C using a table-top centrifuge (Baxter 
Biofuge 17 R, VWR Scientific Products, West Chester, PA).  The pellet was 
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suspended in less than 1.5 ml phosphate buffer in small ampoules, wrapped in 
parafilm and foil and frozen at -30°C.  The pellet was lyophilized and ampoules 
were wrapped until extraction. 
 Lipid extraction 
 Lipid extraction and analysis procedures were developed by Dr. David C. 
White’s lab, the University of TN Center for Biomarker Analysis.  Lipids from 8-18 
mg lyophilized cells were extracted using a modified Bligh/Dyer method (Guckert 
and others 1985; Guckert and others 1986).  The extraction solvent contained 4 
ml phosphate buffer, 10 ml methanol, and 5 ml chloroform.  After three hours the 
phases were split with 5 ml water and 5 ml chloroform and allowed to sit 
overnight for layer separation.  The lower chloroform layer was removed and 
dried under nitrogen.  The total lipid extract was suspended in chloroform and 
separated into the lipid classes (neutral lipids, glycolipids, and polar lipids) with 
silicic acid (500 mg) columns using three solvents of increasing polarity (5 ml 
chloroform, 5 ml acetone, and 10 ml methanol) to elute the lipid classes from the 
silicic acid stationary phase (Guckert and others 1985; Guckert and others 1986).    
 Analysis of fatty acid methyl esters 
 To prepare fatty acid methyl esters (FAME) in a mild alkaline methanolic 
transesterification reaction, 0.5 ml chloroform, 0.5 ml methanol, and 1 ml of 
methanolic KOH were added to the dried polar lipids and heated at 60°C for 30 
minutes.  To extract the FAME, 2 ml hexanes, 200 µl glacial acetic acid, and 2 ml 
nanopure water was added.  After centrifuging, the hexane layer was removed.  
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This was repeated twice.  The FAME were dried under nitrogen and transferred 
three times with 100 µl hexanes to autosampling vials.   
 The samples were diluted with hexanes containing a 21:0 internal 
standard (50pmol/µl).  The samples and a vial of GC-MIX (mixture of 20 FAME 
standards) were analyzed on a HP6890 gas chromatograph (GC) coupled to a 
HP5973 mass spectrophotometer (MS).  The GC was equipped with a RJX1 
fused silica capillary column (60m, 250µm internal diameter x 25 µm film 
thickness, Restek, Bellefonte, PA).  The column was programmed from an initial 
temperature of 60°C for 2 min then raised at a rate of 10°C/min to 150°C.  The 
temperature was increased at 30°C/min to a final temperature of 312°C.  The 
injector port temperature was 230°C in split-less mode.  Helium was used as the 
carrier gas at a flow rate of 1.41 ml/min.  Fatty acids were identified by 
comparison of retention times to the FAME standards and a mass spectral data 
library.  Fatty acids were quantified based on comparison to the 21:0 internal 
standard and area under each sample peak and standard peak.   
 Statistical analysis 
Box and whisker plots were generated with Statistica (StatsSoft, Inc., 
Tulsa, OK) to compare total PLFA and fatty acid composition.  The 2 and 24h 
data were divided and a randomized block design with blocking on each of three 
replications was used to test the effect of treatments or controls on total PLFA 
and fatty acids for 2h or 24h.  Data were analyzed using SAS (Statistical Analysis 
System, Cary, NC) to compare differences in total PLFA and fatty acids between 
treatment and control groups within 2h or 24h with alpha value at 0.05.  The 
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generalized linear model (GLM) was used to test for differences in total PLFA 
and fatty acids between 2 and 24h within each treatment or control group with a 
Bonferonni correction factor.  This correction minimized Type I error, which 
increases with the number of statistical tests.  The Bonferonni p value was 
calculated as the alpha value at 0.10 divided by 6 (the number of follow-up tests 
conducted to test the interaction between the 6 treatments at 2h or 24h), which 
equals 0.017. 
 
Results 
 
Total phospholipid fatty acid (PLFA) 
Total phospholipid fatty acid (PLFA ) is the sum of all fatty acids that were 
hydrolyzed from phospholipids in the membrane.  The mean total PLFA is shown 
in Table 4.1.  Depicted in Figures 4.1 and 4.2 are box and whisker plots 
representing the mean, standard error, and standard deviation of the total PLFA 
of the sterile groups of Salmonella under each of the experimental treatments.  
The boundaries of the box around the mean consist of the mean + standard 
error.  The standard error is the standard deviation of the sample mean and is 
computed as the standard deviation divided by the square root of the sample 
size.  The horizontal bars represent the mean + standard deviation.  The 
standard deviation is the positive square root of the variance.  The variance is the  
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Treatment/control 
and incubation hr  
Total 
PLFA  
(pmol/mg) 
  C12:0 (%) 
  C14:0 (%) 
  C15:0 (%) 
  C16:1w7c (%) 
  C16:0 (%) 
  Cy17:0 (%) 
  C17:0 (%) 
  C18:1w9c (%) 
  
2h                                      
Sterile + CRV 1987.2  34.9A 29.6A 0.0  0.0 B 19.1 C 0.0 B 0.0 2.3 AB 
Sterile + EtOH 191.9  35.4A 29.0A 0.0  0.0 B 21.6 BC 0.0 B 0.0 1.2 B 
Non-adapt + CRV 729.3 Z 15.0BC 27.3A 0.0  0.3 BZ 28.1 AB 0.1 BZ 0.0 4.3 A  
Adapt + CRV 7333.2  31.9AB 28.8AZ 0.0  1.7 BZ 20.9 BCZ 0.0 B 0.0 2.2 AB 
Non-adapt + EtOH 7625.3 Z 0.8C 7.8B 0.0 Z 25.7 AZ 29.5 AZ  2.3 AZ 0.0Z 0.5 B 
Adapt + EtOH 2799.4 Z 2.2C 8.1B 0.0 Z 23.8 AZ 31.9 A 2.4 AZ 0.0Z 0.4 B 
24h                                      
Sterile + CRV 2221.6 B 36.1A 26.7A 0.0 B 0.1 D 16.6 B  0.0 C 0.0C 5.7 A 
Sterile + EtOH 2396.1 B 23.7B 31.7A 0.0 B 0.0 D 21.7 B 0.0 C 0.0C 3.9 A 
Non-adapt + CRV 19541.1 B 3.5CD 6.6B 0.1 B 22.9 A 42.1 A 4.0 BC 0.0C 0.2 B 
Adapt + CRV 8524.0 B 7.9C 9.2B 0.0 B 16.6 B 41.3 A 4.3 B  0.0C 0.3 B 
Non-adapt + EtOH 69791.6 A 0.3D 7.7B 0.2 A 13.7 C 36.7 A 16.0 A 0.1B 0.3 B 
Adapt + EtOH 70051.4 A 1.0CD 7.4B 0.2 A 11.9 C 36.6 A 16.6 A 0.2A 0.2 B 
ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).      
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).    
Table 4.1.  Comparison of total PLFA and fatty acid (FA) composition of CRV-adapted or non-adapted cells with or 
without carvacrol (CRV) to inoculated controls (+EtOH) and sterile controls after 2h and 24h incubation. 
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Treatment/control 
and incubation hr  
C18:1w7c 
(%) 
  C18:1w7t (%) 
  C18:0 (%) 
  Cy19:0 (%) 
  Sat. FA (%) 
  Unsat. FA (%) 
  
Cy17 to 
C16:1 
ratio 
  
Cy19 to 
C18:1 
ratio 
  
SFA to 
UFA 
ratio 
  
2h                                      
Sterile + CRV 1.1 B 0.4  12.6 A 0.0  96.2AB 3.8 BC 0.0  0.0  20.8 AB 
Sterile + EtOH 0.9 B 0.2  11.7 AB 0.0  97.7A  2.3 C 0.0  0.0  30.0 A  
Non-adapt + CRV 4.1 BZ 0.5  20.2 A 0.0  90.6BZ 9.4 B  0.4  0.0  12.6 B 
Adapt + CRV 3.6 BZ 0.7  10.2 ABC 0.0  91.8ABZ 8.2 BCZ 0.0  0.0  11.9 BZ 
Non-adapt + EtOH 32.6 AZ 0.0  0.9 C 0.0 Z 38.9CZ 61.1 AZ 0.1 Z 0.0 Z 0.6 CZ 
Adapt + EtOH 30.0 A 0.0   1.2 BC 0.0 Z 43.4C 56.6 AZ 0.1 Z 0.0   0.8 C 
24h                                      
Sterile + CRV 2.6 C 0.6 AB 11.6 B  0.0 B 90.9A 9.1 D 0.0 B 0.0 B 10.2 B 
Sterile + EtOH 1.5 C 0.7 A  16.7 A  0.0 B 93.8A 6.2 D 0.0 B 0.0 B 15.4 A 
Non-adapt + CRV 19.4 B 0.0 AB 1.1 C 0.1 B 53.5C 46.5 B 0.2 B 0.0 B 1.2 C 
Adapt + CRV 17.3 B 0.0 B 2.9 C 0.1 B 61.3B 38.7 C 0.3 B 0.0 B 1.6 C 
Non-adapt + EtOH 23.2 A 0.0 B 0.5 C 1.2 A 45.6D 54.4 A 1.2 A 0.1 A 0.8 C 
Adapt + EtOH 23.6 A 0.0 B 0.6 C 1.7 A 46.0D 54.0 A 1.4 A 0.1 A 0.9 C 
ABCD: Means in a column with different superscripts within 2h or 24h are different (p<0.05).      
Z: Means in a column are different from 2h to 24h within a treatment or control group (Bonferroni p<0.017).    
Table 4.1.  Continued. 
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Figure 4.1.  Comparison of total PLFA or biomass of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
盨td. Dev.
盨td. Err.
Mean
Treatment
B
io
m
as
s 
(p
m
ol
/m
g)
-10000
10000
30000
50000
70000
90000
1.1e5
Sterile
+CRV
Sterile
+EtOH
Nonadapt
+CRV
Adapt
+CRV
Nonadapt
+EtOH
Adapt
+EtOH
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sum of the squared deviations from the mean divided by the sample size minus 
one.   
An analysis was performed to determine if there was a correlation 
between total PLFA and occurrence of specific fatty acids.  It was found that 
higher total PLFA was positively correlated to the presence of C15:0 (R2=0.81), 
Cy17:0 (R2=0.91), C17:0 (R2=0.78), Cy19:0 (R2=0.85), ratio of Cy17:0 to 
C16:1w7c (R2=0.82), and the ratio of Cy19:0 to C18:1w7c (R2=0.83).  The 
correlation of total PLFA to cyclopropyl fatty acids was expected because as cells 
age and enter stationary phase, the cyclopropyl fatty acids increase (Guckert and 
White 1988; Casadei and others 2002). 
Comparison of total PLFA and each fatty acid across sterile, treatment, 
and control groups (refer to Table 4.1 for means). 
Total PLFA.  Mean total PLFA of treatment groups at 2h is shown in Table 
4.1.  There were no significant (p>0.05) differences among the total PLFA of all 
groups at 2h (Figure 4.1).  The total PLFA found in uninoculated controls was 
due to the fatty acids present in the culture medium from the manufacturer’s 
formulation of BHI.  There was a wide range in total PLFA in the adapted and 
non-adapted treatment groups.  This range may be due to the variation in 
sensitivity of the cells to CRV.  The total PLFA of the adapted control (+EtOH) 
was numerically lower than the non-adapted control because it may have still 
been inhibited but the difference was not significant.  The total PLFA of the CRV 
non-adapted Salmonella was significantly (p<0.05) less than CRV adapted 
Salmonella after 2h indicating a more rapid growth of adapted cells. 
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At 24h the total PLFA of the Salmonella inoculated control groups (no 
CIN) exceeded those of the sterile and treatment groups because the bacteria 
were not inhibited by CRV (Figure 4.2).  The total PLFA did not differ significantly 
(p>0.05) among sterile and treatment groups.  From 2h to 24h the total PLFA 
increased significantly (p<0.01) for the controls and the non-adapted treatment 
group (+CRV) (Table 4.1). 
C12:0 fatty acid.  At 2h, the sterile groups contained more C12:0 than the 
control groups (Figure 4.3).  The bacteria in the controls were able to decrease 
the proportion of this fatty acid within 2h as they grew and used C12:0.  The level 
of C12:0 in the treatment groups was similar to that of the sterile groups.  Since 
bacterial growth was still inhibited by CRV, lipid biosynthesis by the anaerobic 
pathway was decelerated.  They incorporated C12:0 from the medium but could 
not oxidize and convert it to other fatty in the presence of CRV. 
The wider standard error of the non-adapted cells treated with CRV 
implies that some Salmonella cells in a culture were less able to decrease the 
proportion 12:0 than others because they were more inhibited due to CRV 
exposure.  This wider range of response indicates that a population of non-
adapted cells can display a range of sensitivity to CRV and therefore a range in 
the ability to grow and decrease the percentage of C12:0.   
At 24h, all four inoculated groups had significantly (p<0.05) less C12:0 
than the sterile groups (Figure 4.4).  The bacteria in the treatment groups were 
able to grow and convert 12:0 to another fatty acid.  The adapted treatment had a 
higher percentage of C12:0 than the non-adapted control.  The percentage C12:0
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Figure 4.3.  Comparison of C12:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.4.  Comparison of C12:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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did not significantly (p>0.05) change in any group from 2 to 24h, except for a 
decrease in the adapted treatment group, but this was not significant (p>0.05) 
and may have been obscured by variation within the group. 
C14:0 fatty acid.  At 2h, the proportion of this fatty acid in the treatment 
groups did not differ from the sterile groups.  They incorporated C12:0 from the 
medium.  Bacterial growth in the treatment groups was still inhibited and could 
not convert C14:0 to another fatty acid as well as the inoculated controls (Figure 
4.5).  C14:0 was higher in these groups than in the controls, which had a 
significantly (p<0.05) lower percentage of C14:0 as they grew within 2h.   
From 2h to 24h, C14:0 decreased significantly (p<0.01) in the adapted 
treatment group as cells grew (Table 4.1).  The non-adapted treatment group 
showed a similar trend, but this was not significant (p>0.05).  At 24h there were 
no differences among the inoculated groups and they had a significantly (p<0.05) 
lower C14:0 percentage than the sterile groups (Figure 4.6).  Bacteria in the 
treatments grew and converted C14:0 to another fatty acid. 
C15:0 fatty acid.  At 2h C15:0 was not detected in any group (Figure 4.7).  
The control groups significantly (p<0.01) increased C15:0 from 2h to 24h (Table 
4.1).  They had a higher relative abundance of C15:0 than the other groups at 
24h (Figure 4.8).   
C16:1w7c fatty acid.  At 2h C16:1w7c was at a higher percentage in the 
control groups than in the other groups (Figure 4.9).  Compared to 2h, C16:1w7c 
decreased significantly (p<0.005) in the control groups at 24h (Table 4.1 and 
Figure 4.10).  In contrast, the treatment groups significantly (p<0.005) produced 
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Figure 4.5.  Comparison of C14:0 fatty acid of CRV-adapted or non-
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Figure 4.6.  Comparison of C14:0 fatty acid of CRV-adapted or non-
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Figure 4.7.  Comparison of C15:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.8.  Comparison of C15:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
 154 
盨td. Dev.
盨td. Err.
Mean
Treatment
C
16
:1
w
7c
 F
at
ty
 a
ci
d 
(r
el
at
iv
e 
%
)
-4
2
8
14
20
26
32
Sterile
+CRV
Sterile
+EtOH
Nonadapt
+CRV
Adapt
+CRV
Nonadapt
+EtOH
Adapt
+EtOH
Figure 4.9.  Comparison of C16:1w7c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
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Figure 4.10.  Comparison of C16:1w7c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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more of this fatty acid with time.  At 24h, the non-adapted treatment group 
produced the most C16:1w7c, followed by the adapted treatment group (Figure 
4.10).  The percentage was lower in the controls and least in the sterile groups.  
C16:0 fatty acid.  At 2h C16:0 was highest in the control groups as they 
grew (Figure 4.11).  The percentage of fatty acid in the treatment groups was in 
between that of the control and sterile groups since they were still inhibited.  
From 2h to 24h, the non-adapted control and the adapted treatment group 
produced significantly (p<0.02 and p<0.001) more C16:0 (Table 4.1).  In the non-
adapted control there was a trend of increased C16:0 from over time, but this 
was not  (p>0.05).  At 24h C16:0 was more abundant in the inoculated groups 
than the sterile groups.  The abundance of this fatty acid did not differ among 
inoculated groups (Figure 4.12). 
Cy17:0 fatty acid.  At 2h Cy17:0 was highest in the control groups (Figure 
4.13).  There were no differences among the sterile and treatment groups.  Over 
time Cy17:0 significantly increased in the control groups and the non-adapted 
treatment group (p<0.02 and p<0.001) (Table 4.1).  At 24h Cy17:0 was still the 
most relatively abundant in the control groups since they reached stationary 
phase earlier and second highest in the adapted treatment group (Figure 4.14).  
The abundance of Cy17:0 of the non-adapted treatment did not differ significantly 
(p>0.05) from its adapted counterpart.   
C17:0 fatty acid.  At 2h none of the groups synthesized C17:0 (Figure 
4.15).  Compared to 2h, the controls produced more (p<0.005) C17:0 at 24h 
(Table 4.1).  At 24h (Figure 4.16) the percentage of C17:0 was greatest in the 
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Figure 4.11.  Comparison of C16:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.12.  Comparison of C16:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 4.13.  Comparison of Cy17:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
盨td. Dev.
盨td. Err.
Mean
Treatment
C
y1
7:
0 
F
at
ty
 a
ci
d 
(r
el
at
iv
e 
%
)
-2
2
6
10
14
18
22
Sterile
+CRV
Sterile
+EtOH
Nonadapt
+CRV
Adapt
+CRV
Nonadapt
+EtOH
Adapt
+EtOH
Figure 4.14.  Comparison of Cy17:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 4.15.  Comparison of C17:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.16.  Comparison of C17:0 fatty acid of CRV-adapted or non-
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adapted control, followed by the non-adapted control.  There was no significant 
(p>0.05) difference among the sterile and treatment groups.  
C18:1w9c fatty acid.  At 2h there was no definite pattern of differences 
among the groups due to the wide variability of the sterile and treatment groups, 
except that the controls appeared to have the lowest percentage of C18:1w9c 
and least variability (Figure 4.17). The abundance of C18:1w9c decreased in the 
non-adapted treatment and adapted control groups from 2h to 24h (Figure 4.18), 
but this was not significant (p>0.02).  There were no significant changes in the 
other groups over time. 
C18:1w7c fatty acid.  At 2h the abundance of C18:1w7c was highest in the 
control groups (Figure 4.19).  It was lowest in the sterile and treatment groups.  
From 2h to 24h, the non-adapted control significantly (p<0.02) decreased the 
proportion of C18:1w7c (Table 4.1).  The adapted control exhibited a similar 
declining trend, but this was not significant (p>0.02).  In contrast, the non-
adapted and adapted treatment groups produced significantly (p<0.005) more of 
this fatty acid over time.  At 24h, C18:1w7c was most abundant in the controls, 
followed by the treatment groups, and then the sterile groups (Figure 4.20).   
C18:1w7t fatty acid.  At 2h the percentages of C18:1w7t did not differ 
significantly (p>0.05) among the groups perhaps due do the variability within 
groups (Figure 4.21).  It was detected in the sterile groups at 2 and 24h and in 
the treatment groups at 2h, but was depleted at 24h (Figure 4.22).  It was present 
in the treatment groups because the cells were inhibited by CRV and had not yet 
metabolized it.  There were no significant (p>0.05) changes across time within 
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Figure 4.17.  Comparison of C18:1w9c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 4.18.  Comparison of C18:1w9c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to  inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
 161 
盨td. Dev.
盨td. Err.
Mean
Treatment
C
18
:1
w
7c
 F
at
ty
 a
ci
d 
(r
el
at
iv
e 
%
)
-5
0
5
10
15
20
25
30
35
40
Sterile
+CRV
Sterile
+EtOH
Nonadapt
+CRV
Adapt
+CRV
Nonadapt
+EtOH
Adapt
+EtOH
Figure 4.19.  Comparison of C18:1w7c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 4.20.  Comparison of C18:1w7c fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 4.21.  Comparison of C18:1w7t fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 4.22.  Comparison of C18:1w7t fatty acid of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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each group.  At 24h the sterile + EtOH group had significantly (p<0.05) more 
C18:1w7t than the control and adapted treatment groups.  The wide variability in 
the sterile group may have been due to very small pellets that were obtained 
after centrifuging and washing (Figure 4.22).   
C18:0 fatty acid.  At 2h non-adapted control had decreased C18:0 to a 
proportion lower than the sterile groups and the non-adapted treatment group, 
which were similar (Figure 4.23).  The percentage of C18:0 was higher in the 
non-adapted treatment than in the non-adapted control because cells were still 
inhibited by CRV.  The percentage of C18:0 in the treatment groups was more 
similar to the sterile groups than the inoculated controls.  The treatment groups 
had incorporated C18:0 but were unable to convert it as well as the inoculated 
controls.   
Within each group C18:0 did not differ significantly (p>0.05) across time 
(possibly obscured by within-group variation), although there is a declining trend 
of C18:0 in the adapted treatment group.  At 24h the treatment groups grew and 
converted C18:0 to another fatty acid.  Therefore, there were no differences 
among the inoculated groups and C18:0 percentages were lower than in the 
sterile groups (Figure 4.24).      
Cy19:0 fatty acid.  At 2h Cy19:0 was not detected in any group (Figure 
4.25).  Compared to 2h, the controls formed more Cy19:0 at 24h as they entered 
stationary phase earlier (p<0.01) (Table 4.1).  At 24h Cy19:0 was most abundant 
in the control groups and least in the sterile and treatment groups (Figure 4.26).  
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Figure 4.23.  Comparison of C18:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.24.  Comparison of C18:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls  (+EtOH) and 
sterile controls after 24-hr incubation  
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Figure 4.25.  Comparison of Cy19:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 2-hr incubation  
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Figure 4.26.  Comparison of Cy19:0 fatty acid of CRV-adapted or non-
adapted cells with or without CRV to inoculated controls (+EtOH) and 
sterile controls after 24-hr incubation  
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Saturated fatty acids.  At 2h the percentages of saturated fatty acids were 
similar in the sterile and treatment groups (Figure 4.27).  The fatty acids were 
much lower in the control groups since the cells were not inhibited.  The 
percentage of SFA significantly (p<0.005) declined over time in the treatment 
groups as they grew, but it increased for the non-adapted control (p<0.01)  
(Table 4.1).  At 24h, the abundance of SFA was highest in the sterile groups, 
followed by the adapted treatment and then the non-adapted treatment group 
(Figure 4.28).  The controls contained the least SFA. 
Monounsaturated fatty acids.  At 2h UFA were highest in the control group 
(Figure 4.29).  They were lowest in the sterile and treatment groups.  Compared 
to 2h, UFA significantly (p<0.005) increased at 24h for the treatment groups, but 
decreased for the non-adapted control (p<0.01) (Table 4.1).  At 24h the 
abundance of UFA was highest in the control groups, followed by the non-
adapted treatment and then the adapted treatment group (Figure 4.30).  These 
fatty acids were lowest in the sterile groups. 
Ratio of Cy17:0 to C16:1w7c. At 2h there were no differences in the ratios 
among the groups (Figure 4.31).  There was a larger standard error for the non-
adapted CRV due to variation in both Cy17:0 and its precursor, which reflected 
the range in sensitivity.  Over time, this ratio significantly (p<0.005) increased in 
the control groups, indicating earlier entry into the stationary phase (Table 4.1).  
At 24h the ratio was highest in the control groups and lowest in the sterile and 
treatment groups (Figure 4.32).  
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Figure 4.27.  Comparison of saturated fatty acids of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 2 -hr incubation  
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Figure 4.28.  Comparison of saturated fatty acids of CRV-adapted or 
non-adapted cells with or without CRV to inoculated controls (+EtOH) 
and sterile controls after 24-hr incubation  
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Figure 4.29.  Comparison of monounsaturated fatty acids of CRV-
adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 2 -hr incubation  
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Figure 4.30.  Comparison of monounsaturated fatty acids of CRV-
adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 24-hr incubation  
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Figure 4.31.  Comparison of ratio of Cy17:0 to 16:1w7c fatty acids of 
CRV-adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 2 -hr incubation  
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Figure 4.32.  Comparison of Cy17:0 to 16:1w7c fatty acids of CRV-
adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 24-hr incubation  
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Ratio of Cy19:0 to C18:1w7c.  The ratios were zero because Cy19:0 was 
undetected at 2h (Figure 4.33).  From 2h to 24h, this ratio increased significantly 
(p<0.02) for the non-adapted control (Table 4.1).  A similar trend occurred in the 
adapted control, but this was not significant (p>0.05).  At 24h the ratio was 
highest in the control groups and lowest in the sterile and treatment groups 
(Figure 4.34).   
Ratio of saturated to unsaturated fatty acids.  At 2h, this ratio was lowest 
in the control groups, which were able to grow and decrease the proportion of 
SFA (Figure 4.35).  The ratio was highest for the sterile groups, followed by the 
treatment groups, although there is some overlap between the sterile + CRV and 
treatment groups.   
Compared to 2h, this ratio drastically (p<0.02) decreased at 24h in the 
adapted treatment group (and numerically in the non-adapted treatment group), 
but increased significantly (p<0.01) in the non-adapted control group (Table 4.1).  
At 24h, the ratio was lowest in all the inoculated groups (Figure 4.36).  It was 
highest in the sterile + EtOH group followed by the sterile + CRV group.     
 
Discussion 
 
Anaerobes, facultative anaerobes, and also some aerobic bacteria 
synthesize lipids via the anaerobic pathway, which has been studied in E. coli.  
The starting reactants are acetyl-CoA and 3 malonyl-ACP.  A trans double bond 
is produced during elongation.  From that point, it can be reduced to form a 
 171 
盨td. Dev.
盨td. Err.
Mean
Treatment
R
at
io
 o
f C
y1
9:
0 
to
 1
8:
1w
7c
 fa
tty
 a
ci
d
-1.0
-0.5
0.0
0.5
1.0
Sterile
+CRV
Sterile
+EtOH
Nonadapt
+CRV
Adapt
+CRV
Nonadapt
+EtOH
Adapt
+EtOH
Figure 4.33.  Comparison of ratio of Cy19:0 to 18:1w7c fatty acids of 
CRV-adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 2 -hr incubation  
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Figure 4.34.  Comparison of Cy19:0 to 18:1w7c fatty acids of CRV-
adapted or non-adapted cells with or without CRV to inoculated 
controls (+EtOH) and sterile controls after 24-hr incubation  
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Figure 4.35.  Comparison of ratio of saturated to unsaturated fatty 
acids of CRV-adapted or non-adapted cells with or without CRV to 
inoculated controls (+EtOH) and sterile controls after 2-hr incubation  
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Figure 4.36.  Comparison of ratio of saturated to unsaturated fatty 
acids of CRV-adapted or non-adapted cells with or without CRV to 
inoculated controls (+EtOH) and sterile controls after 24-hr incubation  
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saturated fatty acid or isomerized into a cis-monoenoic fatty acid.  This cis fatty 
acid cannot be reduced and remain unchanged with further elongation.  These 
saturated and cis-unsaturated chains are incorporated into phospholipids of the 
membrane.  Since the degree of saturation cannot change after synthesis, the 
ratio of SFA to UFA cannot be changed in cells that cease growth.  Phospholipid 
biosynthesis quickly decelerates if growth stops.  However, post-synthesis 
modification of cis-monoenoic fatty acids to their cyclopropyl derivatives and 
trans-isomers can still occur (Diefenbach and others 1992; Keweloh and 
Heipieper 1996).   
The uptake of fatty acids from the culture medium can occur by acyl-chain 
unspecific or active or passive transport.  They are oxidized or incorporated in 
membrane lipids, which is regulated.  Biosynthesis is regulated as well 
(Diefenbach and others 1992; Keweloh and Heipieper 1996). 
Membrane fluidity has been correlated with changes in fatty acid 
composition (Mazzotta and Montville 1997).  Certain types of lipid may have a 
greater influence on the fluidity than other.  For example, converting a cis-
monoenoic acid to its trans-isomer greatly reduces fluidity, but not as significantly 
as a change in cis to saturated fatty acids (Keweloh and Heipieper 1996).   
The melting points of unsaturated fatty acid (UFA) and branched chain 
fatty acids are lower than that of saturated fatty acids (SFA).  There are 
hydrophobic interactions among acyl chains of SFA.  In membranes rich with 
SFA the membrane is packed and rigid.  The chain can extend at its maximum if 
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the saturated chain rotates into a trans -conformation (Keweloh and Heipieper 
1996).   
In contrast, the double bond in cis-UFA creates a 30° angle in the acyl 
chain.  This kink disrupts the ordered packing of the acyl chains in the membrane 
(Keweloh and Heipieper 1996).  Therefore, an increase in cis UFA causes a 
decrease in the temperature for the transition from the gel to the liquid-crystal 
membrane phase and an increase in fluidity (Keweloh and Heipieper 1996; 
Casadei and others 2002).   
A shortening in the acyl chain length will also lower the melting 
temperature and increase fluidity.  A change in the degree of saturation is 
thought to be more effective than a change in the chain length (Keweloh and 
others 1991).  Cyclopropyl fatty acids (CFA) are more physically similar to cis-
monoenoic fatty acids, which are precursors of CFA.  Trans-fatty acids are more 
stable and resemble SFA (Guckert and others 1986).  Trans-UFA acyl chains are 
long and extended, packing more rigidly and occupying lower molar volume in 
the membrane.  Trans UFA decrease the phase transition temperature, but not 
as drastically as cis UFA (Diefenbach and others 1992; Keweloh and Heipieper 
1996).   
The ratio of UFA to SFA indicates membrane fluidity.  Casadei and 
colleagues (2002) developed a fluidity index that was calculated as the ratio of 
UFA plus cyclopropane fatty acids (CFA) in stationary phase to SFA.  They 
extracted phospholipids from E. coli grown at different temperatures and 
measured the phase transition temperatures by DSC.   
 175 
Casadei and colleagues (2002) confirmed the validity of the fluidity index 
as an indicator of membrane fluidity.  They found that there was a direct linear 
relationship between the phase transition temperature and growth temperature 
and then an inverse linear relationship between the phase transition temperature 
and the fluidity index of phospholipids.  The proportion of SFA increased while 
the proportion of UFA decreased with increasing growth temperature in 
stationary and exponential phase cells.  The fluidity index was slightly greater in 
exponential than stationary phase cells.  They reported that the abundance of 
CFA increased and C18:1 and C16:1 decreased in stationary phase cells.  Since 
most of the treatment groups in this present data contained mostly SFA, a ratio 
was calculated of SFA to UFA plus CFA.   
The measurement of the ester-linked phospholipid fatty acids (PLFA) is 
useful.  The PLFA content quantitatively indicates the viable biomass since they 
have a high turnover rate and are present in consistent abundance in cell 
membranes.  When cells die or lyse, hydrolysis of phospholipids quickly occur 
and the polar head group and diglyceride remain (White and Ringelberg 1997).   
In addition to providing an estimate of the viable biomass, PLFAs can 
indicate nutritional and physiological status using the ratio of trans-monoenoic 
fatty acids to their cis homologues and the ratio of cyclopropyl derivatives to their 
monoenoic fatty acid precursors (White and Ringelberg 1997).  During starvation 
of cultures of Vibrio cholerae, the trans/cis ratio increased.  The cis-monoenoic 
fatty acids (such as 16:1w7c and 18:1w7c) decreased and the SFA, CFA, and 
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trans-monoenoic fatty acids increased.  During starvation, membrane fluidity 
decreased overall (Guckert and others 1986).   
When loss of phospholipid occurred during starvation, cis-monoenoic 
acids were preferentially utilized to possibly enhance survival.  Cis fatty acids 
have faster turnover than saturated fatty acids and are more easily metabolized.  
During starvation, bacteria may synthesize trans-monoenoic acids, which 
bacteria do not readily metabolize, or transmethylate unstable cis- monoenoic 
fatty acids to form their cyclopropyl derivatives to survive (Guckert and others 
1986).   
It has been suggested that CFA are more stable to turnover and 
degradation (Guckert and others 1986).  CFAs were formed (with a decline in 
their cis-fatty acid precursors) in Vibrio cholerae and Pseudomonas putida as 
cells aged and entered the stationary phase (Guckert and others 1986; 
Diefenbach and others 1992; Loffeld and Keweloh 1996).  It has been 
hypothesized that CFA are formed under stress when growth stops (Guckert and 
others 1986). 
The objectives in our study were to: 
1) Determine the effect of exposure to CRV on the fatty acid composition 
of the bacterial membrane of Salmonella. 
Compared to the non-adapted Salmonella at 2h, the non-adapted 
treatment had lower (p<0.05) C16:1w7c, Cy17:0, C18:1w7c, and unsaturated 
fatty acid (UFA) and higher (p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty 
acid (SFA), and SFA/UFA ratio.  The SFA to UFA ratio was drastically (p<0.05) 
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greater than the control.  Therefore, CRV exposure caused a less fluid 
membrane.  The total PLFA was numerically much lower, indicating that CRV 
inhibited growth. 
At 24h, the non-adapted treatment had lower (p<0.05) total phospholipid 
fatty acid (PLFA), lower (p<0.05) C15:0, Cy17:0, C17:0, C18:1w7c, 19:0, and 
UFA than the non-adapted control and higher (p<0.05) C16:1w7c and SFA.  The 
SFA to UFA ratio was only slightly higher, but not significant as it was at 2h.  This 
suggested that CRV exposure for 24h decreased membrane fluidity.  The total 
PLFA of the non-adapted treatment was significantly (p<0.05) lower because of 
growth inhibition by CRV. 
2) Determine whether changes in the fatty acid composition of the 
bacterial membrane of Salmonella occur due to growth in the presence of CIN as 
a possible adaptive response to CRV. 
At 2h there were no significant (p>0.05) differences in the total PLFA or 
fatty acids between the treatment groups as a function of incubation time, 
especially within the non-adapted group in which some cells may have exhibited 
a range of sensitivity to CRV.  The SFA to UFA ratio was numerically higher in 
the non-adapted treatment group.  The effect of CRV adaptation was unclear at 
2h.  Since the concentration used for adaptation and treatment corresponded to 
a 2.5% probability of lethality, the effect of CRV was not pronounced. 
At 24h the only significant (p<0.05) difference was a lower abundance of 
C16:1w7c in the adapted treatment, which led to lower (p<0.05) unsaturated fatty 
acid and higher (p<0.05) saturated fatty acids.  The SFA to UFA ratio was slightly 
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higher in the adapted treatment group.  This suggested that adaptation to CRV 
decreased the fluidity of the membrane.   
3) Determine whether reversal of these changes in fatty acid composition 
occurs when the stressor, CRV, is removed. 
There were no differences at 2h.  However, at 24h the adapted control 
produced more C17:0 than the non-adapted.  Although this difference in fatty 
acid was not seen in the adapted treatment, it seems that adaptation of a less 
fluid membrane was maintained. 
4) Determine whether any adaptive changes in the fatty acid composition 
are maintained after subsequent exposure to the CRV. 
Compared to the adapted control at 2h, the adapted treatment group was 
found to have more C12:0, C14:0, and SFA and less C16:1w7c, C16:0, Cy17:0, 
C18:1w7c, and UFA.  The SFA to UFA ratio was much greater in the treatment.  
Therefore, even after CRV exposure the adaptation of less fluid membrane is 
maintained.   
At 24h it had higher SFA and lower total PLFA, C15:0, C16:1w7c, Cy17:0, 
C17:0, C18:1w7c, Cy19:0, and UFA.  The SFA to UFA ratio was only slightly 
higher, but not significant as it was at 2h.  This suggested that adaptation with 
subsequent CRV exposure for 24h decreased membrane fluidity, keeping the 
adaptive response.  The total PLFA was significantly (p<0.05) lower, indicating 
that CRV inhibited growth. 
5) Determine the effect of growth in the presence of CRV (adaptation) and 
subsequent CRV treatment on affect fatty acid composition. 
 179 
The adapted treatment group had more C12:0, C14:0, C16:0, SFA, and 
and less C16:1w7c, Cy17:0, C18:1w7c, and UFA at 2h.  The SFA to UFA ratio 
was significantly (p<0.05) and drastically greater than the non-adapted control.   
At 24h, this group had a lower total PLFA, C16:1w7c, Cy17:0, C17:0, 
C18:1w7c, Cy19:0 and monounsaturated fatty acids and higher C12:0 and 
C15:0.  The SFA to UFA ratio was only slightly higher, but not significant as it 
was at 2h.  CRV adaptation and treatment decreased membrane fluidity and 
inhibited growth.  
Overall, most of the changes were in the longer chain fatty acids than in 
the shorter chain fatty acids.  It appears that both treatment groups became more 
fluid and the control groups became less fluid with time.  At 2h the SFA to UFA 
ratios of the treatment groups were significantly (p<0.05) greater than those of 
the control groups.  However at 24h, the magnitude of the difference decreased.  
Perhaps this response to 2h incubation is more similar to an adaptation.  
Significant changes from 2h to 24h occurred mostly with the control 
groups and occasionally with the adapted treatment group.  However, significant 
differences may not have been detected due to variability within these treatment 
groups.  At 2h, the proportions of C12:0, C14:0 and C18:0 of the treatment 
groups were more similar to that sterile controls or in between that of the sterile 
controls and inoculated controls.  It is hypothesized that the bacteria of the 
treatment groups had incorporated these fatty acids from the medium but were 
not able to convert them to other fatty acids because growth was inhibited by 
CRV treatment.  With time, the non-adapted treatment overcame the inhibition 
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and was able to grow and synthesize phospholipids (as evidenced by the 
numerical increase in total PLFA and decrease in these fatty acids) for a more 
favorable proportion of SFA to UFA ratio that is closer to homeostasis such as in 
the non-adapted + EtOH group.   
The controls were expected to increase in this ratio because C16:1w7c 
and C18:1w7c decline and CFA increase in stationary phase (Casadei and 
others 2002).  These changes occurred in the controls from 2 to 24h.  Over time, 
SFA increased in the controls, which was a sign of starvation, along with the 
decrease in C16:1w7c and C18:1w7c and significant increase in CFA (Guckert 
and others 1986).  The treatments did not seem to have entered stationary phase 
over time because there were significant increases in C16:1w7c and C18:1w7c.  
However, there were a significant increase Cy17:0 in the non-adapted treatment 
and a numerical increase in Cy17:0 in the adapted treatment as well as numeric 
increases in Cy19:0. 
Essential oil components, such as CRV, act on the membrane, as 
because they are lipophilic (Sikkema and others 1995; Ultee and others 1999).  
Lipophilic compounds accumulate in the cell membrane, which was 
demonstrated in liposomes synthesized from E. coli lipids (Sikkema and others 
1995).  As the CRV interacts with phospholipid bilayer, it may increase 
membrane permeability and cause cellular constituents to leak (Ultee and others 
1998).   
It has been suggested that CRV occupies more area than the typical 
space between the fatty acid chains of two adjoining phospholipid molecules.  
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This interferes with the van der Waals interactions between the chains and 
therefore affect fluidity (Ultee and others 2000b; Ultee and others 2002).  If the 
membranes become too fluid, additional CRV can continue to permeate the 
membrane, accumulate, and cause more damage (Ultee and others 1998).   
It was found that CRV expanded the liposomal membrane using 
fluorescent probes (Ultee and others 2002).  It is believed that this swelling leads 
to a destabilized membrane and therefore a leakage of ions.  During exposure to 
CRV, an influx of protons and efflux of potassium ions in Bacillus cereus was 
reported (Ultee and others 1999).  This leakage was also evident in the decrease 
of the pH gradient across the membrane (Ultee and others 2002).  Griffin and 
others (1999) categorized CRV in a group of oxygenated terpenoids with high 
antimicrobial activity associated with higher hydrogen binding capacity, this 
hypothesis is reasonable.  The leakage of ions leads to a drop in the membrane 
potential and depletion of the intracellular ATP pool (Ultee and others 2002).  It 
was found that 300 mg/L of CRV reduced viable counts of Bacillus cereus cells in 
30 min and depleted intracellular ATP within 7 min without a proportional 
increase in extracellular ATP (Ultee and others 1999). 
 Similarly, Helander and others (1998), reported that CRV at 300 mg/L 
(MIC = 451 mg/L) increased the uptake of hydrophobic fluorescent probe NPN in 
E. coli O157:H7 and S. Typhimurium and decreased intracellular ATP in E. coli 
O157:H7, but with a smaller increase in extracellular ATP.  These effects 
indicated that CRV disintegrated the outer membrane (Helander and others 
1998).  It was suggested that CRV impaired the cell membrane and increased 
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permeability because of the increased fluorescence of nuclear stain EB after 
Staphyloccus aureus and Pseudomonas aeruginosa were exposed to 0.1% CRV 
(Lambert and others 2001).   
 Ultee and others (2000) investigated the adaptation of Bacillus cereus to 
CRV.  Overnight cultures were diluted 100-fold in BHI+0.5% glucose and 
incubated with or without CRV (0 - 60 mg/L) at 30°C for 4h.  These exponentially 
growing cells were centrifuged and washed with 25 mM phosphate buffer (pH 
7.0) or buffer with added 60 mg/L CRV (sublethal).  The pellet was measured by 
Fourier-transformed infrared spectra, which determined the degree of interaction 
between acyl chains.  This interaction indicated the membrane ordering and 
fluidity.   
They reported that after CRV was added to non-adapted cells there was a 
decrease in the melting temperature (Tm) of the membrane (20.5°C to 12.6°C).  
Compared to non-adapted cells, cells adapted to 60 mg/L exhibited a less fluid 
membrane because the Tm increased from 20.5°C to 28.3°C.  When adapted 
cells were exposed again to CRV, the Tm decreased again to 19.5°C, which was 
the same value as non-adapted cells with no exposure to CRV (Ultee and others 
2000b). 
In the same study, iso-C13:0, C14:0 and iso-C15:0 fatty acids (which are 
higher melting) increased in the membrane lipid composition of B. cereus cells 
incubated with 60 mg/L CRV.  Cis-C16:1 fatty acid decreased.  These changes 
correlated with the decrease in membrane fluidity of cells adapted to CRV.  
However, the decrease in long chain fatty acids (C18:0) did not correlate with the 
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decrease in fluidity.  Cells adapted to CRV had additional phospholipids 
compared to non-adapted cells.  There were no noticeable differences in 
proportions of phosphatidylethanolamine (PE), diphosphatidylglycerol (DPG), 
and phosphatidylglycerol (PG).  No glycolipids were detected.   They reported 
that B. cereus did not metabolize CRV since 98% of it remained after 74h of 
incubation.  Cells adapted to CRV were less sensitive when subsequently 
exposed to CRV as indicated by longer times to kill 50% of cells (Ultee and 
others 2000b).  
In this present study, the microorganism, adaptation process, comparison 
of various treatment groups was different from the study of Ultee and others 
(2000).  The concentration of CRV (871 mg/L) was considerably higher.  Their 
finding that adaptation reduced the fluidity of the membrane agreed with the data 
in this study.  In contrast, they reported an increase in fluidity with exposure to 
CRV, which contradicted with this study.  This study found that the SFA to UFA 
ratio was higher in the non-adapted treated cells.  When adapted cells were 
subsequently exposed to CRV in this study, the SFA to UFA ratio was greater 
than that of the non-adapted control.  This disagreed with the finding of Ultee and 
others (2000), which reported that the fluidity of the adapted cells subsequently 
exposed to CRV was similar to the non-adapted control. 
  In a related study of late-log phase Pseudomonas putida cells, which were 
adapted to 0.5g phenol in agar and subsequently exposed to 0.25 – 1.25g 
phenol/l for 3h, it was found that C16:0 and C16:1 trans was greater and 
C16:1cis and C18:1cis was less than the adapted control (Heipieper and others 
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1992).  A comparison of results in this study reveals both agreements and 
differences.  The adapted treatment group had a lower relative percentage of 
C16:0, C16:1w7c, and C18:1w7c at 2h .   
 Keweloh and others (1991) found that exponentially growing E. coli K-12 
cells exposed for 4h with 0.5 or 1g/l phenol in the growth medium had higher 
amounts of C16:0 than in the control, which differed slightly from this present 
study.  The treatment groups had lower C16:0 percentages than the controls at 
2h, but they were higher than the controls at 24h.  They also reported that the 
proportions of C16:1 and C18:1 were lower in the treated cells with an increase 
in cyclopropane fatty acids, which agreed with this study.  Overall, they found 
that there was a higher degree of saturation, which was similar to this study.  It 
was suggested that greater saturation results in a more rigid membrane that 
compensates for increase in fluidity and permeability caused by phenol.  
Saturated fatty acids have acyl chains that are packed more closely, which could 
limit the entry of phenol and therefore, its toxic effect (Keweloh and others 1991).  
In the same way, the increase of saturation upon exposure and adaptation to 
CRV could (a phenolic compound) reduce its accessibility into or its impact on 
the cell. 
 The effect of Tween 20 was not investigated in this study.  It is possible 
that use of 1% Tween 20 affected the fatty acid composition.  L. monocytogenes 
grown in BHI broth with 0.1% Tween at 30°C and harvested in mid-log phase 
was found to have lower C15:0, C17:0, anteiso-, and iso-fatty acids and higher 
straight-chain, even-numbered fatty acids with no significant change in anionic 
 185 
phospholipid.  Despite these modifications that were expected to decrease 
fluidity, no significant change in fluidity was detected.  Cells adapted to Tween 
were more sensitive because of increased binding to nisin (Li and others 2002). 
 
Significant findings 
 
 Compared to the non-adapted Salmonella at 2h, the non-adapted 
treatment had lower (p<0.05) C16:1w7c, Cy17:0, C18:1w7c, and unsaturated 
fatty acid (UFA) and higher (p<0.05) C14:0, C18:1w9c, C18:0, saturated fatty 
acid (SFA), and SFA/UFA ratio.  At 24h, the non-adapted treatment had lower 
(p<0.05) total phospholipid fatty acid (PLFA), lower (p<0.05) C15:0, Cy17:0, 
C17:0, C18:1w7c, Cy19:0, and UFA than the non-adapted control and higher 
(p<0.05) C16:1w7c and SFA.  At 2h there were no significant differences 
between the fatty acid compositions of adapted Salmonella treated with CRV and 
non-adapted cells treated with CRV.  At 24h, the adapted cells treated with CRV 
had lower (p<0.05) C16:1w7c and UFA and higher (p<0.05) SFA than non-
adapted cells treated with CRV.  The SFA/UFA ratio was numerically higher in 
the adapted Salmonella than the non-adapted cells at 24h.  Since the fatty acid 
composition and total PLFA of the non-adapted control and adapted controls 
were similar, the adaptive response had been reversed since the stressor, CRV, 
was not used to treat the adapted controls.   
 Most of the changes from 2 to 24h occurred in the membrane of the non-
adapted and adapted control Salmonella.  Over time there was a decrease in 
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C16:1w7c (p<0.01), C18:1w7c, and UFA (p<0.01) and an increase in total PLFA 
(p<0.01), C16:0, Cy17:0 (p<0.01), SFA, Cy17:0/ C16:1w7c ratio (p<0.01), and 
SFA/UFA ratio in the control groups.  In the adapted and non-adapted treated 
Salmonella there was a decrease in C14:0, SFA (p<0.01), and SFA/UFA ratio 
and an increase in C16:0, Cy17:0, C18:1w7c (p<0.01), and UFA from 2 to 24h. 
Since fatty acid composition is one of the factors that affect membrane 
fluidity it appears that short- and long-term treatment with CRV at sub-lethal 
concentrations decreased the fluidity of the Salmonella membrane by 
significantly increasing the proportion of saturated fatty acids.  This decreased 
fluidity may prevent additional CRV from permeating.  The effect of bacterial 
growth in the presence of CRV on the fatty acid composition was much smaller.  
Determination of any changes in the phospholipid head groups would be useful 
because of their affect on fluidity.  Measurement of the membrane transition 
temperature from gel-to-liquid-crystalline phase by Fourier-transformed infrared 
spectrometry would indicate the interaction between their acyl chains and 
therefore fluidity.  A nuclear magnetic resonance spectrometer or a Langmuir-
Blodgett trough can also measure fluidity.  Investigation about the target site that 
CRV acts upon and the specific interactions of CRV with membrane lipids and 
proteins using differential scanning calorimetry would contribute to the 
understanding of its mechanism of action and the bacterial response. 
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SAS program to compare the effectiveness of essential oil components 
tested against L. monocytogenes using microdilution method 
 
/* This SAS program generates SAS Probit models (probability of lethality) to 
compare the effectiveness of essential oil components tested against L. 
monocytogenes using microdilution method (microtiter plates)*/ 
 
data multi; 
      input stock $ chemical $ Dose Response N;  
      dose=log10(dose); label dose=Log10(Dose) ppm; 
   datalines; 
Nov17 CRV 3200 2 2 
Nov17 CRV 3000 2 2 
Nov17 CRV 2800 2 2 
Nov17 CRV 2600 1 2 
Nov17 CRV 2400 2 2 
Nov17 CIN 1200 2 2 
Nov17 CIN 1000 2 2 
Nov17 CIN 800 2 2 
Nov17 CIN 600 0 2 
Nov17 CIN 400 0 2 
Nov17 CIN 200 0 2 
*rest of data not included in appendix; 
; 
   proc sort; by chemical dose; 
   symbol v=dot color=blue; 
 
   * For each chemical, test for a stock effect; 
   goptions ftext='Arial/bold' htext=12pt; 
   proc probit order=internal data=multi; by chemical; 
      class stock; 
      Stock: model Response/N=  Dose stock / inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 
cframe=ligr inborder; 
   ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr 
inborder;  
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical dose Response N; 
 
    * For each chemical, analyze summarized data; 
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   proc probit order=internal data=multisum; by chemical; 
      Overall: model Response/N=  Dose / lackfit aggregate inversecl; 
      predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          vref(intersect)=(0.50,0.99) vreflabels=('Probability=0.50' 'Probability=0.99'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.50 hreflabels=('Probability=0.50');  
   ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.99 hreflabels=('Probability=0.99'); 
    
   proc probit order=internal data=multisum; 
      class chemical; 
      Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate 
noint inversecl; 
   run; 
   data fill; input chemical $; 
       do dose = 2.4 to 3.8 by 0.025; 
        output; 
       end; 
   datalines; 
CIN 
CRV 
EUG 
RHO 
   data new; set multisum fill; 
   proc sort data=new; by chemical dose; 
   proc genmod order=internal data=new; 
      class chemical; 
   output out=stats l=lower p=prob u=upper; 
   model Response/N = chemical chemical*Dose / noint dist=binomial 
link=probit type3 wald; 
   run; 
 
 data forplot; length chemical $ 8; set stats; 
     p = Response/N; 
     if p = 0 then prob = 0; 
  else if p = 1 then prob = 1; 
  else if 0 < p < 1 then prob = p; 
  if p ne . then do; output; return; end; 
     chemical=substr(chemical,1,3)||' prd'; output; 
 194 
  prob=lower; chemical=substr(chemical,1,3)||' lci'; output; 
  prob=upper; chemical=substr(chemical,1,3)||' uci'; output; 
 proc sort data=forplot; by chemical dose;  
 proc gplot data=forplot; 
     plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1  
      vaxis = 0 to 1 by 0.1 grid nolegend; 
 /* Chemicals in the footnote statement should be in alphabetical order, 
and the order of colors should match that given in the symbol statements which 
follow*/ 
  /*footnote c=black 'Chemical:  ' c=blue '  CIN  ' c=red now black'  CRV  ' 
c=big now vpar '  EUG  ' c=orange '  RHO  ';*/ 
     label  prob=Probability; 
  symbol1 v=circle color=blue i=none; 
  symbol2 v=none color=blue i=join line=2; 
  symbol3 v=none color=blue i=join line=1; 
  symbol4 v=none color=blue i=join line=2; 
     symbol5 v=x color=black i=none; 
  symbol6 v=none color=black i=join line=2; 
  symbol7 v=none color=black i=join line=1; 
  symbol8 v=none color=black i=join line=2; 
  symbol9 v=triangle color=vpar i=none; 
  symbol10 v=none color=vpar i=join line=2; 
  symbol11 v=none color=vpar i=join line=1; 
  symbol12 v=none color=vpar i=join line=2; 
  symbol13 v=square color=orange i=none; 
  symbol14 v=none color=orange i=join line=2; 
  symbol15 v=none color=orange i=join line=1; 
  symbol16 v=none color=orange i=join line=2; 
   
 run; quit; run; footnote; 
 
 
SAS program to compare the effectiveness of essential oil components 
tested against L. monocytogenes using macrodilution method 
 
/* This SAS program generates SAS Probit models (probability of lethality) to 
compare the effectiveness of essential oil components tested against L. 
monocytogenes using macrodilution method (glass tubes)*/ 
 
data multi; 
      input stock $ chemical $ Dose Response N;  
      dose=log10(dose); label dose=Log10(Dose) ppm; 
   datalines; 
Jun20 CRV 3200 4 4 
Jun20 CRV 3000 4 4 
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Jun20 CRV 2800 4 4 
Jun20 CRV 2600 4 4 
Jun20 CIN 1200 4 4 
Jun20 CIN 1000 4 4 
Jun20 CIN 800 4 4 
Jun20 CIN 600 4 4 
*rest of data not included in appendix; 
; 
   proc sort; by chemical dose; 
   symbol v=dot color=blue; 
 
   * For each chemical, test for a stock effect; 
   goptions ftext='Arial/bold' htext=12pt; 
   proc probit order=internal data=multi; by chemical; 
      class stock; 
      Stock: model Response/N=  Dose stock / inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder; 
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder;  
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical dose Response N; 
 
    * For each chemical, analyze summarized data; 
 
   proc probit order=internal data=multisum; by chemical; 
      Overall: model Response/N=  Dose / lackfit aggregate inversecl; 
      predpplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.5 to 3.7 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2.5 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); 
    
   proc probit order=internal data=multisum; 
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      class chemical; 
      Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate 
noint inversecl; 
   run; 
   data fill; input chemical $; 
       do dose = 2.4 to 3.8 by 0.025; 
        output; 
       end; 
   datalines; 
CIN 
CRV 
EUG 
LNO 
RHO 
   data new; set multisum fill; 
   proc sort data=new; by chemical dose; 
   proc genmod order=internal data=new; 
      class chemical; 
   output out=stats l=lower p=prob u=upper; 
   model Response/N = chemical chemical*Dose / noint dist=binomial 
link=probit type3 wald; 
   run; 
 
 data forplot; length chemical $ 8; set stats; 
     p = Response/N; 
     if p = 0 then prob = 0; 
  else if p = 1 then prob = 1; 
  else if 0 < p < 1 then prob = p; 
  if p ne . then do; output; return; end; 
  chemical=substr(chemical,1,3)||' prd'; output; 
  prob=lower; chemical=substr(chemical,1,3)||' lci'; output; 
  prob=upper; chemical=substr(chemical,1,3)||' uci'; output; 
 proc sort data=forplot; by chemical dose; 
 proc gplot data=forplot; legend1; 
     plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1  
      vaxis = 0 to 1 by 0.1 grid nolegend;  
 /* Chemicals in the footnote statement should be in alphabetical order, 
and the order of colors should match that given in the symbol statements which 
follow*/ 
  /*footnote c=black 'Chemical:  ' c=blue '  CIN  ' c=red now black'  CRV  ' 
c=big now vpar '  EUG  ' c=orange '  RHO  ';*/ 
     label prob=Probability; 
  symbol1 v=circle color=blue i=none; 
  symbol2 v=none color=blue i=join line=2; 
  symbol3 v=none color=blue i=join line=1; 
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  symbol4 v=none color=blue i=join line=2; 
     symbol5 v=x color=black ci=black cv=black i=none; 
  symbol6 v=none color=black i=join line=2; 
  symbol7 v=none color=black i=join line=1; 
  symbol8 v=none color=black i=join line=2; 
  symbol9 v=triangle color=vpar cv=vpar i=none; 
  symbol10 v=none color=vpar i=join line=2; 
  symbol11 v=none color=vpar i=join line=1; 
  symbol12 v=none color=vpar i=join line=2; 
  symbol13 v=dot color=lime cv=lime i=none; 
  symbol14 v=none color=lime i=join line=2; 
  symbol15 v=none color=lime i=join line=1; 
  symbol16 v=none color=lime i=join line=2; 
  symbol17 v=square color=orange cv=orange i=none; 
  symbol18 v=none color=orange i=join line=2; 
  symbol19 v=none color=orange i=join line=1; 
  symbol20 v=none color=orange i=join line=2; 
   
 run; quit; run; footnote; 
 
 
SAS program to compare the macrodilution and microdilution methods 
within a component against L. monocytogenes 
 
/* This SAS program compares the macrodilution and microdilution methods 
within a component, against L. monocytogenes */ 
 
data lmtubes; 
      input stock $ chemical $ Dose Response N; 
      method='tubes';  
      dose=log10(dose); label dose=log10(dose); 
   org='lm'; 
   datalines; 
Jun20 CRV 3200 4 4 
Jun20 CRV 3000 4 4 
Jun20 CRV 2800 4 4 
Jun20 CRV 2600 4 4 
Jun20 CIN 1200 4 4 
Jun20 CIN 1000 4 4 
Jun20 CIN 800 4 4 
Jun20 CIN 600 4 4 
*rest of data not included in appendix; 
; 
goptions ftext='Arial/bold' htext=12pt; 
data lmmicro; 
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      input stock $ chemical $ Dose Response N; 
      method='micro';  
      dose=log10(dose); label dose=log10(dose); 
   datalines; 
Oct23 LNO 2800 0 4 
Oct23 LNO 2400 0 4 
Oct23 LNO 2000 0 4 
Oct23 LNO 1600 0 4 
Oct23 LNO 1200 0 4 
Oct24 LNO 2800 0 4 
Oct24 LNO 2400 0 4 
Oct24 LNO 2000 0 4 
Oct24 LNO 1600 0 4 
Oct24 LNO 1200 0 4 
*rest of data not included in appendix; 
; 
data multi; set lmtubes lmmicro; 
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical method dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical method dose Response N; 
 
    * For each chemical, analyze summarized data; 
 
   proc probit order=internal data=multisum; by chemical; 
      class method; 
      Overall: model Response/N=  Dose method / lackfit aggregate inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.95 vreflabels=('Probability=0.95'); 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.25 vreflabels=('Probability=0.25'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); 
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   proc probit order=internal data=multisum; 
      class chemical method; 
      Chemical: model Response/N = chemical method chemical*method  
chemical*Dose 
      method*Dose / lackfit aggregate inversecl; 
   where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or 
chemical eq 'RHO'; 
   run; 
 
 
SAS program to compare the effectiveness of essential oil components 
tested against S. Typhimurium using microdilution method 
 
/* This SAS program generates SAS Probit models (probability of lethality) to 
compare the effectiveness of essential oil components tested against S. 
Typhimurium using microdilution method (microtiter plates)*/ 
 
data multi; 
      input stock $ chemical $ Dose Response N;  
      dose=log10(dose); label dose=Log10(Dose) ppm; 
   datalines; 
Nov17 CRV 1600 2 2 
Nov17 CRV 1400 2 2 
Nov17 CRV 1200 0 2 
Nov17 CRV 1000 0 2 
Nov17 CRV 800 0 4 
Nov17 CIN 800 2 2 
Nov17 CIN 600 2 2 
Nov17 CIN 400 2 2 
Nov17 CIN 200 0 4 
*rest of data not included in appendix; 
; 
goptions ftext='Arial/bold' htext=12pt; 
   proc sort; by chemical dose; 
   symbol v=dot color=blue; 
 
   * For each chemical, test for a stock effect; 
 
   proc probit order=internal data=multi; by chemical; 
      class stock; 
      Stock: model Response/N=  Dose stock / inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1 
cframe=ligr inborder; 
   ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr 
inborder;  
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 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical dose Response N; 
 
    * For each chemical, analyze summarized data; 
 
   proc probit order=internal data=multisum; by chemical; 
      Overall: model Response/N=  Dose / lackfit aggregate inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1 
cframe=ligr inborder 
          vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.2 to 3.7 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2.2 to 3.7 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); 
    
   proc probit order=internal data=multisum; 
      class chemical; 
      Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate 
noint inversecl; 
   run; 
   data fill; input chemical $; 
       do dose = 2.2 to 3.7 by 0.025; 
        output; 
       end; 
   datalines; 
CIN 
CRV 
EUG 
LNO 
RHO 
   data new; set multisum fill; 
   proc sort data=new; by chemical dose; 
   proc genmod order=internal data=new; 
      class chemical; 
   output out=stats l=lower p=prob u=upper; 
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   model Response/N = chemical chemical*Dose / noint dist=binomial 
link=probit type3 wald; 
   run; 
 
 data forplot; length chemical $ 8; set stats; 
     p = Response/N; 
     if p = 0 then prob = 0; 
  else if p = 1 then prob = 1; 
  else if 0 < p < 1 then prob = p; 
  if p ne . then do; output; return; end; 
     chemical=substr(chemical,1,3)||' prd'; output; 
  prob=lower; chemical=substr(chemical,1,3)||' lci'; output; 
  prob=upper; chemical=substr(chemical,1,3)||' uci'; output; 
 proc sort data=forplot; by chemical dose; 
   proc gplot data=forplot; 
     plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1  
      vaxis = 0 to 1 by 0.1 grid nolegend; 
 /* Chemicals in the footnote statement should be in alphabetical order, 
and the order of colors should match that given in the symbol statements which 
follow*/ 
  /*footnote c=black 'Chemical:  ' c=blue '  CIN  ' c=red now black'  CRV  ' 
c=big now vpar '  EUG  ' c=orange '  RHO  ';*/ 
     label  prob=Probability; 
  symbol1 v=circle color=blue i=none; 
  symbol2 v=none color=blue  i=join line=2; 
  symbol3 v=none color=blue i=join line=1; 
  symbol4 v=none color=blue i=join line=2; 
     symbol5 v=x color=black i=none; 
  symbol6 v=none color=black i=join line=2; 
  symbol7 v=none color=black i=join line=1; 
  symbol8 v=none color=black i=join line=2; 
  symbol9 v=triangle color=vpar i=none; 
  symbol10 v=none color=vpar i=join line=2; 
  symbol11 v=none color=vpar i=join line=1; 
  symbol12 v=none color=vpar i=join line=2; 
  symbol13 v=dot color=lime i=none; 
  symbol14 v=none color=lime i=join line=2; 
  symbol15 v=none color=lime i=join line=1; 
  symbol16 v=none color=lime i=join line=2; 
  symbol17 v=square color=orange i=none; 
  symbol18 v=none color=orange i=join line=2; 
  symbol19 v=none color=orange i=join line=1; 
  symbol20 v=none color=orange i=join line=2; 
   
 run; quit; run; footnote; 
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SAS program to compare the effectiveness of essential oil components 
tested against S. Typhimurium using macrodilution method 
 
/* This SAS program generates SAS Probit models (probability of lethality) to 
compare the effectiveness of essential oil components tested against S. 
Typhimurium using macrodilution method (glass tubes) and includes contrasts 
that were from the results of the dissertation*/ 
 
data multi; 
      input stock $ chemical $ Dose Response N;  
      dose=log10(dose); label dose=Log10(Dose) ppm; 
   datalines; 
Mar16 CRV 1600 4 4 
Mar16 CRV 1400 3 4 
Mar16 CRV 1200 1 4 
Mar16 CRV 1000 0 4 
Mar16 CRV  800 0 4 
Mar16 CIN  400 4 4 
Mar16 CIN  200 0 4 
*rest of data not included in appendix; 
; 
  goptions ftext='Arial/bold' htext=12pt; 
   proc sort; by chemical dose; 
   symbol v=dot color=blue; 
 
   * For each chemical, test for a stock effect; 
 
   proc probit order=internal data=multi; by chemical; 
      class stock; 
      Stock: model Response/N=  Dose stock / inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1 
cframe=ligr inborder; 
   ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr 
inborder; run; 
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical dose Response N; 
 
    * For each chemical, analyze summarized data; 
  goptions ftext='Arial/bold' htext=12pt; 
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   proc probit order=internal data=multisum; by chemical; 
      Overall: model Response/N=  Dose / lackfit aggregate inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1 
cframe=ligr inborder 
          vref(intersect)=(0.25,0.95) vreflabels=('Probability=0.25' 'Probability=0.95'); 
   lpredplot var=dose level=('None') cfit=red haxis=2 to 3.4 by .1 cframe=ligr 
inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2 to 3.4 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); run; 
    
   proc probit order=internal data=multisum; 
      class chemical; 
      Chemical: model Response/N = chemical chemical*Dose / lackfit aggregate 
noint inversecl; 
   run; 
   data fill; input chemical $; 
       do dose = 2 to 3.4 by 0.025; 
        output; 
       end; 
   datalines; 
CIN 
CRV 
EUG 
LNO 
   data new; set multisum fill; 
   proc sort data=new; by chemical dose; 
   proc genmod order=internal data=new; 
      class chemical; 
   output out=stats l=lower p=prob u=upper; 
   model Response/N = chemical chemical*Dose / noint dist=binomial 
link=probit type3 wald; 
   contrast 'CIN vs. CRV int' chemical 1 -1 0 0 / wald; 
   contrast 'CRV vs. EUG int' chemical 0 1 -1 0 / wald; 
   contrast 'EUG vs. LNO int' chemical 0 0 1 -1 / wald; 
   contrast 'CIN vs. LNO int' chemical 1 0 0 -1 / wald; 
   contrast 'CRV vs. LNO int' chemical 0 1 0 -1 / wald; 
   contrast 'CIN vs. avg CRV-LNO int' chemical 1 -0.5 0 -0.5  / wald; 
   contrast 'CIN vs. avg CRV-LNO slope' chemical*Dose 1 -0.5 0 -0.5  / 
wald; 
   contrast 'CIN vs. CRV slope' chemical*Dose 1 -1 0 0 / wald; 
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   contrast 'CRV vs. EUG slope' chemical*Dose 0 1 -1 0 / wald; 
   contrast 'EUG vs. LNO slope' chemical*Dose 0 0 1 -1  / wald; 
     contrast 'CIN vs. LNO slope' chemical*Dose 1 0 0 -1 / wald; 
   contrast 'CRV vs. LNO slope' chemical*Dose 0 1 0 -1 / wald; 
   estimate 'CIN vs. CRV int' chemical 1 -1 0 0; 
   estimate 'CRV vs. EUG int' chemical 0 1 -1 0; 
   estimate 'EUG vs. LNO int' chemical 0 0 1 -1; 
   estimate 'CIN vs. CRV slope' chemical*Dose 1 -1 0 0; 
   estimate 'CRV vs. EUG slope' chemical*Dose 0 1 -1 0; 
   estimate 'EUG vs. LNO slope' chemical*Dose 0 0 1 -1; 
   estimate 'CRV vs. LNO int' chemical 0 1 0 -1; 
   estimate 'CRV vs. LNO slope' chemical*dose 0 1 0 -1; 
   contrast 'CIN vs. CRV int/slope' chemical 1 -1 0 0, chemical*dose 1 -1 0 
0 / wald; 
      contrast 'CIN vs. LNO int/slope' chemical 1 0 0 -1, chemical*dose 1 0 0 -1 / 
wald; 
   contrast 'CRV vs. LNO int/slope' chemical 0 1 0 -1, chemical*dose 0 1 0 -
1 / wald; 
   contrast 'CIN vs. avg CRV-LNO int/slope' chemical 1 -0.5 0 -0.5, 
chemical*Dose 1 -0.5 0 -0.5  / wald; 
   run; 
 
 data forplot; length chemical $ 8; set stats; 
     p = Response/N; 
     if p = 0 then prob = 0; 
  else if p = 1 then prob = 1; 
  else if 0 < p < 1 then prob = p; 
  if p ne . then do; output; return; end; 
     chemical=substr(chemical,1,3)||' prd'; output; 
  prob=lower; chemical=substr(chemical,1,3)||' lci'; output; 
  prob=upper; chemical=substr(chemical,1,3)||' uci'; output; 
 proc sort data=forplot; by chemical dose; 
  proc gplot data=forplot; 
     plot prob*dose=chemical / haxis = 2.2 to 3.6 by 0.1  
      vaxis = 0 to 1 by 0.1 grid nolegend; 
 /* Chemicals in the footnote statement should be in alphabetical order, 
and the order of colors should match that given in the symbol statements which 
follow*/ 
  /*footnote c=black 'Chemical:  ' c=blue '  CIN  ' c=red now black'  CRV  ' 
c=big now vpar '  EUG  ' c=orange '  RHO  ';*/ 
      label  prob=Probability; 
  symbol1 v=circle color=blue i=none; 
  symbol2 v=none color=blue i=join line=2; 
  symbol3 v=none color=blue i=join line=1; 
  symbol4 v=none color=blue i=join line=2; 
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     symbol5 v=x color=black i=none; 
  symbol6 v=none color=black i=join line=2; 
  symbol7 v=none color=black i=join line=1; 
  symbol8 v=none color=black i=join line=2; 
  symbol9 v=triangle color=vpar i=none; 
  symbol10 v=none color=vpar i=join line=2; 
  symbol11 v=none color=vpar i=join line=1; 
  symbol12 v=none color=vpar i=join line=2; 
  symbol13 v=dot color=lime i=none; 
  symbol14 v=none color=lime i=join line=2; 
  symbol15 v=none color=lime i=join line=1; 
  symbol16 v=none color=lime i=join line=2; 
   
 run; quit; run; footnote; 
 
 
SAS program to compare the macrodilution and microdilution methods 
within a component against S. Typhimurium 
 
/* This SAS program compares the macrodilution and microdilution methods 
within a component, against S. Typhimurium */ 
 
data sttubes; 
      input stock $ chemical $ Dose Response N; 
      method='tubes';  
      dose=log10(dose); label dose=log10(dose); 
   org='st'; 
   datalines; 
Dec9 RHO 1800 0 5 
Dec9 RHO 1600 0 5 
Dec9 RHO 1400 0 5 
Dec9 RHO 1200 0 5 
Jan22 RHO 1400 0 3 
Jan22 RHO 1000 0 3 
Feb8 RHO 1800 0 3 
Feb8 RHO 1600 0 3 
Feb13 RHO 2800 0 3 
Feb13 RHO 2000 0 3 
*rest of data not included in appendix; 
; 
 goptions ftext='Arial/bold' htext=12pt; 
data stmicro; 
      input stock $ chemical $ Dose Response N; 
      method='micro';  
      dose=log10(dose); label dose=log10(dose); 
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   datalines; 
Nov17 CRV 1600 2 2 
Nov17 CRV 1400 2 2 
Nov17 CRV 1200 0 2 
Nov17 CRV 1000 0 2 
Nov17 CRV 800 0 4 
Nov17 CIN 800 2 2 
Nov17 CIN 600 2 2 
Nov17 CIN 400 2 2 
Nov17 CIN 200 0 4 
*rest of data not included in appendix; 
; 
data multi; set sttubes stmicro; 
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical method dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical method dose Response N; 
 
    * For each chemical, analyze summarized data; 
 
   proc probit order=internal data=multisum; by chemical; 
      class method; 
      Overall: model Response/N=  Dose method / lackfit aggregate inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.95 vreflabels=('Probability=0.95'); 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.25 vreflabels=('Probability=0.25'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); 
    
   proc probit order=internal data=multisum; 
      class chemical method; 
      Chemical: model Response/N = chemical method chemical*method  
chemical*Dose 
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      method*Dose / lackfit aggregate inversecl; 
   where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or 
chemical eq 'LNO'; 
   run; 
 
 
SAS program to compare the concentrations of components needed to be 
lethal against S. Typhimurium and L. monocytogenes 
 
/* This SAS program compares the concentrations of components needed to be 
lethal against S. Typhimurium and L. monocytogenes within the macrodilution 
method */ 
 
data lmtubes; 
      input stock $ chemical $ Dose Response N; 
      method='tubes';  
      dose=log10(dose); label dose=log10(dose); 
   org='LM'; 
   datalines; 
Jun20 CRV 3200 4 4 
Jun20 CRV 3000 4 4 
Jun20 CRV 2800 4 4 
Jun20 CRV 2600 4 4 
Jun20 CIN 1200 4 4 
Jun20 CIN 1000 4 4 
Jun20 CIN 800 4 4 
Jun20 CIN 600 4 4 
*rest of data not included in appendix; 
; 
goptions ftext='Arial/bold' htext=12pt; 
data sttubes; 
      input stock $ chemical $ Dose Response N; 
      method='tubes';  
      dose=log10(dose); label dose=log10(dose); 
   org='ST'; 
   datalines; 
Mar16 CRV 1600 4 4 
Mar16 CRV 1400 3 4 
Mar16 CRV 1200 1 4 
Mar16 CRV 1000 0 4 
Mar16 CRV  800 0 4 
Mar16 CIN  400 4 4 
Mar16 CIN  200 0 4 
*rest of data not included in appendix; 
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; 
data multi; set lmtubes sttubes; 
 
 * Summarize data across stocks; 
 
   proc summary nway data=multi; class chemical org dose; var Response N; 
       output out=multisum sum=; 
   proc print data=multisum; var chemical org dose Response N; 
 
    * For each chemical, analyze summarized data; 
 
   proc probit order=internal data=multisum; by chemical; 
      class org; 
      Overall: model Response/N=  Dose org / lackfit aggregate inversecl; 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.95 vreflabels=('Probability=0.95'); 
   predpplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vref(intersect)=0.25 vreflabels=('Probability=0.25'); 
   lpredplot var=dose level=('None') cfit=red haxis=2.4 to 3.8 by .1 
cframe=ligr inborder 
          vaxis = -15 to 5 by 5; 
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.95 hreflabels=('Probability=0.95');  
   ippplot var=dose level=('None') cfit=red vaxis=2.4 to 3.8 by .1 cframe=ligr 
inborder 
          href(intersect)=0.25 hreflabels=('Probability=0.25'); 
    
   proc probit order=internal data=multisum; 
      class chemical org; 
      Chemical: model Response/N = chemical org chemical*org  chemical*Dose 
      org*Dose / lackfit aggregate inversecl; 
   where chemical eq 'CIN' or chemical eq 'CRV' or chemical eq 'EUG' or 
chemical eq 'RHO'; 
   run; 
 
 
SAS program to compare the differences in biomass and fatty acids among 
CIN-treatment and control groups within 2h or 24h for S. Typhimurium 
 
/* This SAS program compares the differences in biomass and fatty acids among 
CIN-treatment and control groups within 2h or 24h for S. Typhimurium.  Arnold 
Saxton’s mmaov macro analyzed the imported 2h or 24h CIN data set using 
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Randomized Block Design with blocking on each replicate.  The first %mmaov 
compares biomass among groups, averaging 2h and 24h together.  Also includes 
comparing % fatty acids within a group and within 2h or 24h.  Raw data not 
included in appendix. */ 
 
PROC IMPORT OUT= WORK.CIN  
            DATAFILE= "C:\Documents and Settings\Valerie Ling \My 
Documents\Val's Research\Results\CINLipids\CINData.xls"  
            DBMS=EXCEL2000 REPLACE; 
     SHEET="Sheet1$";  
     GETNAMES=YES; 
RUN; 
%include 'c:\mmaov.sas'; 
%mmaov(cin,bio,class=block treat hour,fixed=treat hour(treat), random=block); 
run;  
data cin2; set cin; if hour eq 2; 
data cin24; set cin; if hour eq 24; 
%include 'c:\mmaov.sas'; 
%mmaov(cin2,bio,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,bio,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c12_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c12_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c14_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c14_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c15_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c15_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c16_1w7c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c16_1w7c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c16_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c16_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,cy17_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,cy17_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c17_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c17_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c18_1w9c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c18_1w9c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c18_1w7c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c18_1w7c,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c18_1w7t,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c18_1w7t,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,c18_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,c18_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,cy19_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,cy19_0,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,nsats,class=block treat,fixed=treat,random=block); run; 
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%mmaov(cin24,nsats,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,monos,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,monos,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,cy17to16,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,cy17to16,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,cy19to18,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,cy19to18,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin2,satunsat,class=block treat,fixed=treat,random=block); run; 
%mmaov(cin24,satunsat,class=block treat,fixed=treat,random=block); run; 
 
proc sort data=cin; by treat hour block; 
proc transpose data=cin out=cinout; by treat hour block; var c12_0--cy19_0; 
proc sort data=cinout; by treat hour block descending col1; run; 
proc anova; by treat hour; class _name_; model col1=_name_;  
means _name_ / tukey lines; run; quit; run; 
 
 
SAS program to compare the differences in biomass and fatty acids 
between the 2 or 24h data within a CIN-treatment or control group for S. 
Typhimurium 
 
/* This SAS program compares the differences in biomass and fatty acids 
between the 2 or 24h data within a CIN-treatment or control group for S. 
Typhimurium. */ 
 
PROC IMPORT OUT= WORK.CIN  
            DATAFILE= "C:\Documents and Settings\Valerie Ling \My Documen 
ts\Val's Research\Results\CINLipids\CINData.xls"  
            DBMS=EXCEL2000 REPLACE; 
     SHEET="Sheet1$";  
     GETNAMES=YES; 
RUN; 
 
*test for interaction term, where is the interaction? Use Bonferonni correction.  
This is alpha .10 divided by 6 follow-up tests used to test interaction between 
hour and treatment i.e. each pair - treat 1 at 2h vs 24h.  .1/6 = 0.017 new alpha 
with B. correction to minimize Type I error, which increases with # of tests.  We 
can be sure that the differences we find are true and not due to chance.'; 
 proc sort data=cin; by treat;run; 
 proc glm data=cin; 
 by treat; 
 class hour; 
 model bio=hour; 
 means hour; lsmeans hour; 
 run; quit; 
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proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c12_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c14_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c15_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c16_1w7c=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c16_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model cy17_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
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 class hour; 
 model c17_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c18_1w9c=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c18_1w7c=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c18_1w7t=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model c18_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model cy19_0=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model nsats=hour; 
 means hour; lsmeans hour; 
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 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model monos=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model cy17to16=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model cy19to18=hour; 
 means hour; lsmeans hour; 
 run; quit; 
proc sort data=cin; by treat;run; 
proc glm data=cin; 
 by treat; 
 class hour; 
 model satunsat=hour; 
 means hour; lsmeans hour; 
 run; quit; 
 
 
/* To run the same SAS programs for CRV, import the CRV data file and use 
“Find and Replace” under the “Edit” menu to find “CIN” and replace with “CRV”  */ 
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